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Abstract. 
 
Top-down (TD) mass spectrometry (MS) is a protein structural analysis technique consisting in mass 
determination of intact proteins followed by their gas-phase fragmentation and mass analysis of structure-
specific product ions. Applied to large scale studies, i.e., proteomics, this is the only approach that can 
provide identification of proteoforms, i.e., genetic products with specific chemical or genetic 
modifications. From this comes the great impulse to advance TD MS. High instrumental requirements in 
terms of mass accuracy, mass resolution and signal-to-noise ratio, in addition to difficulties in achieving 
efficient fragmentation of intact proteins and interpreting the resulting convoluted tandem MS (MS/MS) 
spectra have so far limited TD MS analysis primarily to small, ~20 kDa, proteins. The present work 
represents the attempt to structurally investigate progressively more complex peptides, proteins, and their 
mixtures, finally reaching detailed characterization of intact monoclonal antibodies. These, also known as 
immunoglobulins G (IgGs), are ~150 kDa homoheterodimers composed of two identical light (~25 kDa) 
and two identical heavy  (~50 kDa) chains. We first examined the potential of the state-of-the-art radical-
driven MS/MS techniques, namely electron capture dissociation (ECD) and electron transfer dissociation 
(ETD), as well as of high mass accuracy and resolution measurements at the peptide level. Particularly, 
ECD demonstrated its utility in combination with Fourier transform MS (FTMS) to decipher the 
sophisticated pool of modified products derived from the catalytic activity of the enzyme tissue 
transglutaminase on its peptidic substrate. High mass accuracy was also at the base of an elegant label-free 
quantitation approach applied to the analysis of glycopeptides derived from stably and transiently 
produced IgGs. Afterwards, an ETD-based top-down MS investigation of proteins from 30 kDa (carbonic 
anhydrase) to ~79 kDa (serotransferrin) was performed. For the first time a protein of this size was 
characterized with ETD MS/MS. The capability of this ion activation technique to cleave disulfide bridges 
was confirmed for large proteins, after having being reported for peptides and smaller proteins. Finally, 
top-down analysis of monoclonal IgGs was accomplished using two distinct high-resolution, ETD-enabled 
MS platforms, equipped with either time-of-flight (TOF) or Orbitrap mass analyzers. Remarkably, 
proteins of this size have been previously analyzed in a top-down fashion only in ion cyclotron resonance 
mass analyzers. ETD led to reach up to 32% sequence coverage for an immunoglobulin G1, and several 
IgGs belonging to different organisms or subclasses were analyzed. Notably, we also identified some 
conformational and structural constrains that are at the base of the specific fragmentation patterns 
observed for the IgGs. The sequence coverage of IgGs was then improved by the application of a 
dedicated middle-down MS approach, taking advantage of a robust and quick novel proteolytic protocol, 
and of all the technical advances developed for TD MS, including fine-tuning of ETD parameters, product 
ion transmission, and data analysis. The demonstration of capabilities of TOF and Orbitrap mass analyzers 
for TD MS of large proteins has opened the new horizons for development and application of the top-
down approach. Particularly, the achieved results should be useful to advance in the near future the 
possibility of studying immunoglobulin mixtures from different biological sources in a proteomic fashion, 
potentially improving the efficiency of the drug discovery process. 
 
Keywords: mass spectrometry, MS; tandem mass spectrometry, MS/MS; top-down MS, TD MS; middle-
down MS, MD MS; electron capture dissociation, ECD; electron transfer dissociation, ETD; time-of-
flight, TOF; Fourier transform mass spectrometry, FTMS; Orbitrap; ion cyclotron resonance, ICR; 
protein; peptide; monoclonal antibody, mAb; immunoglobulin G, IgG; proteolysis. 
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Abstract in italiano. 
 
La spettrometria di massa (MS) top-down (TD) è una technica consistente nella determinazione della 
massa di proteine intatte seguita dalla loro frammentazione in fase gassosa e analisi di massa di ioni 
frammento struttura-specifici. Applicato a studi su ampia scala, ossia proteomica, questo è l’unico 
approccio che puó fornire l’identificazione di proteoforme, ovvero prodotti genici con specifiche 
modifiche chimiche o genetiche. Da ció deriva il grande impulso per migliorare la TD MS. Elevati 
requisiti strumentali in termini di accuratezza di massa, risoluzione di massa e rapporto segnale-rumore, in 
aggiunta a difficoltà nell’ottenere una frammentazione efficiente di proteine intere e nell’interpretazione 
dei complessi spettri di MS tandem (MS/MS) risultanti hanno finora limitato l’analisi TD MS 
prevalentemente a proteine piccole, di ~20 kDa. Il presente lavoro rappresenta il tentativo di investigare 
strutturalmente peptidi e proteine progressivamente piú complessi, fino a giungere alla caratterizzazione 
dettagliata di anticorpi monoclonali interi. Questi, anche noti come immunoglobuline G (IgG), sono 
omoeterodimeri composti di due identiche catene leggere (~25 kDa)e due identiche pesanti (~50 kDa). 
Pertanto, abbiamo da prima esaminato il potenziale dello stato dell’arte di tecniche MS tandem guidate da 
radicali, ovvero la dissociazione per cattura elettronica (ECD) e la dissociazione per trasferimento 
elettronico (ETD), nonchè di misure ad alta accuratezza di massa e risoluzione al livello dei peptidi. 
Specificamente, l’ECD ha dimostrato la sua utilità in combinazione con la spettrometria di mass a 
trasformata di Fourier (FTMS) nel decifrare il sofisticato gruppo di prodotti modificati derivati dall’azione 
catalitica dell’enzima transglutaminasi tissutale sul suo substrato peptidico. L’alta accuratezza di massa è 
stata invece alla base di un elegante approccio di quantificazione label-free applicato all’analisi di 
glicopeptidi  derivati da IgG. Di seguito è stata svolta un’investigazione top-down MS basata su ETD di 
proteine da 30 kDa (anidrasi carbonica) ai ~79 kDa della serotransferrina. Per la prima volta una proteina 
di queste dimensioni è stata caratterizzata tramite ETD, e in questa occasione è stata provata in modo 
definitivo la capacità di questa tecnicadi attivazione ionica, prima riportata per peptidi corti,  di rompere 
ponti disolfuro. Infine, l’analisi top-down di IgG monoclonali è stata compiuta usando due distinte 
piattaforme MS ad alta risoluzione e con funzione ETD, equipaggiate o con analizzatore di massa a tempo 
di volo od Orbitrap. E’ da sottolineare che proteine di queste dimensioni erano state in precedenza 
analizzate in top-down solo attraverso analizzatori di massa a risonanza ionica ciclotronica. L’ETD ha 
portato a raggiungere fino al 32% di copertura di sequenza per un’immunoglobulina G1, e diverse IgG 
appartenenti a diversi organismi o sottoclassi sono state analizzate. Da segnalare come siano stati anche 
evidenziate alcune limitazioni conformazionali e strutturali alla base del peculiare pattern di 
frammentazione che si osserva per le IgG. In seguito la copertura di sequenza delle IgG è stata estesa 
grazie all’adozione di un un approccio middle-down dedicato, che si avvantaggia di un robusto e veloce 
protocollo di proteolisi, e degli avanzamenti tecnici sviluppati per la TD MS, includenti l’ottimizzazione 
fine dei parametri di ETD, trasmissione degli ioni prodotto e analisi dei dati. La dimostrazione delle 
capacità di analizzatori di massa TOF e Orbitrap per TD MS di grandi proteine ha aperto nuovi orizzonti 
per lo sviluppo e l’applicazione dell’approccio top-down. In particolare, i risultati raggiunti dovrebbero 
essere utili ad aprire nel futuro prossimo la possibilità di studiare mix di immunoglobuline provenienti da 
differenti fonti biologiche in uno stile proteomico, migliorando potenzialmente l’efficienza del processo di 
scoperta di farmaci. 
Parole chiave: spettrometria di massa, MS; spettrometria di massa tandem, MS/MS; top-down MS, TD 
MS; middle-down MS, MD MS; dissociazione per cattura elettronica, ECD; dissociazione per 
trasferimento elettronico, ETD; tempo di volo, TOF; spettrometria di massa a trasformata di Fourier, 
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FTMS; Orbitrap; risonanza ionica ciclotronica, ICR; proteina; peptide; anticorpo monoclonale, mAb; 
immunoglobulina G, IgG; proteolisi. 
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The term "intelligent design" (ID) was introduced in its modern acceptation in 1987 by the 
Supreme Court of the United States, which sentenced that the teaching of this specific form of 
creationism is unconstitutional in American public schools. Although absolutely anti-scientific, 
ID has the merit of efficaciously illustrating the high complexity of biological systems that 
scientists have to investigate. The ID movement tried indeed to give explanation of this 
complexity as the necessary product of a superior mind (possibly, of God). Scientists, to whom 
this Thesis is addressed and will probably not be interested in discussing theological topics, will 
be convinced of the absolute level of sophistication reached by cells of superior organisms by 
numbers: in April 2003, with the completion of the sequencing of human genome, the Human 
Genome Project officially declared that ~20'500 genes are encoded in our DNA.[1] Genes are 
not, though, the effectors in molecular mechanisms governing cells. These are represented by 
gene products known as proteins.[2] From the chemical point of view, proteins are large 
polymers of amino acids, whose structure is differentiated by the so-called side chain. Although 
amino acid could exist in a variety of different stereo configurations and could potentially carry 
any chemical group at the side chain, insomuch that more than 500 have been classified so far, 
only 22 of these molecules are known as proteinogenic amino acids (i.e., effective building 
blocks of proteins), 21 of which are encoded in eukaryotes whilst only 20 are directly encoded by 
the genes. Each amino acid is represented in the DNA by a codon, which is a sequence of three 
nucleotides.[3] The molecular steps required in a cell for gene expression are essentially two 
(Figure 1.1): transcription and translation. During transcription, the double-stranded DNA helix 
is temporarily opened so that one of the strands is accessible to the molecular machinery 
responsible for the synthesis of a molecule of RNA, named messenger RNA or mRNA, 
complementary to the DNA filament used as template. The central enzyme involved in this 
process is the RNA polymerase, which copies with high fidelity the gene for its whole length, 
including both non-coding DNA regions, or introns, as well as coding ones, or exons. The 
product of RNA polymerase catalytic activity is a pre-mRNA which has to undergo maturation, a 
multistep process including splicing, which serves to remove introns and leave in the RNA 
uniquely the coding portion of the gene sequence.[4] 
After maturation, the codons present in mRNAs are converted by ribosomes, large ribonucleic 
protein assemblies, into specific sequences of amino acids. 
14 
 
 
 
Figure 1.1. Gene expression pathway. Several processes are required for passing from DNA, 
protein blueprint, to the final proteoform. Modifications to the gene product can occur either at 
the DNA level or as post-transcriptional events. 
Described in these terms, the complexity of genes and their products would seem identical. This 
assumption was also at the base of the famous hypothesis, formulated in 1941 by Beadle and 
Tatum, known as “one gene – one protein”. The two scientists speculated that each step in a 
metabolic pathway had to be regulated by an enzyme codified by a specific gene. Implicit in this 
hypothesis was the concept that one gene could produce only a single enzyme. The inaccuracy of 
Beadle and Tatum’s hypothesis, though, became rapidly apparent. Currently, the consensus view 
states that a single gene encoding for a polypeptide can produce more than a product. Variation 
sources are classified, according to IUPAC, at two different levels: DNA mutation and post-
15 
 
transcriptional events. The former level includes genetic variations as polymorphisms (e.g., single 
nucleotide polymorphism, SNP), which can induce the substitution of the original codon with a 
different one, possibly encoding for a different amino acid or causing protein truncation (as 
specific sequences of three nucleotides, called stop-codons, determine the termination of 
polypeptide synthesis). The latter is a more heterogeneous class of modifications, comprising 
alternative mRNA splicing events as well as chemical modifications (which can be induced by 
enzymes or chemical agents) called post-translational modifications (PTMs). Gene products 
subjected to the first class of modifications are named isoforms, whereas they are referred to as 
protein species when including modifications of the second kind. With a newly introduced 
terminology, each combination of modifications on a gene product, independently from the origin 
of the modifications themselves, can be classified generally as a proteoform.[5] 
The importance of proteoforms can be deduced taking into consideration, for instance, that 
mutations in protein sequence are often responsible for abnormal folding (i.e., the process 
through which the protein reaches its three-dimensional conformation) and are therefore 
implicated in the onset of diseases, and PTMs are often used by cellular mechanisms to activate 
or de-activate specific enzymes. 
The set of modifications which can be applied to a gene product cannot be inferred by the 
analysis of neither the genome, which includes all the genes present in a certain organism, nor the 
transcriptome, which is a dynamic pool of active genes transcribed into RNA molecules. Hence, 
the need for the direct analysis of proteins seems apparent and inevitable. The first methods for 
protein sequencing, such as Edman degradation,[6] were laborious and could not easily complete 
the sequencing of very long polypeptides, and furthermore were limited to the analysis of single, 
purified proteins. Similar issues are common to all the biochemical protein characterization 
techniques. 
To improve qualitatively as well as quantitatively the information about the proteins to 
investigate, analytical techniques were applied to protein characterization. The technique of 
choice for the analysis of gene products and, particularly, of proteoforms is currently represented 
by mass spectrometry. 
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1.1 Mass spectrometry for proteins: what approach? 
Mass spectrometry (MS) is defined as an analytical method aimed at determining the mass-to-
charge ratio (m/z) of charged particles, or ions. A typical MS experiment, performed using a mass 
spectrometer, consists of three parts: ionization, separation and detection. The ionization process 
ensures the indispensable acquisition of a charge by the analyte and, if this was originally in the 
solid or liquid phase, its passage to the gas phase. Subsequently, analyte ions can be manipulated 
by the application of electric and/or magnetic fields, in order to separate them from ions with 
other m/z values or temporarily confine them in specific areas of the spectrometer for several 
purposes. Finally, ions are detected, so that ion abundances are associated to ions' mass-to-charge 
ratios.[7]  
The above described procedure determines the m/z of analyte ions and, therefore, leads to the 
calculation of the mass of the analyte as a neutral molecule. According to the contemporary 
terminology, the sequence of these events is known as MS1 or survey scan. For the 
characterization of biomolecules, and particularly of those, such as nucleic acids and 
polypeptides, which are polymers built from multiple monomers with different chemical formula, 
the accurately measured mass is theoretically sufficient to infer the monomer composition, but 
not their sequence. Therefore, after MS1 an additional step is performed, consisting in the gas 
phase fragmentation of a selected ion type (precursor ion). This methodology, which produces 
charged fragments of the precursor called product ions, is referred to as tandem mass 
spectrometry (MS2 or MS/MS). Further selection and fragmentation of product ions are known as 
MSn: for instance, the fragmentation of a product ion obtained by MS2 is termed MS3. 
Through the years, mass spectrometry has developed so that from the very first application by J.J. 
Thomson, which revealed the existence of isotopes for non-radioactive elements, it could be 
applied to the analysis of small organic molecules and, currently, to large protein complexes. 
Nowadays, biomolecular mass spectrometry is used to address very sophisticated biological 
questions. 
When describing the different approaches which have been developed for mass spectrometry-
based protein analysis, one should always consider that for satisfying the requests coming from 
the world of life sciences, the goal rapidly passed from the characterization of a single protein 
(i.e., targeted analysis) to that of a protein mixture of various complexity, up to the proteome 
17 
 
level. According to its original definition, a proteome is defined as the set of all the proteins 
expressed by a cell in a defined moment. Let us assume, using arbitrary underestimation, that a 
human cell expresses only one fifth of its genes. It then follows that, with the products on average 
differentiated into two proteoforms, the proteome will be composed of at least 8’000 
proteoforms. On the other hand, if we consider the transcriptome (i.e., the equivalent of the 
proteome for RNAs) of human cell lines, a significantly larger proteome would be expected, with 
roughly one order of magnitude more proteoforms.[8]  
To reduce this extreme degree of complexity, ensuring efficient protein analysis, MS is often 
coupled on-line or off-line with protein purification, fractionation and separation techniques, so 
that in the unit of time only a limited number of analytes is ionized and subjected to MS 
processing. The most popular separation technique is liquid chromatography (LC) and, 
specifically, reversed phase LC which can be performed in a fully MS-compatible fashion. 
Two main philosophies, ultimately ending in three possible approaches, can be identified in MS-
based protein analysis, Figure 1.2. The first one relies on proteolysis, a chemical or enzymatic 
cleavage of proteins into shorter polypeptidic chains known as peptides. Depending of the 
method applied for the generation of peptides, these can have different lengths. When proteolytic 
peptides are smaller than 3 kDa on average, like in the case of the widely employed digestion 
with the protease trypsin, the analysis is named bottom-up (BU) MS (or bottom-up proteomics, 
whether applied to an entire proteome).[9, 10] If peptides are produced by the cleavage of rarely 
expressed amino acids or combinations of amino acid residues, like for the chemical cleavage at 
methionine with cyanogen bromide, their average mass exceeds the 3 kDa limit and can normally 
vary from ~5 to 15 kDa. This approach is called middle-down (MD) MS.[11, 12] Proteolytic 
peptides are subjected to MS and MS/MS analysis, with resulting mass spectra of reduced 
complexity. 
Conversely, the opposite philosophy is based on the analysis of intact gene products. This 
methodology, known as top-down (TD) MS, includes the same MS and MS/MS steps used for 
smaller peptides.[13-15] 
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Figure 1.2. Schematics of proteolysis-based approaches for protein analysis, namely bottom-up 
and middle-down MS, and intact protein analysis or top-down MS. 
Operations prior to ionization, parameters of MS analysis and data interpretation are significantly 
different among the three methods. Proteolytic peptides produced by bottom-up and middle-down 
create complex mixtures but, on the other hand, these relatively short polypeptides are easy to 
separate, ionize, and produce relatively simple mass spectra dominated by a limited number of 
ions with similar charge state (i.e., the number of charges of a single ion); moreover, their 
MS/MS results in relatively easily interpretable mass spectra composed of a reduced population 
of product ions. Conversely, proteins are more difficult to separate, ionize and both their MS1 and 
MS/MS spectra are complicated by the larger size of these analytes. In MS1, proteins show a 
wide charge state distribution; their MS/MS spectra are often convoluted, and product ion 
assignment is complicated not only by their high number but also by their high charge state and 
potential overlaps of ions with very similar m/z values. 
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Besides the technical differences, which will be discussed more in detail in the following 
chapters, the most relevant discriminant between the two approaches is conceptual, and precisely 
connected to the final outcome of the analysis. Most of the currently used protein databases are 
gene-centered, as they include protein entries obtained by in silico translation of genes sequenced 
and annotated for a certain organism of choice. Bottom-up and middle-down MS can directly 
determine the presence of specific peptides, which can be assigned to a related protein (or, 
eventually, to all those which share that polypeptidic sequence) which is considered as positively 
identified through statistical validation and, possibly, assignment of multiple peptides. Despite 
the fact that several kinds of modifications can be also attributed to single peptides, their 
identification always points to a protein family, which includes all the possible proteoforms 
generated by the translation of a given gene. The ways these modifications are actually combined 
within a single intact protein are, in fact, impossible to infer. On the contrary, top-down MS can 
determine the mass of the intact protein analyzed in MS1, which already accounts for all the 
modification present in that specific analyte, whereas MS/MS should confirm possible 
modifications and precisely assign their position. In this way, top-down MS should theoretically 
lead to the identification of a specific proteoform. 
Despite the theoretical advantages of top-down MS over proteolysis-based approaches, protein 
identification throughput allowed by middle-down and bottom-up MS is largely superior due to 
the above mentioned ease in peptide analysis. Furthermore, top-down requires a specific, 
sophisticated pipeline to be implemented in a mass spectrometry laboratory, which includes 
dedicated high-end instrumentation and data analysis software that can cope with the increased 
complexity of this type of analysis. 
Therefore, the current scenario in MS-based protein analysis is variegated, and the strategy to 
implement for a specific study is chosen on the basis of available instrumentation, scale of 
proposed investigation and its specific aims, with the awareness that, oftentimes, more than one 
solution would be potentially applicable to the case. 
 
 
 
20 
 
1.2 Aim of the thesis. 
In a single sentence, the common trait of the hereinafter presented research can be defined as the 
development of novel analytical methods for the characterization of complex proteins through 
direct application to targeted studies of state-of-the-art mass spectrometry technology. 
Going from general to particular according to the deductive method, it is apparent that the 
development of new ways of studying complex objects requires a targeted investigation. Large 
scale studies would indeed introduce issues in the interpretation of results. Moreover, the 
complexity we aimed to challenge is represented by the objects under investigation per se, not by 
their number. Specifically, this thesis is focused on proteins whose complexity arises from the 
large size, the presence of multiple polypeptidic chains interconnected by solid bonds (e.g., by 
covalent bonds such as disulfide bridges between side chains of cysteins), multiple chemical 
modifications, or combinations of these elements. The beauty of the designed methods relies on 
the fact that these proteins were mostly studied in intact form, without over-manipulating them. 
The term mass spectrometry technology refers in this context to the synergy of instrumentation 
(i.e., hardware), ion fragmentation techniques applied to structurally explore protein analytes as 
well as data treatment and analysis dedicated and adapted to a specific study. Although hardware 
modifications on mass spectrometers are beyond the scope of this thesis, the final outcome is that 
for pursuing the goals of this research we introduced new ways in using commercially available 
instruments and re-modelled the commonly employed instrument control and data collection 
strategies.  
As described in detail in the following Chapter, several mass analyzers and ion fragmentation 
methods are currently available. The term state-of-the-art is not referred simply to 
hardware/software sophistication, but rather to the application of advanced instruments to 
extreme cases, finalized to obtain a proof-of-concept and to push the limits of technology 
underlining its actual limitations. Notably, we prefer to deeply exploit the information condensed 
in traditional MS1 and MS2, for instance by using not only the sequence information derivable by 
tandem mass spectrometry but also analyzing the abundance of identified product ions, rather 
than to combine them with a number of additional MS-related techniques. 
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In order to provide a logical and, possibly, comprehensive explanation of results, this Thesis is 
structured as follows: Chapter 2 is aimed at clarifying in detail the techniques used in the single 
studies, and the rationale supporting their choice. Chapters 3 to 5 report an introduction and 
summary of results achieved: for the elucidation of the effects of enzymatically-induced 
modifications on a peptide (Chapter 3); in the analysis and quantification of modifications on 
large proteins by the application of intact mass measurement and BU MS (Chapter 4); in the TD 
MS characterization of large proteins (Chapter 5), Finally, Chapter 6 includes the research 
articles related to the works described in the previous Chapters, whilst Chapter 7 summarizes the 
obtained results and outlines future research directions. 
  
22 
 
 
  
23 
 
Chapter 2: Experimental methods 
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2.1 Mass spectrometry basics for the analysis of biological molecules 
As expected from Chapter 1, the analytical technique employed in the research studies described 
in this Thesis is mass spectrometry. Therefore, before proceeding with the description of the 
experimental procedures employed for characterizing complex biomolecules, it is appropriate to 
define some basic concepts, which will also help in clarifying the peculiarities and sophistication 
of the research projects described hereinafter. 
 
2.1.1 Molecules, elements and isotopes in mass spectrometry. 
The only particles that can be detected in MS are the charged ones, and in almost all of MS 
applications these are ions. Generally, most of the studied ions are cations, or positively charged 
species, and this is the case for polypeptides. Although in principle a cation can be obtained by 
removal of one or more electrons from a neutral molecule, in the case of biopolymers the 
ionization in positive mode is carried out through the adduction to the molecule of a positively 
charged particle. Commonly, the charged adduct is a proton, but also metals such as sodium or 
potassium can be bound to polypeptides. An ion formed by charging the analyte during the 
ionization process is known as the molecular ion (more strictly speaking, “pseudomolecular ion” 
when protonation occurs). If we assume protons as charging adducts, we can conclude that the 
elemental composition of the analyte cation is the same as of the neutral analyte, plus the 
adducted protons. Indeed, each organic molecule is formed by a number of different elements and 
these are normally present in multiple isotopes, which differ from each other by the number of 
neutrons present in the nucleus, and hence have different masses.[16] 
The practical consequence of the existence of isotopes is that when ionizing a pure analyte we 
deal with a mixture of molecules with the same elemental formula but different masses, and, 
consequently, different m/z values even when the number of added protons is fixed. In other 
words, given that we almost always analyze a group of ions at a time, and practically never a 
single ion, for each charge state of our analyte cation, defined by the number of positive charges 
it owns, we will detect not a single signal but multiple ones, arising from the different 
combinations of isotopes. The groups of signals detected for a selected charge state of the analyte 
of interest is collectively called an isotopic envelope or an isotopic distribution. Each 
combination of isotopes for the same molecule, to which a specific m/z signal should correspond, 
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is defined as an isotopologue.[17] The relative abundance of each isotopologue within a given 
isotopic distribution can be calculated theoretically by considering the elemental formula and the 
relative abundances of each element included in it. Amino acids and, thus, polypeptides are 
composed of a limited number of different elements, specifically: carbon, hydrogen, nitrogen, 
oxygen and sulfur. It is important to remind that these five elements are not equally represented 
in amino acids (sulfur, for instance, is present only in two of the proteinogenic amino acids, 
cysteine and methionine); moreover, the relative abundance of the respective isotopes changes 
substantially among these elements, and it is primarily carbon that presents, aside of the most 
abundant isotope (12C, constituting 98.9% of overall carbon content), a fairly abundant heavier 
isotope, 13C, accounting for ~1.1% of overall carbon content. The presence of these specific five 
elements in natural polypeptides explains why the so-called monoisotopic peak, which by 
definition corresponds to the peak of the isotopologue composed exclusively of the most 
abundant of the isotopes of each element, corresponds also to the peak of the lightest 
isotopologue. Figure 2.1 summarizes the concepts introduced above and shows the effect of mass 
variation on the relative abundance of the monoisotopic peak within a certain isotopic 
distribution. With the increase in the mass of the analyte, the monoisotopic peak intensity is 
progressively reduced. Importantly, the (spectral) dynamic range provided by modern mass 
analyzers, expressed as the ratio between the intensities of the most abundant over the least 
abundant peak within the mass spectrum typically span three to four orders of magnitudes. As a 
consequence, the monoisotopic peak may not be detectable for polypeptides of considerable 
mass.[7] 
 
2.1.2 Mass accuracy, mass resolution and their relevance in proteomics. 
It is apparent that, with over 20’000 possible gene products, to confidently identify a polypeptide 
sequence, not only MS2 experiments have to be applied, but the measured mass (actually, m/z) of 
the analyte has to be determined with high accuracy. Mass accuracy is defined as the difference 
between experimental and theoretical m/z value of an analyte relative to the theoretical m/z value, 
and it is commonly measured in parts-per-million (ppm). In MS-based proteomics, two 
definitions for mass are usually considered: monoisotopic mass, or the mass of the monoisotopic 
isotopologue, and average mass, calculated on the base of the molecular formula considering the 
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average atomic masses of each element. Experimentally, the average mass is determined as the 
centroid of the isotopic distribution of the biomolecule of interest; unfortunately, due mainly to 
statistical limitations (i.e., the number of ions considered in a MS analysis is generally too low to 
reflect precisely the real relative ratios of different isotopes of a certain element), it has been 
proven that the average mass determination has an inherent uncertainty, such that the mass 
accuracy is limited to 10 ppm for biomolecules larger than 10 kDa and ±0.1 Da for smaller ones, 
as estimated by Zubarev et al.[18] This consideration immediately emphasizes the importance of 
measuring directly, whether possible, the mass of the monoisotopic peak with high accuracy, as 
in practice the monoisotopic mass is much less affected by poor statistics than the average mass. 
High mass accuracy measurements are highly beneficial in proteomics for confident protein 
identification: for instance, with mass accuracy of ±1 ppm it has been calculated that it is possible 
to filter out 99% of peptides having the same nominal mass (i.e., the mass of a molecule or ion 
calculated considering the integer mass of the most abundant isotope of each atom) but different 
elemental composition.[19]  
Another fundamental parameter in MS analysis of polypeptides is mass resolution (or, simply, 
resolution).[20] This is defined as the capability of the mass analyzer to distinguish two ion 
signals in a mass spectrum. Historically, this parameter has been based on the resolution of two 
ion signals above 10% of their intensity, and calculated as R=M/∆M=M2/(M1-M2), where M1 and 
M2 (with M1 > M2) are the m/z values of the signals and ∆M, known as resolving power, is the 
m/z difference of the two measured signals. A more recent definition is based on the width of the 
ion signal at its half height. In this case the resolution is known as full width at half maximum, or 
FWHM. The relevance of high resolution in MS-based proteomics and in protein characterization 
is twofold. First, it allows the discrimination between isotopologues even for large, multiply 
charged polypeptides or proteins, which is necessary if we intend to determine the ion charge 
state in a complex mixture and to use the monoisotopic mass, and also the differentiation between 
(partially) overlapping isotopic distributions. In fact, we have to consider that in the most 
commonly employed ionization technique for proteomics, the number of proton adducts, and 
therefore the cation charge state, is generally increased with the polypeptide mass (as it will be 
explained in the section 2.3.1). If we approximate the distance between isotopologues in a 
distribution to the mass of a neutron, which for the sake of simplicity we can now consider as 
equal to 1.003 u (for the most common case of 13C), this then implies that the m/z distance 
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between two consecutive isotopologues for a singly charge peptide cations is of 1.003/1~1 m/z 
units, whereas for a quadruply charged one this corresponds to only 1.003/4~0.25 m/z units. In 
other words, the resolution required for discriminating consecutive isotopologues increases with 
the mass of the analyte. Note, that this aspect becomes more relevant, thus, passing from BU to 
MD and TD proteomics. Secondly, the achieved mass accuracy is a function of the determination 
of the ion peak position in the mass spectrum; the higher the resolution, the lower the possibility 
that two close peaks can interfere with each other with subsequent mass shift which would 
ultimately lower the mass accuracy. 
 
Figure 2.1. Variation of the isotopic distribution according to the analyte mass. Three examples 
are reported for (from left to right) polypeptides composed of 10, 50 and 150 alanine amino acid 
residues. Monoisotopic, average and most abundant masses are indicated. Point at which the 
FWHM resolution is calculated is marked for a selected peak. 
 
2.1.3 Signal-to-noise ratio and high resolution mass spectrometry. 
As previously mentioned, the dynamic range is the parameter indicating what components of a 
complex mixture can be detected in a single mass spectrum. In the current generation of high 
resolution mass spectrometers, it is limited to three-four orders of magnitude, effectively 
preventing the possibility of observing the monoisotopic peak of proteins larger than ~25-30 kDa 
(as beyond this threshold the ratio between the most abundant isotopologue in the distribution 
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and the monoisotopic peak exceeds this range). The lower limit of abundances in a mass 
spectrum is populated by non-analyte signals, i.e., spectral noise (and specifically, for most mass 
analyzers, either chemical or electrical noise). Increasing the signal-to-noise ratio (SNR) 
beneficially contributes to analysis of polypeptides. First, it is intuitively obvious that high SNR 
prevents the possibility that lowest components of an isotopic distribution, including for large 
polypeptide ions even the monoisotopic peak, can be confused with noise. Secondly, high SNR 
measurements have been demonstrated to lead to mass estimations with higher mass accuracy. 
 
2.2 Protein structure and intrinsic complexity 
In Chapter 1, we described the complexity characterizing proteomes in terms of high number of 
proteoforms present. Hereinafter we will introduce basic concepts about intrinsic structural 
complexity of proteins, underlining the importance of those aspects which are generally relevant 
from a mass spectrometry-centered perspective, and more specifically for high resolution MS. 
 
2.2.1 Amino acids: functional groups and possible interactions in a polypeptidic chain. 
As mentioned in Chapter 1, 20 proteinogenic amino acids are encoded in genomes of eukaryotes. 
As suggested by the name, an amino acid invariably includes two main functional groups: an 
amino group, and a carboxylic acid. The central carbon, termed alpha carbon or Cα, interconnects 
the amino and the acid group, and is linked to a hydrogen and to the so-called side chain, a 
variable group that discriminates the different amino acids. These are classified according to the 
physical-chemical properties of their side chains as displayed in Figure 2.2. Importantly, the 
protonation process mentioned in the previous section (and further explained in the following 
one) involves the N-terminal amino group (when unmodified) and the amine groups on the side 
chains of lysine, arginine and histidine. 
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Figure 2.2. The 20 proteinogenic amino acids grouped by physical-chemical properties of their 
side chains. Amino acids are indicated with both three and single letter codes.[21] 
Polypeptides are polymers of amino acids.[22] A condensation reaction between the amino and 
the carboxylic acid group of two distinct amino acids, with the elimination of a water molecule, 
serves to covalently bind two monomers, which are called residues, through the formation of an 
amide bond also known as the peptide bond, Figure 2.3. As highlighted in the Figure, the 
repeated sequence N- Cα-C is known as the peptide backbone. The geometry of each polypeptide 
can be described as a function of the angles between these covalent bonds. Particular importance 
has to be attributed to the dihedral angles Φ, Ψ and Ω between backbone planes. Given that side 
chains can introduce steric hindrance, an interesting use of dihedral angles, specifically of Φ and 
Ψ, is provided by the Ramachandran plot, which indicates the allowed combinations of values for 
these two angles for the amino acid residues constituting a polypeptide. Notably, different 
structural elements are characterized by specific (Φ, Ψ) pairs.[23, 24]   
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Figure 2.3. Top panel: schematic representation of the formation of a peptidic bond through a 
condensation reaction and water elimination. Bottom panel: positioning of the dihedral angles on 
the peptide backbone (marked with a dashed line) of the tripeptide H-Ala-Gly-Ala-OH. 
Main interactions between amino acid residues in a polypeptide include: electrostatic interactions 
between positively and negatively charged amino acids; hydrogen bonds; dipole-dipole 
interactions; Van der Waals interactions; and hydrophobic interactions. Notably, interacting 
residues can be placed at variable distances, depending on the nature of the interaction. For 
instance, electrostatic interactions generally require amino acid side chains to be closer than 400 
pm, with interaction force decreasing with the square of the distance.[25] Hydrogen bonds are 
generally formed within 200-300 pm of distance between donor and acceptor.[26] 
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2.2.2 Protein structure: a category-based nomenclature. 
Spatial organization of polypeptides is fundamental to any of their functions. If, for the sake of 
simplicity, we grossly divide proteins into two main groups, enzymes and structural proteins, we 
can immediately pinpoint how overall geometry and three-dimensional reciprocal positioning of 
amino acids are governing protein activities. Enzymes are biological catalyzers of chemical 
reactions, and generally they present an active site with highly specific spatial compatibility for 
reaction substrates. Structural proteins, on the other hand, stabilize cell structures by interacting 
spatially with each other, creating supramolecular entities based on the interaction and binding of 
several protein units. It is intuitive that strength of binding and geometry of the final structure of 
a supramolecular entity depends on the spatial conformation and shape of the subunits. 
The process through which a polypeptidic chain reaches its native three-dimensional 
conformation, capable of executing a specific biological function, is known as folding.[27] This 
process starts before the polypeptidic chain is completely translated by ribosomes, and is believed 
to start at a local level, with single portions of the polypeptide that start being structured. These 
nucleation sites are then driving the rest of the chain to a more complex and ordered three-
dimensional structure. The number of interactions involved in folding and in keeping stable the 
native conformation is high (vide supra), so that a classification for describing protein structure 
according to a reductionist principle was necessary.[28] Currently, four levels of structural 
organization are considered for proteins:  
1. The ordered sequence of amino acids within a polypeptide is called primary structure. 
This level includes all the information required for the determination of higher order 
structure. From the MS point of view, identifying the primary sequence of a protein is the 
first step towards the assignment of a selected protein family and, then, of a specific 
proteoform. This operation is conducted by combining information from MS1, which 
returns the amino acid composition, and MS2, which is used for establishing the amino 
acid order. Primary structure determination can be performed in a database-driven 
fashion, as in proteomics (i.e., by matching MS1 and related MS2 mass spectra to a certain 
number of entries listed in a protein database, or, in the case of middle-down and bottom-
up approaches, in a database composed of peptides obtained by in silico digestion of the 
same proteins). Conversely, de novo sequencing relies more extensively on MS2, as no 
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sequence information stored in a database can be used and all the amino acid residue 
positions have to be determined by gas phase fragmentation. Further fragmentation of a 
product ion (i.e., MS3) may be necessary for distinguishing between structural isomers of 
amino acids such as α- and β-aspartate (i.e., “normal” aspartate and its variant with a 
carbon atom – Cβ – moved from the side chain to the backbone). Note that, by convention, 
the amino acid sequence is ordered from the amino acid residue with the free amino group 
(N-terminus) to that with the free carboxylic acid group (C-terminus). 
2. Simple structural elements composed by a limited number of amino acids, normally 
consecutively positioned within a polypeptidic sequence, are known on the whole as 
secondary structure. In general, the secondary structure elements present in a protein can 
be classified according to two different, but correlated, features: the hydrogen bond 
connectivity or the dihedral angles. The former classification relies on the observation that 
secondary structure is based on hydrogen bonds connecting amide and carboxyl groups of 
polypeptidic backbone. The latter refers to the aforementioned Ramachandran plot, as 
each secondary structure element is characterized by a specific range of possible dihedral 
angular values for the amino acid residues involved. Among the most common elements 
we can mention the α-helix, the β-sheet and the β-turn. Portion of proteins which do not 
present any specific classified secondary structure elements are normally defined as 
random coils. 
3. The achievement of the final, three-dimensional conformation of a protein, or tertiary 
structure, can be chemically described in terms of a hydrophobicity-driven process. 
Indeed, as proteins are immersed in a water-based environment, hydrophobic amino acids 
will naturally tend to exclude water molecules and aggregate. Energetically, the native 
conformation is positioned at the bottom of an energy funnel, Figure 2.4. If 
hydrophobicity is fundamental for determining what will be the amino acid residues 
exposed to the interface with a solvent, other interactions are important for maintaining 
native folding. Particularly, non-covalent Coulombic interactions between charged amino 
acids (also known as "salt bridges") and dipolar interactions, as well as covalent disulfide 
bridges formed between side chains of cysteine residues (see Section 2.2.3) all contribute 
to tertiary structure stability.  
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4. Although most proteins are biologically active when they reach a stable tertiary structure, 
some need to form complexes with others. The association of multiple 
polypeptides/proteins is called a quaternary structure. It is apparent how this structural 
level can be properly achieved only in presence of a correct tertiary structure. Generally, 
quaternary structure is reached through non-covalent interactions among the different 
polypeptides. For example, proteins which are composed of multiple chains linked also by 
inter-molecular covalent bonds, such as antibodies, are considered as having a quaternary 
structure. 
 
Figure 2.4. Graphic representation of the energy funnel theory for protein folding. Proteins 
minimize their potential energy by reaching the native conformation, whereas partially-folded 
conformations are energetically unfavorable. Figure adapted from [27]. 
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2.2.3 Post-translational modifications and protein structure. 
Most of currently known PTMs involve the addition of small molecules to selected amino acid 
side chains. This is the case, for instance, with the widely studied acetylation, methylation and 
phosphorylation processes. Other PTMs involve the addition of larger molecules, such as 
peptides (e.g., ubiquitination[29] and SUMOylation[30]) or oligosaccharides (e.g., N-linked 
glycosylation[31]). Large scale MS-based studies of these PTMs benefit from the relatively large 
mass difference between unmodified and modified amino acid residues, which, combined with 
the fact that specific modifications can be present only on selected amino acid side chains, allows  
in some cases for the localization of the modified sites even with low mass accuracy and low 
resolution instruments, although high mass resolution and accuracy surely increase the 
identification confidence. 
Despite the fact that some of the above-mentioned PTMs might induce non-negligible changes in 
the physical-chemical properties of the involved proteins, as is the case of phosphorylation which 
accounts for the introduction of a negatively charged chemical group, their overall impact on the 
protein structure is limited compared to that of structural PTMs. Among them, the most important 
is surely represented by the formation of a disulfide bridge (i.e., a covalent bond) between thiol 
groups of two cysteine residues. The role played by disulfide bridges in stabilizing protein 
structures is achieved by placing in vicinity two non-consecutive portions of the polypeptidic 
sequence, potentially enhancing hydrophobic interactions and preventing the possibility that 
water molecules, which will have no access to the disulfide-protected area, will disrupt secondary 
structure elements by creating alternative hydrogen bonds with backbone amide groups. It is 
noteworthy that disulfide bridges can limit the efficiency of polypeptide sequencing in MS2, as 
their presence requires the cleavage of two bonds for obtaining a product ion. Interestingly, other 
cross-linkages between side chains are possible, like enzymatically-induced transamidation 
which involves the ɛ-amino group of lysine and the amide group of glutamine. 
Finally, a limited number of PTMs, induced either chemically or enzymatically, provokes the 
variation substitution of an amino acid in the sequence with another one. For instance, 
deamidation of glutamine or asparagine results in the formation of glutamate or aspartate, 
36 
 
respectively. The mass variation caused by deamidation is lower than 1 Da, therefore high mass 
accuracy and mass resolution are required especially when the overall mass of the polypeptide of 
interest is large. 
2.3 Instrumentation 
This section is dedicated to the description of mass spectrometers employed for the research of 
this Thesis, and will particularly underline, in an order that allows ideally to follow to the logics 
of a real experiment (i.e., ionization, ion separation, m/z isolation, ion activation and 
fragmentation followed by product ion detection, and finally analysis of the acquired data), the 
following aspects: 
• The type of ionization employed, namely electrospray. 
• High resolution hybrid mass spectrometers. 
• Tandem mass spectrometry techniques for complex polypeptides. 
• Data analysis. 
 
2.3.1 Electrospray ionization. 
Analyte ionization represents the sine qua non operation for mass spectrometry analysis. 
Biomolecules, and polypeptides in particular, are composed of a number of relatively weak 
covalent bonds (e.g., most of those connecting PTMs to amino acid side chains). From this 
derived the need of soft ionization methods, which could induce the analyte charging 
phenomenon avoiding destructive effects. 
Two techniques suitable for biomolecule ionization were introduced between the 80s and 90s, for 
which John B. Fenn and Koichi Tanaka were awarded the Nobel Prize in Chemistry in 2002:[32, 
33] electrospray ionization (ESI) and ionization techniques that finally led to development of 
matrix-assisted laser desorption/ionization (MALDI) by Franz Hillenkamp and Michael 
Karas.[34, 35] The studies presented in this Thesis are entirely realized applying ESI in its 
different variants. The success of ESI is largely due to its ability to form multiply-charged ions 
(vide infra) and possibility of coupling on-line this continuous ionization method with 
widespread separation techniques such as chromatography (and, particularly, reversed phase 
chromatography) or capillary electrophoresis, which entail a constant liquid flow. 
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From the theoretical point of view, an electrospray source resembles a controlled current 
electrolytic cell. Indeed, a liquid pushed through a capillary is put under a high voltage (in the kV 
range), with the electric field being comprised between the tip of the capillary and the inlet of the 
mass spectrometer, Figure 2.5. Essentially, talking about the generation of analyte cations, the 
capillary tip acts as an anode and the mass spectrometer inlet as a cathode. 
With regard to the sequential stages required for ion formation, we distinguish between formation 
of spray, desolvation of droplets, emergence of charged particles from droplets and sampling of 
ions from the atmospheric pressure environment inside the mass spectrometer. The formation of 
the spray is ensured by the application of the electric field. In presence of low field, a droplet 
eluting from the capillary appears spherical. Its shape changes into an elongated form by ramping 
up the voltage until, at onset field, the spray is formed as the pressure is higher than the surface 
tension. What is formed is the so-called Taylor cone, from which droplets are released. 
Depending on the flow of the liquid through the capillary we discriminate between ESI (also 
known as microESI, as it is characterized by a flow in the order of µl/min) and nanoESI (with a 
lower flow in the order of hundreds of nl/min). The formation of droplets and their desolvation is 
caused by the accumulation at the liquid surface of particles charged by the combination of the 
applied field and the presence in the ESI solution of proton donor species (generally, acids such 
as trifluoroacetic acid or formic acid). The droplet desolvation/evaporation process, favored also 
by the proximity of the instrument inlet, which is usually heated, and by the eventual use of 
nebulizing gas, increases the charge per unit of volume, so that, because of the excessive 
Coulombic repulsion, higher than the surface tension, larger droplets divide into smaller ones and 
finally release ions. In other words, these charged droplets reach a radius value lower than the 
stability one, also known as Rayleigh radius, due to their progressive evaporation, with the result 
of undergoing a fission.[36] To better understand this phenomenon, we can mention that in a 
typical microESI source the first generation droplets released from the Taylor cone have a 
diameter of ~1.5 µm, whilst offspring droplets have a reduced diameter of ~0.1 µm; this implies 
for the second generation a volume equal to ~2% of the parent droplet but a charge content 
estimated in ~15% of the initial one.[7, 37] Considering the mechanism of this process, it is 
apparent why organic solvents such as methanol or acetonitrile are often used to help the spray 
stability, as they have a lower surface tension than water. The nanoESI allows for a higher 
sensitivity as the parent droplets formed at the Taylor cone are already smaller than in the 
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microESI counterpart by about one order of magnitude. NanoESI is also more tolerant towards 
salts. Finally, ions formed at atmospheric pressure have to be introduced in the mass 
spectrometer, whose analyzer generally operates in medium to high vacuum conditions. Besides 
the already mentioned heated ion inlet (generally, a glass or metallic capillary), the solution for 
creating a pressure gradient is offered by the so-called differential pumping system, consisting in 
the definition of compartments, on which vacuum pumps operate, connected by small apertures 
so that a large difference in pressure between consecutive chambers can be maintained. An ion 
optics system, placed in the region at intermediate vacuum and composed of focusing lenses 
and/or multipoles, ensures efficient ion transmission towards the internal part of the mass 
spectrometer.   
 
Figure 2.5. Graphic representation of an electrospray ion source. Image adapted from the Royal 
Society of Chemistry. 
Main features of ESI of polypeptides (in positive mode) include: formation of multiply-charged 
ions (in contrast with MALDI, which produces almost uniquely singly-charged ions) by 
protonation (or, eventually, complexation of other charged species such as metal ions); 
generation of a charge state distribution (or charge state envelope), composed of analyte ions 
with different charge states (i.e., with different number of proton adducts) and, hence, different 
m/z; concentration of polypeptides of interest that, depending on the mass analyzer employed for 
their analysis, finds a lower limit in the pmol or even fmol range. The advantages offered by the 
here described ESI peculiarities will be illustrated in the following sections of this Chapter. 
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2.3.2 High resolution hybrid mass spectrometers 
An important characteristic shared by all the employed instruments mentioned in this Thesis is 
their hybrid design.[38, 39] This means that two mass analyzers, generally a low resolution and a 
high resolution one, are positioned in series. This technology has a high impact on the general 
characteristics of the instrument as the low resolution mass analyzer is chosen to be also capable 
of working as a collision or reaction cell, i.e., to enable tandem mass spectrometry. In this way, 
the capabilities of the mass spectrometer are extended, as often (but not always) MS2 parameters 
are not compatible with operational conditions of high resolution mass analyzer (vide infra). In 
extreme cases, the first mass analyzer actually operates exclusively for selection of ions for MS2. 
Furthermore, a sophisticated design allows for the ion manipulation in the low resolution mass 
analyzer while either precursor or eventually product ions are analyzed with high mass resolution 
and accuracy in the high resolution mass analyzer, improving the duty cycle of a typical sequence 
composed by one MS1 scan followed by a series of MS2 scans of selected precursors. 
Research studies presented in the following Chapters of this Thesis were performed with three 
different high resolution mass analyzers: time-of-flight (TOF) and Fourier transform – ion 
cyclotron resonance (FT-ICR) and Orbitrap.[7] These will be hereinafter described according to 
their ion detection principle, that is single ion counting for TOF and induced current detection for 
FT-ICR and Orbitrap. For reason that will be explained in the dedicated paragraph of this 
Chapter, MS analysis relying on mass analyzers of the latter group is also known as Fourier 
transform mass spectrometry (FTMS).  
2.3.2.1 Fourier transform mass spectrometry. 
High resolution mass spectrometry can rely on a non-destructive ion detection principle, the 
induced current detection. Specifically, ions can be trapped in a confined space (i.e., an ion trap), 
where their periodic motion produces an induced current in the detection electrodes circuit. This 
current is digitized as a time-domain signal containing all the motion frequencies of measured 
ions, with intensities proportional to the abundance and charge of the ions in the trap. Effectively, 
the time-domain signal, whose length can last up to some seconds (with a record duration of 50 
sec on the employed FT-ICR MS), contains a convoluted waveform resulting from the sum of all 
the waveforms produced by the motion of different ions. The time-domain signal, also known as 
transient, can be converted to a frequency-domain signal by applying the mathematical operation 
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of Fourier transform. The resulting frequency spectrum is a complex one, i.e., it contains both a 
real and an imaginary part. Importantly, the real part returns the so-called absorption spectrum, 
whereas the imaginary part gives a second spectrum, the dispersion one. Mathematically, it is 
fundamental to know the phase of ion at zero time (i.e., the phase at the beginning of signal 
recording). In fact, at zero degree phase the absorption spectrum only contains positive values 
and peaks have the highest possible resolution, whereas the dispersion spectrum includes both 
positive and negative values at a slightly lower resolution. This means that at zero degree phase 
the absorption mode spectrum can be used alone to determine the frequencies of trapped ions. For 
any other phase value different than zero, though, both components, real and imaginary, are 
composed of linear combinations of absorption and dispersion modes, i.e., they both contain 
asymmetric peaks described by positive and also negative values (with a reduced resolution). The 
final conclusion is that, whether it is not possible to establish the ion phase at time zero (which is 
necessary to eventually apply a phase correction), a third spectral representation is used: the 
magnitude spectrum, which allows the representation of symmetric peaks independently from the 
initial phase value. It is obtained by combining both real and imaginary parts according to the 
following equation: 
22 ImRe +=magnitude     (eq. 2.1) 
The drawback of a magnitude mode spectrum is that its final resolution is about one half of that 
achieved by the corresponding absorption spectrum at zero degree phase. 
In summary, in FTMS m/z values are represented by specific frequencies and it is the possibility 
of measuring frequencies with high accuracy that ensures, ultimately, high mass accuracy. The 
conversion of frequencies into masses is realized by calibrating the instruments for the m/z range 
of use with a limited number of ions with accurately known m/z. Since averaging the current 
period improves the accuracy in induced current detection, elongating the time of signal 
recording, i.e., increasing the length of the transient signal, allows for proportional increase in 
final mass resolution (and, thus, accuracy).[40] 
Hereinafter we will briefly summarize the working principles and illustrate the technical features 
of the two instruments present in our laboratory, LSMB. 
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• Fourier transform – ion cyclotron resonance-based hybrid mass spectrometer. 
The first FTMS instrument in use in the lab, installed in 2007, is a hybrid LTQ FT Ultra (Thermo 
Scientific, Bremen, Germany). As shown in the schematics, Figure 2.6, its architecture consists of 
(from left, ion inlet, to right): an ion optics system interfaced with the atmospheric pressure inlet; 
a linear ion trap (linear trap quadrupole, LTQ); transfer multipole (octopole); and an ICR cell 
immersed in a homogeneous high magnetic field. The instrument present at LSMB is a 
customized version currently equipped with a 10 T superconductive magnet.  
 
Figure 2.6. Schematics of the LTQ FT Ultra mass spectrometer (courtesy of Thermo Scientific). 
Going further into detail, the mass spectrometer works with different spray-based sources (micro 
and nasoESI; atmospheric pressure photoionization (APPI) source). Importantly, as depicted in 
Figure 2.6, the vacuum is increased by a differential pumping system from the inlet towards the 
ICR cell, so that ions formed at atmospheric pressure are in a ~1E-3 torr environment when they 
reach the central multipole, called MP0, of the ion optics placed before the linear ion trap. The 
pressure drops further in the LTQ, which has an operational pressure of ~5E-5 torr, arriving 
finally to the so-called ultrahigh vacuum (UHV) region located at the level of the ICR cell (~1-
2E-10 torr).   
The front end of this mass spectrometer belongs to the LTQ XL series of Thermo Scientific 
instruments. The ion inlet consists of a heated stainless steel capillary (no orthogonal ion 
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injection implemented), and the first part of the ion optics is of the tube lens – skimmer type, 
specifically with a configuration that includes two consecutive skimmers followed by a 
quadrupole and a transfer octopole, spaced out to the LTQ. In the ion trap, ions are confined and 
manipulated (including ion ejection for detection as well as ion selection) through the application 
of a radiofrequency (RF)-modulated electric fields. The linear ion trap, derived from the Paul or 
3D ion trap, consists of four rods with parabolic section and exploits the quadrupole principle, 
such that the radial ion confinement is performed through a quadrupolar alternate electric field, 
whereas the axial confinement is provided by additional static or RF-based electric fields applied 
at both ends of the trap.[41, 42] Note, that for trapping both positively and negatively charged 
ions simultaneously, RF trapping potentials are used. Neutral gas molecules (He) present in the 
trap are used to lower ion kinetic energy, and eventually for ion activation/fragmentation (vide 
infra). Main features of the LTQ are higher trapping efficiency (~20-fold) and increased ion 
capacity (~50-fold) relative to a 3D ion trap. The given LTQ can scan up to m/z 4000.[43] 
Ion m/z measurement in the LTQ is performed by ramping the RF voltage and ejecting the ions 
orthogonally towards ion detectors. Particularly, in the LTQ the radial ion ejection is followed by 
detection operated by a dual dynode system for ion-electron conversion. Signal gain is obtained 
through a secondary electron cascade through electron multipliers. Despite the high scan speed 
allowed by the LTQ (~15’000 Th/s) and its high sensitivity, the linear ion trap has been primarily 
used for ion isolation and, eventually, activation. Ion isolation window can have a width up to 
100 m/z units. The function named data dependent acquisition allows for the automatic isolation 
(and, whether desired, activation) of the most intense peaks in a spectrum.  
Finally, a noteworthy feature of the LTQ is the possibility of controlling the number of trapped 
ions (more precisely, of overall injected charges) by a function named automatic gain control 
(AGC). Briefly, a short prescan (of a defined time, 50 ms) is used to determine the ion current 
within the selected mass range. This current value is associated to a corresponding number of 
charges (through a specific routine performed during the instrument calibration), therefore the 
instrument control software can calculate a specific ion injection time to fill the LTQ according to 
a user-defined desired number of charges (AGC target value). The number of charges (and, thus, 
number of ions) injected and stored in the trap is important to determine the operation duty cycle, 
instrument sensitivity, spectral SNR etc. Furthermore, as ions confined in a limited space interact 
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with each other, an excessively high number of trapped ions can cause phenomena collectively 
known as space-charge effects that might negatively affect ion measurements. This is valid for 
both low and high resolution ion trap mass analyzers.  
From the LTQ, ions can be transferred to the ICR cell, immersed in a static magnetic field. A 
charged particle with a velocity vector perpendicular to the magnetic field experiences a force, 
the “Lorentz force”, perpendicular to the plane defined by the velocity and the magnetic field 
vectors. The ion velocity vector is thus changed in its direction (but not in its magnitude), so that 
the ion starts a circular trajectory being finally trapped by the magnetic field in the radial 
direction.[44] This low amplitude motion is called cyclotron motion and its frequency can be 
described as follows: 
 
m
qB
c =ω      (eq. 2.2) 
Where ωc represents the cyclotron frequency, q the charge of the ion, B the applied magnetic field 
and m the mass of the ion. Note, that ωc is an angular frequency and it thus depends on the 
velocity v and the radius r. Importantly, for measuring the cyclotron frequency, from which the 
m/z value of ions is derived, ions are excited by the application of an RF electric field on two 
opposite plates of the ICR cell. This amplifies the cyclotron motion radius and increases the 
induced current detected by two other plates on the cell, connected to a preamplifier (Figure 2.7, 
left panel). 
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Figure 2.7. FT-ICR cell working principle and schematics. Left panel, the schematics of an ICR 
cell section illustrates the ion cyclotron motion as well as detection and excitation plates. Right 
panel, picture and schematics of the Ultra ICR cell equipping the LTQ FT Ultra mass 
spectrometer. Figure adapted from reference [40]. 
As shown in Figure 2.7, right panel, which displays a schematic of the Ultra ICR cell equipping 
the LTQ FT Ultra mass spectrometer, trapping electrodes are used to axially confine ions within 
the cell. Other two characteristics of ion motions arise from the application of trapping voltages 
in the ICR cell: the axial motion and the magnetron motion.  
The FTMS mass spectra obtained with the LTQ FT Ultra mass spectrometer in this work are 
represented in magnitude mode. To extend the MS2 capabilities of the LTQ, the back end of the 
instrument is equipped with a CO2 laser and a cathode assembly, with which it is possible to 
activate ions trapped in the ICR cell with photons and electrons, respectively (vide infra). 
• Orbitrap-based hybrid mass spectrometer. 
Since 2012 the LSMB is equipped with a second FTMS instrument, an LTQ Orbitrap Elite mass 
spectrometer (Thermo Scientific).[45] The scheme presented in Figure 2.8 clearly illustrates that 
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the logics behind the design of this instrument represents a direct evolution of that employed in 
the LTQ FT Ultra. 
 
 
Figure 2.8. Schematics of the hybrid LTQ Orbitrap Elite mass spectrometer. Note, that the only 
relevant difference, in terms of hardware, with the LTQ Orbitrap Velos Pro is the type of 
employed Orbitrap (standard for Velos Pro, high-field in the case of Elite). Figure adapted from 
http:\\ planetorbitrap.com. 
The instrument front end corresponds to the LTQ Velos Pro series of high performance ion traps. 
Improvements relative to the XL series involve both the ion optics placed immediately after the 
ion inlet and the LTQ itself. In regard to the inlet region, the tube lens – skimmer ion optics 
equipping the XL series has been replaced with a stacked ion ring guide (S-lens), composed of 
six progressively spaced circular ion guides. The S-lens allows for a ~10-fold increase in 
sensitivity compared with the old tube lens – skimmer design. Furthermore, after the S-lens the 
transfer quadrupole owns a curved design with a neutral blocker, limiting the transmission of 
neutrals to the LTQ and maximizing the number of transmitted ions. Finally, the LTQ has a 
completely renewed design, and it is composed by a high pressure and a low pressure cell, where 
He is present, in standard operating conditions, at 5E-3 and 3.5E-4 torr, respectively. The high 
pressure cell is dedicated to the ion storage, activation and isolation, whereas the low pressure 
cell serves for fast and efficient ion ejection and, subsequently, detection. The scan speed of the 
low pressure cell is increased in comparison to the old generation of LTQ XL to ~33’300 Th/s 
when operating in “normal mode”.[46] 
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Core of the LTQ Orbitrap Elite is the high resolution mass analyzer, a high-field compact 
Orbitrap, Figure 2.9. This mass analyzer consists essentially of two electrodes: a larger outer 
electrode, split into two parts for induced current detection, and a central electrode of elongated 
spindle shape around which trapped ions move. A negative potential is applied to the central 
electrode when cations are analyzed. Ions stabilized within the Orbitrap by the applied quadro-
logarithmic electric field start oscillating along the central electrodes with trajectories resembling 
spirals. It is possible to distinguish two motions of the ions, which are considered as independent 
in the first-order approximation: a rotational motion, highly dependent on ion initial energy, and 
an axial motion, independent from ion initial energy and which is therefore used for determining 
the m/z of trapped ions.[47, 48] Specifically, the frequency of harmonic oscillation of ions along 
the z-axis (i.e., along the central electrode) is defined as: 
)/( qm
k
z =ω      (eq. 2.3) 
Where ωz represents the axial oscillation frequency, q the ion total charge and k is a constant 
proportional to the potential difference between central and outer electrode. Increasing the 
electric field is fundamental for increasing ions ωz, with beneficial effects on the final mass 
resolution (vide infra). As previously mentioned, the LTQ Orbitrap Elite is equipped with an 
evolution of the original Orbitrap presented in 2005, whose compact geometry allows for a higher 
electric field (Figure 2.9).[49, 50] The compact Orbitrap works under UHV conditions improved 
in respect to those typical of the Ultra ICR cell described above: the standard operating pressure 
of our instrument at LSMB is 0.5E-10 torr. It is noteworthy that this version of the Orbitrap mass 
analyzer is coupled with a signal processing algorithm, commercially named “eFT”, that enables 
mass spectra representation in absorption mode.[51] 
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Figure 2.9. Comparison between standard and high-field Orbitrap. Left panel, picture of both the 
mass analyzers, indicating the size reduction occurred passing from the old to the new generation 
of mass analyzer. Right panel, some dimensions and other features distinguishing the two 
Orbitrap generations. 
Another principal component of the instrument is the C-trap. The name of this RF-only, gas-
filled multipole derives from its shape, resembling that of the letter “C”. The C-trap is used to 
store a packet of ions prior to their injection in the Orbitrap, which takes place from a tiny hole 
present in one of the outer electrodes.  
Furthermore, the LTQ Orbitrap Elite is equipped with a N2-filled HCD cell. This multipole is 
generally used for ion activation (vide infra), but can also be exploited for improving the 
efficiency of large ion injection to the Orbitrap through mild ion collisional cooling with neutral 
N2 gas molecules. 
Finally, a chemical ionization-type ion source is placed at the back end of the instrument, and it is 
used for the production of radical anions used for a specific ion activation technique (vide infra). 
Note, that part of the measurements reported in this Thesis was performed on a LTQ Orbitrap 
Velos Pro mass spectrometer.[52] The main differences of this instrument relative to the above 
described LTQ Orbitrap Elite consist in the lack of eFT signal processing (i.e., magnitude mode 
representation is given for the mass spectra) and the presence of a standard Orbitrap in place of 
the high-field one. 
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2.3.2.2 Time-of-flight mass spectrometry. 
Differently from the previously described mass analyzer, where ions where trapped either by 
applying a magnetic (FT-ICR) or an electric (Orbitrap) field, time-of-flight mass analyzers rely 
on ion separation by their m/z values performed in a field-free area.[53] Briefly, ions are first 
accelerated by a source potential Vs, and continue moving further into a field-free space under 
ultra high vacuum conditions until they reach a detector, typically a microchannel plate electron 
multiplier or an array detector. Therefore, for an ion of mass m and total charge q=ze, moving 
with velocity v, the initial kinetic energy Ek is expressed as follows: 
sk qV
mvE ==
2
2
    (eq. 2.4) 
The velocity of the ion is considered constant within the field-free region of the flight tube with 
length d. Therefore, with the time needed for reaching the detector, t, being equal to 
v
d
t =       (eq 2.5) 
We finally obtain that:  
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2
2      (eq. 2.6) 
With t that can be measured accurately by a time-to-digital converter (TDC), thus enabling the 
calculation of the ion m/z. 
In practice, one of the limitations of this design is that ions entering the mass spectrometer upon 
ionization are not perfectly focused when they reach the acceleration zone. This limited focusing 
is translated in a dispersion of Ek which can be corrected by the implementation of an 
electrostatic reflector, also known as ion mirror or reflectron, in the flight tube. This device 
consists of a series of ring electrodes to which a potential of the same polarity as analyzed ions is 
applied. The reflectron creates an electric field that reflects the ions and sends them back through 
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the flight tube. The Ek dispersion is corrected as ions with higher kinetic energy penetrate the ion 
mirror more deeply before being reflected.  
Among the figures of merit of modern TOF mass analyzers there are high sensitivity (e.g., 
attomolar for peptides, when couple to MALDI)[54] as well as elevated scan speed (e.g., modern 
qTOFs can perform MS2 at 50 Hz rate) and dynamic range (determined by signal detection and 
digitization, with modern 10 bit signal converters capable of exceeding 5 orders of magnitude), 
generally higher than in FTMS mass analyzers. 
• High resolution quadrupole – time-of-flight mass spectrometer 
The instrument chosen for intact mass measurement and top-down characterization of large 
proteins in a research project described in the following Chapters is a hybrid quadrupole – time-
of-flight maXis UHR qTOF (Bruker Daltonics GmbH, Bremen, Germany). The schematics of 
this instrument, designed with a quadrupole and a TOF mass analyzer in series, is shown in 
Figure 2.10. This configuration is typically used for TOF analyzers coupled to ESI sources. 
 
Figure 2. 10. Schematics of the maXis UHR qTOF mass spectrometer (Bruker Daltonics GmBH). 
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The off-axis ion inlet (solution applied to limit the introduction of neutral molecules in the rest of 
the mass spectrometer) is followed by two ion funnels and a multipole. The central portion of the 
instrument is dominated by the presence of a low resolution mass analyzer, the quadrupole, used 
as an ion filter and for ion activation. Precursor ions selected in the quadrupole are subjected to 
ion activation in the collision chamber.[55] Product ions resulting from precursor ion 
fragmentation are transferred to a thermalizing chamber (named Ion Cooler) for collisional 
cooling (with N2) prior to orthogonal acceleration. This design is often referred to as QqTOF, 
where “Q” indicates a mass resolving quadrupole (that used also for precursor ion selection), and 
“q” an RF-only quadrupole or multipole dedicated to ion activation.[56] 
Once left the thermalizing chamber, ions are focused by an optics device (skimmer) and enter the 
modulator present at the base of the TOF mass analyzer. Initially, the modulator region is field-
free, so that the ions continue moving along their original trajectory. Then, a pulsed electric field 
is applied along the modulator gap so that ions are accelerated orthogonally to their initial 
direction. From here, they can be analyzed by the TOF mass analyzer working under UHV 
conditions (~1E-7 torr). This is equipped with a multichannel plate detector coupled with an 
analog-to-digital converter (ADC) operating with a digitization frequency up to 4 GHz. The 
pulsed ion current from the MCP is thus digitized at 250E-12 s intervals. 
The employed maXis UHR qTOF was additionally equipped with a chemical ionization source 
for generation of radical anions to be introduced from the front end into the mass spectrometer 
and trapped in the collision chamber. 
 
2.3.2.3 Concluding remarks on mass resolution and accuracy of the employed instruments. 
As previously mentioned, the mass resolution achieved by FTMS mass analyzers is a function of 
the transient length. This implies that when time constrains are applied to the analysis, this cannot 
be conducted with the highest resolution possible for the employed mass analyzer. Importantly, 
due to the non-linear relationship between ion frequencies and corresponding m/z values, the 
mass resolution of ion peaks in FTMS changes along the m/z axis. In detail, whilst in FT-ICR MS 
the ion cyclotron motion frequency is inversely proportional to the ions’ mass-over-charge, in 
Orbitrap FTMS ion axial motion frequency is inversely proportional to the square root of m/z. As 
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a final result, even when a high magnetic field is used to increase the mass resolution, the 
advantage of FT-ICR MS over Orbitrap FTMS can be limited to high frequency ions (i.e., those 
with low m/z) whereas high-field Orbitrap mass analyzers can overcome the mass resolution 
obtained by ICR-based instruments for lower frequency ions (typically, Orbitrap starts 
outperforming the mass resolution of ICR above 1000-2000 m/z, depending on the ICR and 
Orbitrap configurations used in the comparison). 
With regard to the instruments that equip LSMB, the Ultra ICR cell in the 10 T magnet 
configuration can substantially exceed 1’000’000 resolution FWHM at 400 m/z with a transient 
length of 12.288 s. The transient length in our customized instrument has been successfully 
extended to 24.576 s, but the resolution has been observed to increase linearly with transient 
length up to 1.536 s, value after which the mass resolution increase is non-linear. For achieving 
resolutions that allow top-down MS analysis, for instance ~50’000 or ~100’000 FWHM at 400 
m/z, transients of 384 and 768 ms are used, respectively.   
The compact, high-field Orbitrap has been proven to reach ~1’000’000 resolution FWHM at 400 
m/z with transient length of 3.072 s but, most importantly for routine operations, it provides 
120’000 resolution with 384 ms transients (and enabled spectral representation in absorption 
mode with eFT). 
The maXis UHR qTOF of the second generation is accredited of a maximal mass resolution of 
~50’000 FWHM (recently improved to >60’000 in the newest version) which is substantially 
equal throughout the entire mass range considered. Nevertheless, due to the characteristics of the 
signal detector, the mass resolution decreases when particularly complex mixtures (i.e., in both 
the number of ions and their dynamic range) are analyzed, like in the case of top-down MS. 
Under these operational conditions, the resolution is attested at ~20-30’000 FWHM. 
Moreover, an additional consideration has to be done for what concerns the usable mass range. In 
a hybrid configuration, the first mass analyzer may restrict the upper m/z limit reachable by the 
second mass analyzer. In fact, despite the undeniable benefits in terms of ion selection and 
extended ion activation capabilities granted by linear or 3D traps, their m/z ranges do not 
generally exceed 4-5000 m/z (specifically, both LTQ XL and Velos Pro have a fixed upper limit 
at 4000 m/z). Notably, ICR and Orbitrap alone are capable of a much more extended m/z range.  
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Usually less stringent m/z limitation is present for quadrupoles when operating as mass filters. 
The maXis is accredited of an upper m/z limit of 20000, but practically, similarly to ion traps, for 
the quadrupole an increase in the allowed upper limit is generally accompanied by a 
corresponding increase in the minimal m/z detected with good sensitivity. 
The mass accuracy of all the three high resolution mass analyzers described above is at the state-
of-the-art. Particularly, high field Orbitrap and Ultra ICR cell reach ~1-2 ppm mass accuracy 
with external calibration, and can further increase the accuracy to parts-per-billion with internal 
calibrants. Similarly, the mass accuracy achieved by the maXis UHR qTOF is between 1 and 5 
ppm with external calibration, and goes to sub-ppm values by using a mass-lock. 
 
2.3.3 Tandem mass spectrometry 
After mass-to-charge and, therefore, accurate mass determination of the polypeptide of interest in 
MS1, tandem mass spectrometry (MS2 or MS/MS) adds a second dimension to the analysis by 
fragmenting selected precursor ions. Originally, the term “tandem” was used as in the early days 
of mass spectrometry the (i) precursor selection, (ii) fragmentation and (iii) product ion detection 
steps were performed in different mass analyzers/collision cells; the most typical example in this 
sense is represented by triple quadrupole instruments. In this case, MS2 is named in space, as the 
different operations take place in different regions of the mass spectrometer. When all the steps 
occur sequentially in the same mass analyzer, as for instance in the case of Paul or linear ion 
traps, the MS2 process is defined as in time.[7] 
Sequencing a polypeptide implies the cleavage of the bonds forming the backbone. More in 
detail, for facilitating the identification of the backbone cleavage site a single cleavage should 
occur, such that each polypeptide ion is split into two fragments, one containing C- and another 
the N-terminal portion of its sequence. Additional backbone cleavages might lead to the 
production not only of smaller fragments containing N- and C-termini, but also internal 
fragments which are difficult to characterize and complicate the tandem mass spectrum. Other 
cleavages such as neutral losses (e.g., the loss of H2O, CO, CO2 etc.) or losses of side chain 
groups can be useful for confirming the putative amino acid sequence or eventual PTM position 
at the cost of more convoluted MS2 spectra. The nomenclature used for defining the product ions 
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generated in MS2 of polypeptides, introduced in the currently accepted version by Biemann, takes 
into account the possibility of cleavage at all the three backbone bonds (i.e., N-Cα, Cα-C and C-
N), Figure 2.11.[57] 
 
Figure 2.11.  Scheme of product ions produced by MS2 for a polypeptide parent ion with n 
residues, fragmented at the C-terminal side of the ith amino acid residue.  Product ions are the N-
terminal a-, b- and c-type ions, and complementary C-terminal x-, y- and z-ions. 
Besides the practical differences that can be observed in experiments with MS2 performed in time 
or in space, and which will be discussed in a separate section at the end of this Chapter and 
specifically referred to the mass spectrometers used for this Thesis, the different fragmentation 
techniques applied to polypeptides can be classified on the basis of the applied mechanism for 
backbone cleavage. Two main groups of ion activation techniques can be defined: that based on 
vibrational bond activation, and the radical-driven one. Hereinafter some of the most widely 
employed ion fragmentation techniques are briefly described. 
 
2.3.3.1 Vibrational activation-based tandem MS 
The MS2 techniques belonging to this group exploit interaction of ions with either IR photons or 
neutral molecules to increase ion internal energy until the fragmentation threshold is reached. 
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Generally these fragmentation techniques lead to the cleavage of the weakest bonds in the 
polypeptide, eventually including even those present at side chains of amino acid residues. 
• Collision-induced fragmentation 
Ion trap devices (namely 3D or linear ion traps and quadrupoles/multipoles) filled with neutral 
gas molecules, such as N2 or He, can be used for ion activation by inducing collision of the ions 
themselves with neutrals. In collision-induced dissociation (CID), the most widely employed ion 
activation technique in MS-based molecular structure analysis, including proteomics, ions’ 
kinetic energy is first increased by the application of ramping RF potentials, with the 
consequence that the ions’ velocity is increased and with that also the frequency of inelastic 
collisions with neutrals. As these collision are progressively more energetic with the increase in 
ions’ kinetic energy, the fragmentation threshold is finally reached.[58]  In higher-energy 
collision dissociation (HCD; formerly called higher-energy C-trap dissociation, from the bent 
multipole where it was originally performed) the fragmentation mechanism is similar, but the RF 
potentials are replaced with a high axial potential applied along the gas-filled multipole that acts 
as collision cell.[59] Both CID and HCD induce mainly the cleavage of the peptidic bond (C-N), 
resulting in the formation of complementary b- and y-type ions. In HCD, due to the higher energy 
of the process, not only the used ion activation time is generally much lower than in CID 
(typically, 0.1-1 ms against the 10-30 ms used in CID), but also the obtained product ions differ 
from CID, as b-ions, less stable than y-ions, are a minority and ultimately HCD returns mostly y-
ions. 
• Infrared multiphoton dissociation. 
Ions’ internal energy can be increased also by absorption of infrared (IR) photons. As the single 
IR photon absorption leads to a small increment in ion internal energy, multiple photons have to 
be absorbed to increase the vibrational energy of an ion to the bond dissociation threshold. 
Therefore this dissociation technique is termed infrared multiphoton dissociation (IRMPD).[60] 
Specifically, the FT-ICR mass spectrometer is equipped with a 10.6 µm CO2 laser, such that each 
photon absorbed accounts for a 0.117 eV increment in ions’ internal energy. This energy is 
typically lower than that gained through the collision of an ion with a neutral, with the 
consequence that the activation time in IRMPD is generally longer than in CID/HCD. 
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Nevertheless, IRMPD can lead to the peptide bond fragmentation (i.e., yielding b- and y-type 
ions) under both UHV conditions, like in the case of an ICR cell, and in the higher pressure linear 
ion trap. The internal energy relaxation process due to slow ion collisions with neutral gas 
molecules are to be overcome in the latter case.  Furthermore, the IR laser can be used for ion 
pre- or post-activation, by irradiating ions with a proper combination of irradiation time-laser 
power that induces an increase in ion internal energy without reaching the dissociation limit. 
2.3.3.2 Radical-driven tandem MS 
In contrast with activation methods based on the increase of ions’ vibrational energy, other 
activation techniques consist in the formation of a radical species within the poplypeptide 
backbone followed by backbone rupture. Several techniques can be used for the generation of 
radical ions, however the most commonly employed ones are based on the acquisition by a 
biomolecular multiply-charged cation of an electron. Particularly, the polypeptide fragmentation 
following the capture of a low energy (~1eV) electron is named electron capture dissociation 
(ECD),[61] whereas the fragmentation occurring after the transfer of an electron from a radical 
anion to a polypeptide cation is termed electron transfer dissociation (ETD).[62] 
ECD was discovered in 1998, whereas ETD was introduced six years later. The electron-cation 
reaction on which ECD is based can be expressed as follows: 
[ ] [ ]( ) fragmentsnHMenHM nn →+→++ •+−−+ 1   (eq. 2.7) 
Similarly, the ion-ion reaction characteristic of ETD is written as: 
[ ] [ ]( ) fragmentsAnHMAnHM nn →++→++ •+−−+ 1  (eq. 2.8) 
Where "A" represents the electron donor molecule.  
The mechanism underlying ECD is still under debate. The so-called "Cornell mechanism" 
postulates the electron attachment to occur at one protonated nitrogen of a basic amino acid 
residue, followed by electron relaxation with subsequent hydrogen transfer to the amide group, 
forming a radical aminoketyl group. The formation of this group finally leads to the 
fragmentation of the backbone. To explain phenomena observed in ECD and not accounted by 
this mechanism, the "Utah-Washington mechanism" was then introduced. This mechanism 
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hypothesizes the capture of the electron directly on the π* orbital of the amide group, with 
formation of the radical aminoketyl species followed by fragmentation. Both the mechanisms, as 
well as others suggested recently, agree on the non-ergodic nature of the process, that implies that 
the fragmentation occurs rapidly after the electron capture event, so that the energy acquired by 
the electron capture itself is not redistributed among all the vibrational levels of the polypeptide 
cation. A similar scenario is suggested for ETD, which energetically is an even softer process 
than ECD. 
It is apparent how the charge annihilation subsequent to the electron capture/transfer event 
prevents the possibility of using singly charged precursors for electron mediated tandem MS. 
From an analytical chemistry point of view, the fragmentation efficiency of ECD and ETD 
(expressed as ratio between overall abundance normalized to the charge state of product ions over 
abundance normalized to the charge state of the selected precursor ion) is a function of the charge 
state of the precursor ion. Conversely, the duration of the process (i.e., the electron-ion 
interaction period in ECD or the ion-ion interaction period in ETD) is progressively reduced by 
increasing the precursor charge state. Both the fragmentation techniques lead to the fragmentation 
of mainly N-Cα bond, with formation of even-electron c'-ions and odd-electron radical z•-ions. 
Depending on the lifetime of the [c'+ z•](n-1)+• complex, hydrogen rearrangement can take place 
resulting in the presence in the final spectrum of c• and z'-ions. For the sake of simplicity, N- and 
C-terminal product ions obtained by N-Cα bond cleavage will be referred to as c- and z-type ions. 
Note, that the cleavage at the N-terminal side of proline cannot lead to product ion formation due 
to the structure of this amino acid. 
Experimentally, ECD and ETD are performed under very different conditions. The former is 
commercially enabled uniquely in FT-ICR instruments, where cations interact with the electron 
beam produced by a cathode positioned close to the ICR cell under UHV conditions. 
Implementations of ECD in other types of mass spectrometers, specifically ion traps and 
TOF,[63, 64] although successful, have never been adopted on commercial instruments, and are 
replaced by more efficient ETD implementations. ETD, which requires the simultaneous trapping 
of precursor cations and radical anions, is performed in ion trap mass analyzers. The previously 
described maXis UHR qTOF and the LTQ Orbitrap of both Velos Pro and Elite series are ETD-
enabled mass spectrometers. The former uses the collision cell for trapping cations and anions, 
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both injected from the front end of the mass spectrometer, whereas the LTQ Orbitrap instruments 
are designed with radical anion injection from the back end followed by ETD in the linear ion 
trap. 
ECD and ETD are classically the ion activation techniques of choice for analysis of complex 
polypeptides or protein top-down analysis as their figures of merit include: (i) the capability of 
cleaving disulfide bridges;[65] (ii) the retention of labile PTMs, which are normally lost using 
collision-based ion activation of peptide ions;[66, 67] (iii) an extended sequence coverage with 
cleavage sites that are not limited to the N- and C-terminal ends of the protein, but are rather the 
function of charge location.[68] 
 
2.3.3.3 Further considerations on MS2 in a top-down approach. 
In the tandem mass spectrometry of a protein, i.e., a polypeptide containing more than 50 amino 
acid residues, a large number of fragmentation channels are open, not only due to the length of 
the peptide chain, but also because electrospray-generated ions are multiply charged and, 
therefore, a single cleavage site can be identified by complementary b- and y-type, or c'- and z•-
type ions present in different charge states. As a consequence, the population of each product ion 
is relatively limited in top-down MS. Therefore, differently from bottom-up MS, in TD MS the 
application of strategies aimed at maximizing the SNR of the measurements is inalienable. As 
previously mentioned, this parameter is important as it allows the determination of the 
monoisotopic peak and, moreover, high SNR peaks are characterized by improved mass 
accuracy. The typical strategy used to increase SNR consists in averaging a number of tandem 
mass spectra. For TOF mass analyzers, spectra can be averaged directly, eventually requiring 
recalibration whether they were obtained from different experiments. Differently, in FTMS what 
is averaged, following sophisticated procedures, are time-domain transients. This is necessary in 
the case of data acquired in separate experiments, but the same strategy is available in the 
commercial instrument software control, which can set a number of so-called microscans, 
corresponding to transients that are averaged before FT conversion. At a practical level, although 
no significant difference in terms of duty cycle or data acquisition rate is apparent between 
summing an x number of already FT-processed mass spectra and using the same x number of 
microscans in a single scan, the latter strategy results in a slightly higher SNR improvement than 
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the former.[69] It is useful to recall that the theoretical SNR improvement in the case of transient 
summation prior to Fourier transformation is proportional to the square root of the number of 
summed transients.[70] 
Another aspect that is important to consider is the role played by ion transmission in tandem mass 
spectrometry in space. As mentioned before, to this category belongs ETD, which is the 
activation technique on which most of the studies of this Thesis are based. While in TOF-based 
instruments the transmission of ions occurs without a substantial preference for low mass or high 
mass ions, in hybrid Orbitrap-based instrument there are instrumental parameters capable of 
affecting deeply the results of transmission from the first mass analyzer to the Orbitrap. As 
exemplified in Figure 2.12, which shows ETD mass spectra of a ~23 kDa protein, myoglobin, 
recorded in the Orbitrap, the gas pressure at the HCD cell, which is proportional to the gas 
pressure in the C-trap (as the gas is leaking from the HCD cell to the C-trap), and here is 
measured as the difference in pressure between gas switched on and off (i.e., the “∆p”), 
determines the quality of transmission of heavy, highly charged ions. It is apparent how, by 
reducing the gas pressure, the intensity of remaining precursor and of charge-reduced species is 
increased. Contemporary, as shown in the insets of each panel, the SNR of large, highly charged 
product ions such as c6710+, which has a mass of ~7.4 kDa, becomes progressively higher. On the 
contrary, the SNR of light product ions can be reduced. For a protein of the size of myoglobin the 
pressure reduction is generally beneficial, but for larger proteins, whose fragmentation generates 
in general a larger number of product ions, and specifically a high number of heavy fragments, 
favoring too strongly the transmission of large ions can be counterbalanced by the loss of 
information on the edges of the polypeptide chain.   
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Figure 2.12. Orbitrap ETD MS2 of horse myoglobin, precursor 22+. The four panels represent 
the broadband mass spectra obtained with different pressure of collision gas (N2) in the HCD 
chamber. Mass spectra are obtained by averaging 2 scans recorded at 120'000 resolution at 400 
m/z, each scan being composed of 10 microscans. Insets show the c6710+ ion in each mass 
spectrum. Differences in SNR are visually apparent. 
 
2.3.4 Data analysis 
The analysis of large polypeptides is generally not performed manually, although manual 
validation of results is often advised. Essentially, for large polypeptides like those typical of MD 
and, particularly, TD proteomic experiments, two operations are required, in the following order: 
(i) spectral deconvolution and (ii) product ion assignment. 
Deconvolution of a mass spectrum (either MS1 or MS2) is the operation through which ion 
clusters having different charge states are all transformed in their neutral or singly charged 
counterparts. Sometimes, depending on the software in use, this operation includes also peak 
centroiding. Software used for this Thesis include Maximum Entropy for processing Bruker BAF 
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files and Xtract,[71] THRASH[72] and MS-Deconv for Thermo Scientific RAW files. 
Deconvoluted spectra were processed for product ion assignment with either ProSightPC 
(Thermo Scientific) or MS-Align+.[73] 
Deconvolution is a fundamental operation as the assignment of product ions, i.e. the 
determination of cleavage sites, depends on its accuracy. Therefore, the efficacy in determining 
the charge state of an ion and the possibility of including a selected peak into an isotopic 
envelope distinguish the different available deconvolution algorithms. The problem is not trivial. 
As an example of the solutions introduced to remedy its complexity, the “averagine” concept 
used in THRASH can be cited. Averagine is defined as an “amino acid with weighted average 
mass” and it was firstly used for charge state determination in high resolution FTMS spectra.[74] 
THRASH applies the average amino acid concept for simulating a charge state distribution of a 
theoretical ion that resembles in mass the one under analysis. The match between this 
theoretically simulated distribution and the experimentally obtained one will be measured, and a 
threshold value on the similarity score can be applied to filter out spectra peaks prior to the 
subsequent product ion assignment process. Obviously, the results obtained by this method are 
heavily dependent on ion statistics, as a poor ion population will generally result in distorted 
isotopic distributions.[18] Finally, hydrogen transfer between c- and z-type ions (i.e., resulting in 
c
•
- and z'-type ions) in ETD experiments, or simple misassignment of the monoisotopic peak 
(usually mismatched with the first 13C peak of the isotopic distribution) by the deconvolution 
algorithm should be taken into account during validation of identified protein cleavage sites. In 
targeted top-down analysis, a partial solution for the problem is to search for ions which differ in 
mass from the theoretical ones ±1.003 Da (13C misassignment) or 1.007 Da (hydrogen transfer). 
The latter event is not often observed in top-down spectra due to the high charge states of product 
ions involved and the subsequent high coulombic repulsion (i.e., short lifetime of the [c'+ z•](n-1)+• 
complex). Unfortunately, manual validation of top-down spectra is not used when this 
methodology is used for large scale studies (e.g., proteomics). Description of the strategies used 
for reducing the misassignment of monoisotopic peaks in top-down spectra can be found in 
Chapter 6, Papers V and VI. 
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Chapter 3: ECD high resolution MS in the study of peptides  
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This Chapter is focused on the investigation of two post-translational modifications, namely 
deamidation and transamidation, by electron capture dissociation and Fourier transform - ion 
cyclotron resonance MS. Hereinafter reported considerations are based mainly on this published 
research article, enclosed in Chapter 6: 
• Deamidation and transamidation of substance P by tissue transglutaminase revealed by 
electron-capture dissociation Fourier transform mass spectrometry (paper I). 
 
3.1 Relevance of non-widely studied PTMs in contemporary biology and biotechnology. 
For reasons related to both their undisputable biological relevance and also the relative ease in 
identification via MS-based analysis, a restricted number of PTMs has historically been the 
center of proteomic studies. To this list belong phosphorylation,[75] methylation[76] and 
acetylation.[77-79] Biologically, reversible phosphorylation represents the main way to modulate 
enzymatic activity, protein-protein interactions and other signal transduction processes; 
methylation and acetylation play important roles in determining the functionality of relevant 
classes of proteins such as histones and tumor suppressor proteins. From an analytical chemistry 
point of view, these three PTMs induce a pronounced mass shift in the modified residues, and 
although proteomic research is mainly based on collision-based ion activation techniques, which 
do not always preserve labile PTMs, neutral losses can be used for localization of these 
modifications. On the other hand, confident identification of modifications introducing small 
mass variations in an amino acid residue requires high mass resolution and accuracy MS. This is 
the case, for instance, of arginine citrullination[80] and the hereinafter described glutamine and 
asparagine deamidation. Deamidation converts Gln and Asn in glutamate and aspartate, 
respectively, with a mass shift of +0.984 Da. This implies that deamidation replaces a polar 
amino acid with a charged one, with potential structural consequences on the involved protein. 
Importantly, deamidation occurs via the formation of a cyclic intermediate, so that the final 
product can be a structural isomer of Glu and Asp, like γ-glutamic acid or β-aspartic acid (also 
known as iso-Asp), respectively (Figure 3.1).[81] 
Notably, deamidation is a spontaneous phenomenon believed to target proteins for 
degradation,[82] but it can also be enzymatically induced. Tissue transglutaminase (tTGase) is an 
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enzyme that can deamidate glutamine residues. It has been reported to play a major role in celiac 
disease and it is suspected to contribute to the onset of neurodegenerative pathologies such as 
Alzheimer’s disease and Parkison’s disease.[83, 84] However, as its name indicates, tTGase main 
catalytic activity is transamidation, a reaction through which this enzyme can form a new 
covalent bond between the side chains of Gln and Lys, introducing protein cross-linking.  
Therefore, an in vitro study based on the activity of tTGase on model peptides can serve to 
investigate the potential of high resolution MS not only in elucidating a specific enzymatic 
activity but also in future application to biotherapeutics quality control. 
 
3.2 Radical-driven ion activation as a tool for deep characterization of deamidation and 
transamidation. 
Although the evidences of deamidation and subsequent amino acid rearrangements leading to the 
formation of structural isomers were first detected in MS-base studies applying collision-induced 
ion activation, electron capture dissociation and electron transfer dissociation introduced new 
possibilities for detailed analysis of deamidation products. Specifically, ECD has been used for 
the quantification of deamidation in O2 labeled peptides,[85] discrimination of α-glutamic acid 
and γ-glutamic acid[86] and finally the differentiation of α-aspartic acid from β-aspartic acid, 
even at a proteome-wide scale.[87, 88] ETD was instead applied to the differentiation of α-Asp 
from β-Asp.[89] The distinction between amino acid isomers is achieved through the observation 
of specific reporter ions that can be identified in the ECD/ETD tandem mass spectrum only in 
presence of non-α amino acids.  
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Figure 3.1. Pathways leading to the formation of structural isomers of Asp and Glu as a 
consequence of deamidation of Asn and Gln, respectively. Left panel shows the formation of a 
succinimide intermediate with possible production of either α-Asp or β-Asp. Right panel 
illustrates the formation of α-Glu or γ-Glu from a glutarimide intermediate. Schemes derived 
from [87] and [86] 
Despite the potential demonstrated by ETD and ECD in resolving structural amino acid isomers, 
their application has been so far limited uniquely to peptides, with the notable exception of the 
top-down study on β2-microglobulin by Li et al. Even in this case, however, ECD was used as 
MS3 on an isolated CID-produced fragment of β2-microglobulin, and not directly on the intact 
protein, despite its relatively small molecular weight of ~11.7 kDa.[90] This methodology, in 
other words, relies on low abundant ions that are difficult to detect in convoluted top-down 
tandem mass spectra. Extending the mass range of precursor ions for which the isomerization is 
detectable by ECD/ETD MS is one of the future goals for applying routinely this methodology to 
the analysis of biotherapeuticals. 
Results published in the research article about deamidation and transamidation of the 
undecapeptide substance P show no evidence of isomeric rearrangement of Gln. Nevertheless, in 
this study the intriguing and at the same time challenging aspect is represented by the competition 
of two mechanisms, deamidation and transamidation, both possible for this peptide (which 
contains within its sequence both Gln and Lys residues) and that might use as a substrate two Gln 
residues, consecutively placed along the peptide sequence. Tandem mass spectra generated by 
collision-induced dissociation generally present side chain losses, and furthermore CID generally 
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cleaves the amide bond at the backbone (C-N bond) and potentially other labile bonds such as 
those of several PTMs. As illustrated in Figure 3.2, transamidation leads to the formation of an 
amide bond interconnecting the side chains of glutamine and lysine. 
 
Figure 3.2. Schematics of deamidation and transamidation catalyzed by tissue transglutaminase. 
The combination of high resolution MS and ECD is fundamental for elucidating the order in 
consecutive deamidation of both the Gln residues present in substance P, as well as for 
determining the position of the Gln residue involved in transamidation without rupture of the 
newly formed bond.  
The experience reached through this proof-of-principle study will be important for future 
applications on biopharmaceuticals and, particularly, organic molecule-labeled biotherapeutics.  
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Chapter 4: High mass accuracy MS for biotechnological applications 
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After the description of results achieved by the investigation of post-translational modifications at 
the peptide level (Chapter 3), and before introducing top-down and middle-down MS approaches 
for structural characterization of large proteins, a logical interlude is represented by the 
application of different MS-based approaches, from intact mass measurement to bottom-up MS, 
for the qualitative and quantitative study of a typical biotherapeutic, an IgG1, an its major PTM, 
N-glycosylation. The information and experimental results on which the present Chapter is based 
derive from the following peer-reviewed research article: 
• Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E 
cells 
 
4.1 N-linked glycosylation in biotechnology and mass spectrometry. 
Glycosylation in proteins is differentiated between N- and O-linked glycosylation, the former 
referring to oligosaccharidic chains linked to Asn residues, the latter indicating short sugar chains 
(generally mono-, di- or tri-saccharides) covalently bond to Ser and Thr residues.[91-94] For 
most biotherapeutics, N-linked glycosylation is the most relevant as it usually deeply affects the 
biological activity and function of the protein. Erythropoyetin, follicle-stimulating hormones and 
antibodies are some examples of glycosylated biopharmaceutical proteins.[95, 96] Furthermore, 
N-glycosylation also conditions the half-life of antibodies in serum (vide infra).[97]  
From a structural point of view, N-linked oligosaccharides are relatively long and branched 
heteropolymers, with multiple linkage possibilities among single monomers; therefore, their MS-
based analysis is performed by limiting the size of the analyte, either by releasing the glycans 
from polypeptides or by proteolytically digesting the glycoprotein into peptides. Enrichment or 
purification procedures are hence needed prior to MS experiments. In principle, a complete 
structural analysis of glycans, released or associated to short peptides, is composed of MS1 
followed by MS2. Product ions produced by fragmentation of released sugars have a specific 
nomenclature that accounts for all the possible bond ruptures observed in MS2. 
Interestingly, different ion activation methods lead to complementary information: in the case of 
released glycans, vibrational-based (e.g., CID or IRMPD) and electron-based (e.g., ECD or ETD) 
fragmentation techniques are known to cleave different bonds in the oligosaccharidic chains. 
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Similarly, the analysis of glycopeptides by CID or IRMPD generates primarily fragmentation of 
the sugar moiety, whereas ETD and ECD mainly conserve the PTM intact and produce extended 
cleavage of the peptide backbone. 
In summary, it is apparent how the biological and biotechnological relevance of N-glycosylation 
is matched by the complexity of MS-based glycan analysis. 
 
4.2 Conceptual and practical relevance of the obtained results 
In principle, although chemistry alone would allow an extremely large number of different 
combinations from a reduced number of possible initial monomers, actual biological processes 
are normally limited to a reduced fraction of the theoretical possibilities. This is the case for N-
linked glycans, which exist in a restricted number of combinations. 
This consideration enables creation of searchable databases, e.g., GlycoPep DB,[98] which group 
known glycopeptides according to the protein source, i.e., their expression system. N-linked 
glycosylation is, in fact, a multistage process which requires different enzymes to be 
accomplished.[31] Type and stoichiometry of these enzymes depend on the source organism.[99] 
As a consequence, when high mass accuracy MS is used, within a small mass tolerance (i.e., of a 
few ppm) in general only one possible glycan structure with biological relevance can be 
associated to the monoisotopic mass of a glycopeptide of interest. Obviously, only tandem mass 
spectrometry can confirm linkage and branching between monomers, as GlycoPep DB returns 
only a list of monomers. 
On these bases, high mass accuracy MS was therefore applied, using an FT-ICR mass 
spectrometer, to perform identification and subsequent label-free quantitation of tryptic 
glycopeptides obtained from ten batches of an IgG transiently expressed in HEK293E cells, the 
final goal being the batch-to-batch comparison of IgG glycosylation. On-line LC-MS of tryptic 
peptide was employed, with separation of modified peptides carried out with a special variant of 
traditional reversed phase chromatography. Traditional aliphatic chain-based stationary phases 
(e.g., the so-called C4, C8 or C18) poorly bind glycopeptides, whereas porous graphitized carbon 
columns efficiently retain peptides modified with a large hydrophilic moiety such as 
glycopeptides.  
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Although the composition of single oligosaccharidic chains derived from tryptic proteolysis of 
the IgG of the ten batches already provided a good estimation of the similarity of overall IgG 
glycosylation, a final confirmation in this sense could be inferred only from glycoforms, that is 
by IgG intact mass measurements. High resolution qTOF MS was therefore employed for 
obtaining a qualitative estimation of the similarity in glycoform abundances for the recombinant 
IgG expressed in the ten batches. 
In conclusion, high mass accuracy and resolution MS, proposed in its different possible uses, 
elegantly served the purpose of answering an intriguing applied biology question, leading to the 
validation that transient expression of IgG with a robust protocol can effectively result in the 
production of batch-to-batch consistent IgG glycoforms.  
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Chapter 5: ETD-based top-down and middle-down MS of large 
proteins 
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This Chapter is dedicated to the ETD top-down and middle-down MS analysis of large proteins. 
Specifically, the focus is on the structural characterization of ~150 kDa monoclonal antibodies. 
The present summary is based on the experimental results reported in the following research 
studies included in Chapter 6: 
• Top-down analysis of 30-80 kDa proteins by electron transfer dissociation time-of-flight 
mass spectrometry (paper III). 
• Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass 
spectrometry (paper IV). 
• Analysis of intact monoclonal antibody IgG1 by electron transfer dissociation Orbitrap 
FTMS (paper V). 
• Top-down analysis of immunoglobulins G with electron transfer dissociation high-field 
Orbitrap FTMS (paper VI). 
• Middle-down analysis of monoclonal antibodies with electron transfer dissociation 
Orbitrap FTMS (paper VII). 
The reasons for thinking of the structural analysis of intact antibodies as the acme of a mass 
spectrometry-based research aimed at characterizing large proteins in a top-down fashion are 
intrinsically linked to the complexity of these biomolecules, as described hereinafter (Section 
5.1). Preliminary steps evaluating the feasibility and efficiency of the analysis of large proteins 
by electron transfer dissociation MS are also illustrated (Section 5.2). Finally, results of different 
TD MS analyses of antibodies are collectively analyzed (Section 5.3), for outlining current 
achievements and limitations, and proposing therefore possible alternatives or complementary 
approaches that will not completely sacrifice the theoretical advantages of TD MS, such as 
middle-down MS (Section 5.4).     
 
5.1 Monoclonal antibodies. 
Antibodies or immunoglobulins (Igs) are proteins playing an important role in the immune 
system. Produced by B cells, they are characterized by a quaternary Y-shaped structure composed 
by two identical light chains, and two identical, N-glycosylated heavy chains.[100]  
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Igs primary function is the recognition and binding of a specific molecule, known as an antigen. 
Each region formed by the combination of the N-termini of light and heavy chains (i.e., the 
superior tips of the "Y") is called a paratope which selectively binds a specific portion of the 
antigen, or epitope. Monoclonal antibodies are produced by a single B cell clone and, being all 
identical, bind exclusively a single epitope on the antigen. Polyclonal antibodies, in contrast, 
represent a mixture of Igs produced by different clones and are generally active against different 
epitopes on the same antigen. 
Among immunoglobulins we distinguish different classes or isotypes, differentiated by the kind 
of heavy chain they present. In placental mammals we recognize 5 isotypes: IgA, IgD, IgE, IgG 
and IgM. IgGs are the most common in human blood and the most studied. Immunoglobulins G 
are further distinguished in 4 subclasses, named with numbers in decreasing order of abundance 
in human blood. 
The IgG subclass is the object of research projects presented in this Thesis also due to their 
increasing relevance as a biotherapeutic, i.e., as a biotechnological drug. Particularly, most of the 
IgGs already approved by the Food and Drug Administration and available on the market belong 
to the IgG1 subclass, and only the IgG3 subclass is not targeted as potential biotherapeutic 
molecule at the moment.[101] 
If we take the structure of an IgG1 as reference (structural differences among the subclasses are 
limited), two characteristics are immediately clear, Figure 5.1. First, the presence of so called 
“constant” and “variable” domains in both light and heavy chains (indicated by the letters “V” 
and “C”, respectively, followed by the initial of the chain where they are located and, eventually, 
a progressive number). Secondly, a high number of disulfide bonds (sixteen for IgG1 and IgG4, 
higher number for IgG2 and IgG3). These bonds are either inter-molecular, connecting each light 
chain with one of the heavy and the two heavy chains between themselves, or intra-molecular. 
As mentioned above, the regions responsible for the high specific and selective binding of an IgG 
to its antigen are the tips of the “Y” structure, where the variable regions are located. On each 
variable region of each chain there are three short sequences (i.e., generally not longer than 15 
amino acids, and often much shorter) known as complementarity determining regions (CDRs). 
The folding of the IgG, with heavy and light chain bound together and exposing the 
corresponding CDRs, forms the antigen binding domain. From a genetic point of view, the hyper 
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variability of CDRs, required for producing an extremely high number of different antibodies 
against all possible antigens, finds its origin in a phenomenon called “V(D)J recombination”, 
which is a DNA rearrangement process that randomly combines Variable, Diverse and Joining 
genes, originally separated in the genome, in a unique one before its translation in mRNA.[102] 
Another common way for classifying regions of an IgG is based on the proteolytic action of 
specific enzymes such as papain. This protease cleaves the IgG above the junction between the 
two heavy chains (so-called hinge region), producing two identical “fragments antigen binding” 
(Fab), each composed of one light chain and the N-terminal portion of one heavy chain (also 
known as Fd), and a “fragment crystallizable” (Fc), which biologically is important for binding 
the IgG to its receptor and structurally is a dimer of two identical C-terminal portions of the 
heavy chain (called Fc/2). 
 
Figure 5.1. Schematic representation of an immunoglobulin of the G class (isotype: IgG1).  
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The half-life of immunoglobulins G in blood is very high, reaching or even exceeding 30 days. 
This is mainly due to their extremely robust and compact structure. Besides the already 
mentioned hinge region, the only highly flexible areas in an IgG correspond to the solvent 
exposed loops interconnecting consecutive variable or constant domains, characterized by the 
presence of polar and basic amino acid residues. Each domain is, in fact, highly structured and 
constitutes a compact configuration known as immunoglobulin domain.[103] Observed also in 
other classes of proteins than antibodies, these domains are characterized by the presence of 
seven to nine beta strands organized in two antiparallel beta sheets. In IgGs, the rigidity of the 
immunoglobulin domain is enhanced by the presence of an intra-molecular disulfide bridge, 
Figure 5.2. 
 
Figure 5.2. Three-dimensional structure of an immunoglobulin domain. The disulfide bond is 
highlighted. Image from crystallographic data of the IgG1 Trastuzumab (PDB entry: 3D6G). 
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The role of mass spectrometry in the characterization of immunoglobulins is fundamental for 
different reasons. First, the size of these proteins complicates the analysis with other traditionally 
employed techniques such as gel electrophoresis. Secondly, these antibodies can carry several 
different post-translational modifications, whose masses are always very small compared to the 
overall size of the intact protein. Among the most common PTMs we find: N-glycosylation 
(+>1000 Da), which plays a role in antibody-dependent cell-mediated cytotoxicity and in 
complement-dependent cytotoxicity;[104] clipping of C-terminal Lys;[105] and block of the N-
terminus due to conversion of Gln or Glu to pyroGlu.[106] Aside of these PTMs involving the 
chain termini or the Fc region, others can be found in the CDRs where they can effectively affect 
or even impair the binding capability of the IgG. Among these we list: deamidation of Asn and, 
less commonly, Gln (+0.984 Da); isomerization of Asp to iso-Asp; racemization of Asp; as well 
as oxidation of Met and Trp (+16 Da). 
Finally, it is absolutely important to confirm the Ig sequence obtained by genomic data, 
particularly for the CDR domains, given the high variability of these sequences. 
Traditionally, detailed characterization of Igs has been carried out primarily by bottom-up 
MS.[107] The combination of data derived from the digestion of the antibody by different 
proteases can effectively result in high sequence coverage (up to 100%) and facilitates the 
identification of both large (e.g., glycosylation) and small (e.g., deamidation) PTMs.[108] 
Nevertheless, top-down as well as middle-down mass spectrometry own theoretical and practical 
advantages over bottom-up MS. As previously mentioned, the measurement of intact mass of the 
antibody or of some large fragments (e.g., the Fc) is fundamental for a first assessment of the 
main glycoforms, as BU MS can provide detailed information about single glycans, but not about 
their combinations. Furthermore, the intact mass can be used for determining the presence of 
possible truncation or unexpected modifications. This is of particular importance for 
bioengineered Igs, which are often expressed in host system which differ metabolically and 
genetically from the source system of the Ig. 
Considering the increasingly growing interest in IgGs as biopharmaceuticals, the challenges that 
an MS-based analysis has to face are numerous. Aside from the traditional primary sequence 
confirmation or, in the case of de novo sequencing, determination, important goals are 
represented by detection of disulfide bond scrambling, localization of covalently bound organic 
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molecules in the so-called antibody-drug conjugates, precise determination of binding sites. 
Finally, if currently these analyses are performed on selected, isolated antibodies, a future goal is 
surely the extension of the throughput of analysis, to be able to accurately investigate IgGs 
present in mixtures. 
The research on which this Thesis is based does not pretend to focus on all the above mentioned 
tasks. It is, on the contrary, specialized essentially on the structural analysis of monoclonal 
antibodies by a single activation technique, electron transfer dissociation. Conceptually, the 
starting point is represented by the analysis of a model protein to evaluate ETD capabilities in TD 
MS. 
 
5.2 ETD analysis of intact transferrin: importance of disulfide bridges and protein gas 
phase conformation. 
Experimental results contained in paper III are useful for describing in detail the workflow 
required for a complete protein analysis by ETD top-down MS, from parameters affecting 
experimental results to, notably, data analysis. Although the introductory part is based on  ~29 
kDa carbonic anhydrase, the experimental part is primarily focused on serotransferrin. 
This is a ~79 kDa protein commonly employed as a standard in bottom-up MS experiments. 
Besides the large number of tryptic peptides it can generate, one of the main features of this 
protein is the presence of nineteen disulfide bridges, which can hinder efficient fragmentation in 
TD MS.  
The ETD-based analysis of oxidized transferrin described in paper III was concluded with the 
assignment of mainly c-type product ions derived from a disulfide-free loop interconnecting two 
disulfide protected areas. Nevertheless, four of the identified N-terminal containing (i.e., c-type) 
product ions arose from disulfide-protected regions. After chemical reduction of disulfide bridges 
prior to MS analysis, ETD generated a different fragmentation pattern, with most of the assigned 
c- and z-type ions deriving from areas, generally not far from the termini, previously protected by 
disulfide bonds. Effectively, the central portion of the protein sequence remained unaffected by 
fragmentation.  
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These two data sets provide good evidences for a number of important conclusions. First, 
although ETD is capable of cleaving disulfide bonds the probability of this occurrence seems 
relatively low in this large, structured protein. Secondly, the imbalance towards N-terminal 
assigned product ions characteristic of the oxidized proteins, which disappears after reduction 
(for the reduced protein 34 and 39 c- and z-type ions were identified, respectively), might suggest 
that also protein tertiary structure is playing a non-negligible role in determining the final protein 
fragmentation, most likely by limiting the residues susceptible to protonation and by preventing 
an easy dissociation of fragments that are tightly bound together by non-covalent interaction. 
Finally, as general consideration, the fragmentation maps for the two investigated protein states 
(i.e., oxidized and reduced) suggest that disulfide bonds direct the protein fragmentation, 
determining the areas susceptible of extended sequencing. 
 
5.3 Top-down MS of immunoglobulins G. 
The here summarized results should be interpreted both as an attempt of improving the 
characterization of intact immunoglobulins G as a specific class of biomolecules, and also, more 
generally, as an exploration of  the current limits in ETD-based top-down FTMS analysis of large 
proteins. 
 
5.3.1 Intact mass measurement and glycoforms 
High resolution time-of-flight mass spectrometry and Orbitrap FTMS demonstrated similar 
performances in terms of mass accuracy for the determination of IgG glycoforms. Both the 
employed mass analyzers were used on-line coupled to reverse phase LC, which was solely 
applied for ensuring efficient desalting and partial denaturation of the antibody. Upon averaging 
of all the spectra recorded during elution (typical elution time of some minutes, due to to LC 
column overloading), the final mass accuracy for the most abundant glycoforms in a single LC 
run was lower than 1 Da for both the mass analyzers. Although the use of different IgGs prevent 
a direct comparison between the two setups, time-of-flight mass spectrometry seems to present an 
advantage over Orbitrap FTMS in detecting low-abundant proteoforms (e.g, essentially 
glycoforms), probably due to the higher dynamic range of this technology over FT-based 
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instruments. It is important to underline, however, that in both cases no isotopically resolved 
information was obtained and all the values are referred to protein average mass. A more detailed 
discussion about glycoforms is reported in Chapter 4.  
 
5.3.2 Sequence coverage and disulfide bridge cleavage of IgGs by ETD MS/MS 
The capabilities of electron transfer dissociation of producing extensive backbone cleavage and 
also induce rupture of disulfide bonds were tested on intact human IgGs of subclass 1 and 2 as 
well as on murine IgG1. Independently from the employed MS platform, the results we obtained 
overtook the previous state-of-the-art in MS/MS of IgGs. The main reference in this sense was 
represented by report of Bondarenko et al. who performed CID on reduced and alkylated isolated 
chains of a murine IgG2 on a hybrid Orbitrap XL mass spectrometer.[109] The final sequence 
coverage for that IgG was attested around 10%. In our first study, conducted by ETD qTOF mass 
spectrometry, we reached ~15% for a human IgG1 and ~21% for the murine IgG1. It is 
noteworthy that the above mentioned difference in sequence coverage derived mostly from the 
sequencing of the N-terminus of both heavy and light chains:  in the case of the murine IgG, we 
achieved almost complete sequencing of the region preceding the Cys residue involved in the 
intra-molecular disulfide bond of the variable domains of both chains; on the contrary, poor 
sequencing for the same area was reached for the human IgG1. This might reflect differences in 
the (gas phase) conformation of the variable domains of the two IgGs. Following studies carried 
out on two different generations of ETD-enabled hybrid LTQ-Orbitrap mass spectrometers 
pushed the sequence coverage up to ~32% for a human IgG1. The increase in identified unique 
backbone cleavages can be attributed to both the higher resolution of the mass analyzer and, 
particularly, to improved ETD efficiency. The latter aspect derived from: (i) a refined 
experimental design that took advantage of the acquired experience in fragmentation of large 
proteins, and substantiated in the selection of multiple highly charged precursors for ETD 
(allowed by a large isolation window, up to 600 Th) and the variation of ETD duration time in 
different experiments; (ii) geometry of the ETD reaction cell (linear ion trap) that, presumably, 
offers superior trapping of both multiply-charged cations and radical anions, as proved by 
reduced ion-ion reaction time required for maximum sequence coverage in comparison with the 
qTOF platform (ETD duration of 10-25 ms versus ~60 ms). 
83 
 
A common feature of all the here presented studies is the application of strategies aimed at 
improving the spectral signal-to-noise. Depending on the ion detection principle used by the 
specific mass analyzer the operations on data recorded in single LC-MS/MS experiments were 
conducted directly on m/z spectra (qTOF) or on time-domain (transient) signals (Orbitrap). The 
creation of high SNR spectra from data recorded in consecutive LC runs allowed the reduction of 
sample preparation to the minimum, differently from what typically happens when proteins have 
to be highly purified and desalted off-line for direct infusion. The main limitation of this 
approach consisted in its time-consuming nature, which we tried to balance in our most recent 
work by optimizing both ETD experimental parameters (i.e., selection of highly charged 
precursors) and the transfer efficiency of product ions from the linear ion trap to the high 
resolution mass analyzer (Orbitrap). 
Finally, these ETD experiments showed the presence of backbone cleavages in disulfide-
protected areas. Most of those belong to the CH3 domain, which probably has a relatively loose 
and/or flexible structure, particularly towards the C-terminus. Several basic residues are also 
located within this C-terminal portion of this globular domain. The presence of these residues 
could be important not only as protonation might induce unfolding as a consequence of 
Coulombic repulsion, which also favors the gas phase dissociation of the non-covalently bound 
fragments after fragmentation, but also because the sequencing of disulfide protected areas 
requires a double ETD event to occur, which implies double charge reduction. 
 
5.3.3 Preferential ETD cleavage sites in intact IgGs: a product ion abundance analysis 
Independently from the MS platform in use, electron transfer dissociation on IgG resulted in the 
fragmentation of the same portions of sequence within a specific IgG subclass. Furthermore, if 
we exclude from the analysis the above mentioned complete sequencing of the N-terminal ends 
of light and heavy chains achieved for murine IgG1 only, we can extend the similarity of 
fragmentation pattern to all the analyzed IgGs, independently from subclass they belong to. More 
in detail, as previously described we found only one disulfide-protected domain which was 
highly sequenced (i.e., the CH3 domain), whereas the remaining fragmented areas corresponded 
to disulfide-free loops interconnecting consecutive immunoglobulin domains. This is the case for 
both heavy and light chain. This common fragmentation pattern might find an explanation in the 
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retention of a relatively compact tertiary/quaternary structure in the gas phase, caused primarily 
by the difficulty in unfolding disulfide-protected immunoglobulin domains. A similar scenario 
would also give reason of the apparently impassable limit of ~30% sequence coverage that we 
reached by ETD and corresponds also to state-of-the-art results achieved by ECD. Technical 
expedients such as the reduction of the HCD gas pressure in the hybrid Orbitrap Elite mass 
spectrometer (see Chapter 2 and paper VI) helped in gaining higher SNR mass spectra but did not 
substantially changed the final sequence coverage. 
Passing from a general view to a detailed observation only of the sequenced areas, it appeared 
manifest that specific cleavage sites were identified by several highly intense product ions of 
different charge states, whilst other cleavage sites had to be manually verified due to the presence 
of a single product ion of medium or low intensity. The phenomenon was validated when, on side 
of the assignment of typical ETD product ions, namely c- and z-type ions, also y-type ions were 
searched (for the light chain and, importantly, the C-terminal portion of the heavy chain). Most of 
the identified y-ions arose from cleavage sites for which related z-ions in multiple charge states 
had been discovered.  
A product ion abundance (PIA) analysis on C-terminal containing product ions (i.e., z-ions) on 
different IgGs revealed that, as expected, a large discrepancy exists between product ions derived 
from disulfide-free and disulfide-protected regions, the formers being substantially more 
abundant than the latters. Furthermore, specific hot spots of fragmentation, luckily conserved 
between different IgGs due to their positioning in the constant domains and hence pinpointed in 
experiments involving different IgGs, were identified. Notably, they are located in proximity of 
basic residues. Increase of ETD duration caused reduction in the average charge state of assigned 
product ions, presumably due to secondary electron transfer events (and possible re-
fragmentation), but did not dramatically modify the general fragmentation landscape which 
remained dominated by the presence of product ions from disulfide-free areas. These facts come 
out in favor of the retention of a relatively compact structure by IgGs from ionization to the gas 
phase. Notably, this hypothesis would account for the peculiar IgG sequencing pattern which 
alternates highly sequenced regions with areas totally unaffected by ETD. To a limited extent, 
PIA analysis of top-down spectra of highly-complex, large proteins might be useful for 
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determining or hypothesizing disulfide bonds connectivity and, possibly, discriminate between 
solvent exposed (i.e., highly protonated) regions from those inaccessible to the solvent.   
 
5.3.4 What do we learn from the ETD-based top-down MS analysis of IgGs? 
Electron transfer dissociation is an ion activation technique whose efficiency is increased with the 
charge state of the precursor ion. Therefore, one would expect that an extremely short ion-ion 
reaction time is required for a ~150 kDa protein fragmentation. Nevertheless, despite the use of a 
high number of electron donor radical anions, in large excess relative to the number of protein 
cations, activation times needed to reach good sequence coverage are in the order of tens of 
milliseconds. The results of the PIA analysis combined with a look at the localization of basic 
amino acid residues and disulfide bridges, suggest that structural constraints present in the gas 
phase are the major limitation for obtaining a more extended sequence coverage than the 
achieved ~30%. This hypothesis would find additional support in the observation that only a few 
identified fragments are larger than 20 kDa, which can be the consequence of a difficulty in 
cleaving all the inter-molecular disulfide bonds: generally only the intra-molecular ones are 
considered, but it must be underlined that currently the data analysis software cannot deal with 
internal fragments (i.e., non-canonical product ions where both the termini has been cleaved) nor 
with branched product ions composed by more chains (or parts of them). Effectively, the 
presence of these specific ions is suggested not only by the high number of unassigned peaks in 
IgG top-down spectra, but also by the results achieved through the PIA analysis, which shows 
evidences of secondary fragmentation of z-type ions by increasing ETD duration. 
Moreover, structural constraints are not only reducing the finally achieved sequence coverage, 
but are impeding the analysis even of large PTMs (e.g., the portion of the heavy chain where the 
glycosylation is located is not sequenced). The only confidently assigned PTMs so far were 
located at the chain termini. 
In conclusion, while improvements for TD MS of IgGs can be suggested on the base of the 
achieved results, approaches alternative to TD should also be pursued, ideally provided that they 
are based on the removal of major aforementioned structural constraints without affecting the 
sample quality (e.g., by introducing artifacts) like it can happen in BU MS. 
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5.4 Reducing IgGs to large polypeptides: a middle-down MS approach. 
Processing an IgG in solution prior to its gas phase analysis represents the most logical approach 
to overcome the limitations in TD MS sequencing caused by retention in the gas phase of tertiary 
and quaternary structure of the IgG. Nevertheless, in order to avoid problems typical of BU MS 
the final size of the polypeptides produced in the sample preparation step must be adequately 
large, and the sample processing itself has to be fast, robust and occur under mild conditions. 
The immunoglobulin-G degrading enzyme of Streptococcus pyogens (Ides) shows a papain-like 
activity, cleaving the IgG at the hinge region and releasing two Fab fragments and an Fc.[110] 
Differently from papain, the peculiarity of this enzyme is its high specificity and, most 
importantly, high efficiency: the proteolytic reaction can be performed in only ~30 minutes. The 
proteolysis is followed by denaturation and chemical reduction of disulfide bridges to yield three 
fragments of ~25 kDa each: light chain (Lc), C-terminal portion of the heavy chain (Fd) and the 
monomeric Fc (Fc/2). Notably, the entire protocol is carried out under optimal storage conditions 
for the IgGs (i.e., in IgG formulation buffer of slightly acidic phosphate buffer), and finally in 
slightly acidic environment which decreases the possibility of reduced disulfide bonds to be re-
oxidized, and thus eliminates de facto the need of alkylating free thiols. 
Polypeptides of 25 kDa require analysis conditions, from the point of view of the employed mass 
spectrometry parameters, typical of TD MS. Therefore, in Orbitrap FTMS (the only technique 
employed for this analysis in the Thesis) 10 microscans were used for both MS1 and MS2 spectra. 
Moreover, other settings concerning ion transmission (e.g., reduced HCD gas pressure) were 
borrowed from the analysis of intact IgGs. In addition, reversed phase liquid chromatography was 
used not for desalting but for polypeptide separation, which was fully achieved (i.e., with 
baseline resolution of chromatographic peaks) under ultrahigh pressure conditions (UPLC). The 
beneficial consequences of the application of typical TD MS instrumental parameters coupled 
with UPLC are apparent when results of single ETD LC-MS/MS runs are analyzed: almost 50% 
sequence coverage is obtained for Lc and Fc (including the localization of the N-glycosylation 
site) with the average of 7 mass spectra (corresponding to 70 microscans). Similarly to TD MS, 
upon averaging of transients derived from distinct ETD-based LC runs and variation of ETD 
activation time, for the same two fragments almost 70% sequence coverage was reached. 
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Importantly, the method was demonstrated to be sensitive enough to localize up to two oxidized 
methionine residues in the Fc. 
Considering the similarity in size of the three IgG fragments and the sharpness of elution peaks 
under UPLC conditions, the results obtained in targeted studies, both in terms of chromatographic 
separation and also of MS-based protein sequencing, were encouraging enough to suggest the 
application of the same method to the analysis of IgG mixtures, which represents an important 
future goal. Preliminary results showed that reversed phase chromatography can partially 
separate a simple mixture of these polypeptides. This is an important achievement given that the 
analysis of mixtures of intact IgGs cannot rely on reversed phase chromatography and would 
require the use of an alternative chromatographic separation such as ion exchange 
chromatography (IEC). However, IEC is highly sensitive to the presence of specific PTMs such 
as charged glycans or deamidated amino acids and therefore can produce the elution of different 
proteoforms of the same IgG in multiple peaks, increasing the chromatogram complexity.  
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Deamidation and Transamidation of Substance P by Tissue Transglutaminase
Revealed by Electron-Capture Dissociation Fourier Transform Mass
Spectrometry
Luca Fornelli,[a] Adrien W. Schmid,[a, c] Luigino Grasso,[b] Horst Vogel,[b] and
Yury O. Tsybin*[a]
Introduction
Tissue transglutaminase (type 2 transglutaminase; tTGase)
is a ubiquitously expressed enzyme that is found extra- and
intracellularly.[1] tTGase is the only member of its protein
family to be expressed in human brain.[2] It is involved in
several biological processes[1] and acts as a GTPase[3] and a
kinase.[4] The most studied biological function of tTGase
enzyme is the formation of peptidase-resistant isopeptidic
bonds in a Ca2+-dependent acyl-transfer reaction.[1,5–7]
Under physiological conditions, the acyl-donor group can be
the g-carboxamide of a peptidyl-glutamine (Gln) residue,
whereas the acyl-acceptor group can be either a low-molecu-
lar-weight primary amine or the e-amino group of a lysine
(Lys). In the latter case, the transamidation reaction (also
known as a cross-linking) yields an e-(g-glutamyl)lysine
Abstract: Tissue transglutaminase
(tTGase) catalyzes both deamidation
and transamidation of peptides and
proteins by using a peptidyl glutamine
as primary substrate. A precise consen-
sus sequence for the enzyme is un-
known and the ratio between deami-
dated and transamidated (or cross-
linked) reaction products is highly sub-
strate-dependent. Due to its overlap-
ping body distribution with tTGase and
ease of manipulation with tandem mass
spectrometry, we used the neuropep-
tide substance P as a model to investi-
gate the associated enzymatic kinetics
and reaction products. Online liquid-
chromatography Fourier-transform ion-
cyclotron-resonance mass spectrometry
(FT-ICR MS) combined with electron-
capture dissociation (ECD) was em-
ployed to study the tTGase-induced
modifications of substance P. A particu-
lar strength of ECD for peptide-
enzyme reaction product monitoring is
its ability to distinguish isomeric amino
acids, for example, Glu and iso-Glu, by
signature product ions. Our studies
show that the primary reaction ob-
served is deamidation, with the two
consecutive glutamine residues con-
verted sequentially into glutamate: first
Gln5, and subsequently Gln6. We then
applied ECD FT-ICR MS to identify
the transamidation site on an enzymati-
cally cross-linked peptide, which turned
out to correspond to Gln5. Three popu-
lations of substance-P dimers were de-
tected that differed by the number of
deamidated Gln residues. The higher
reactivity of Gln5 over Gln6 was further
confirmed by cross-linking SP with
monodansylcadaverine (MDC). Over-
all, our approach described herein is of
a general importance for mapping both
enzymatically induced post-translation-
al protein modifications and cross-link-
ing. Finally, in vitro Ca-signaling assays
revealed that the main tTGase reaction
product, the singly deamidated SP
(RPKPEQFFGLM-NH2), has in-
creased agonist potency towards its
natural receptor, thus confirming the
biologically relevant role of deamida-
tion.
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bond. In the absence of a good acyl acceptor, tTGase can
also deamidate Gln to glutamic acid (Glu)[8] by using a
water molecule to react in place of the primary amine with
the Gln–enzyme intermediate (Scheme 1). The tTGase acyl-
transfer activity, which can result in both inter- and intramo-
lecular protein cross-linking, has been widely investigated in
relation to the onset of several neurodegenerative patholo-
gies, characterized by the presence of protein aggregates.[9]
Specifically, tTGase has been proven to induce the forma-
tion of protease-resistant aggregates, which are thought to
play a crucial role in the initiation and development of Alz-
heimer disease, using both Ab-40 and Ab-42 at physiologi-
cally relevant concentrations in vitro.[10] Moreover, tTGase-
mediated intramolecular cross-linking of a-synuclein has
been shown to prevent the formation of typical amyloid ag-
gregates.[11]
On the other hand, glutamine deamidation is a post-trans-
lational modification (PTM) that introduces the charged
amino acid Glu in place of the uncharged Gln within a poly-
peptide chain. Gln-to-Glu substitution can strongly influ-
ence protein–protein or protein–receptor interactions by al-
tering signaling pathways and inducing pathological insur-
gence. An example of the latter case is tTGase-mediated
deamidation of gliadin, a protein found in wheat gluten.[12,13]
Deamidation of gliadin protein was reported to be responsi-
ble for the inflammatory responses associated with celiac
disease.[14] Deamidation-induced formation of new disease-
associated protein complexes might be recognized as neo-
epitopes by T-cell receptors and lead to autoimmune re-
sponse.
The substrate specificity of tTGase has been widely inves-
tigated recently.[15–17] Although a number of generic require-
ments have been reported, no conclusive amino acid se-
quence pattern for substrate–enzyme recognition has been
found yet, neither for the acyl-donor nor for the acyl-accept-
or group.[18,19] The lack of a defined consensus amino acid
sequence that indicates the glutamines and lysines that can
serve as substrates for tTGase, together with the fact that
not all the actual substrates show the same affinity for the
enzyme, requires the development and use of specific tools
for determining the residues that are deamidated or transa-
midated by transglutaminase on peptides and proteins of in-
terest, including pathology-related neuropeptides.[20,21] Tradi-
tional strategies for the identification utilize cross-validation
approaches, as they comprise both the use of mutant pep-
tides or proteins and bottom-up experiments, which consist
primarily of mass-spectrometry-based analysis of protein di-
gests sometimes coupled with collision-induced dissociation
(CID) for the biomolecular ion fragmentation.[11]
Taking into account the current understanding of the cen-
tral biological and pathological role of the tTGase-induced
modification of peptides and proteins, we selected tTGase-
catalyzed transamidation and deamidation of the neuropep-
tide substance P (SP)[22] to demonstrate the applicability of
the tandem mass spectrometry for the characterization of
tTGase reaction products. The undecapeptide SP belongs to
the tachykinin neurotransmitter family.[23,24] It is distributed
both in the peripheral nervous system,[25] where it mediates
different physiological responses, including smooth muscle
contraction,[26] vasodilation,[27] and increase in vascular per-
meability,[28] as well as in the central nervous system,[29]
where it is involved mainly in inflammatory response[30] and
pain perception.[31] SP action is regulated through its binding
to the specific neurokinin-1 receptor (NK-1R), a G-protein-
coupled transmembrane protein.[32–34] Binding to NK-1R re-
sults in phospholipase C activation and to the subsequent in-
crease in the intracellular Ca2+ concentration.[35] Moreover,
stimulated neurokinin-1 receptor can affect different neuro-
nal pathways.[23] For example, analgesic response of the opi-
ates can be influenced by NK-1R activation, mediated by its
primary agonist SP, to modulate the reward (addition)
mechanism of the opiates.[36,37] The use of SP as a substrate
for tTGase is widely described in the literature. Particularly,
Scheme 1. Representation of two calcium-ion-dependent peptide-modify-
ing reactions catalyzed by tissue transglutaminase (tTGase): A) deamida-
tion and B) transamidation using the g-acyl group of Gln as a first sub-
strate, and water or e-amino group of Lys as a second substrate.
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the presence of two consecutive Gln residues in the SP se-
quence (positions 5 and 6) has been exploited to induce the
formation of cross-linked species with low-molecular-weight
fluorescent amines, for example, spermidine, putrescine, and
monodansylcadaverine.[38–40] First, this method allows to
detect SP–amine complexes in different assays using the flu-
orescent properties of the amines.[38] Secondly, peptides
modified with low molecular weight compounds can be effi-
ciently analyzed by low-resolution mass spectrometry.[39] Al-
though the overlapping body distribution with tTGase sug-
gests that SP could be a natural substrate for this enzyme,
no conclusive analysis of tTGase-induced SP deamidation
and transamidation have been conducted. Importantly, as
the C-terminal part of SP (residues 5–11) is involved in the
NK-1R binding process,[41,42] SP deamidation could change
the properties of the peptide sufficiently to affect its biologi-
cal function.
The current study is thus aimed to provide in-depth analy-
sis of tTGase-mediated deamidation of SP by using liquid
chromatography (LC) coupled with high-resolution tandem
Fourier-transform ion-cyclotron-resonance mass spectrome-
try (FT-ICR MS).[43] Identification of residue-specific modi-
fications was carried out by electron-capture dissociation
(ECD).[44–46] Electron addition to the multiply charged ions
in the gas phase during the ECD process leads to formation
of intermediate charge-reduced radical species. These meta-
stable species readily dissociate by the cleavage of the NCa
backbone bonds of the peptides, whereas the lateral chains
of the amino acids and also labile post-translational modifi-
cations (PTMs) are typically preserved. Importantly, ECD
FT-ICR MS has been recently shown to be able to differen-
tiate aspartic acid from iso-aspartic acid[47] and glutamic
from g-glutamic acid.[48] The differentiation is based on the
specific side-chain loss that is characteristic for the structure
of the residues.
This study first confirms the previously reported higher
reactivity of Gln5 compared to Gln6.
[38] Second, we report
the detection and characterization of SP dimers.[39] Both re-
sults are accompanied by the kinetics studies of tTGase dea-
midation and also transamidation. The latter point is of par-
ticular importance, considering that the mechanism of the
highly substrate-dependent tTGase acyl-donor recognition is
not completely understood.[15,49] Finally, to determine a puta-
tive biological role of tTGase-mediated deamidation of SP, a
singly deamidated variant of SP was used to reveal changes
in agonist potency upon binding to neurokinin-1 receptors.
Results
Kinetics of tTGase-induced deamidation of substance P :
Figure 1 shows the kinetics of the reaction between substan-
ce P and tTGase monitored by LC–MS. More specifically,
the time dependence of the population of singly deamidated
substance P versus the unmodified peptide is shown. Ac-
cording to the literature, tTGase exhibits high specificity
toward acyl-donor group recognition.[15] Theoretically, both
glutamine residues in SP, namely, Gln5 and Gln6, could be
deamidated. To monitor the deamidation order and rate, a
reaction was performed with relatively low concentrations
for both substrate (74 mm) and enzyme (0.002 U).
As depicted in Scheme 1, the deamidation reaction occurs
when a water molecule enters the active site of tTGase after
the formation of an intermediate between enzyme and Gln
residue of the substrate. A low concentration of SP should
favor the deamidation process over transamidation, whereas
low enzyme concentration was chosen to allow the study of
a fast process. Figure 1 shows that the singly deamidated
substance P is the main reaction product under the em-
ployed reaction conditions (both SP and tTGase concentra-
tions are low) at 300 min from the reaction onset. Figure 1,
left, displays two baseline-resolved peaks from a total-ion
chromatogram related to substance P control (substrate re-
tention time12.6 min) and singly deamidated substance P
(product retention time12.9 min). The combined isotopic
distribution of the two peaks that differ in molecular weight
by 0.98 Da demonstrates their relative abundance change as
a function of time (Figure 1, right).
Competition between deamidation and transamidation of
substance P : The results presented in Figure 1 demonstrate
that substance P is a good substrate for tTGase, but do not
clarify which one of the two Gln residues is deamidated.
Figure 1. Time-course LC–MS analysis of substance-P deamidation cata-
lyzed by tissue transglutaminase (tTGase). Four timepoints are consid-
ered, namely, 5, 10, 30, and 60 min. Left: Total ion current chromato-
grams exhibit a first peak that corresponds to unmodified (or control)
substance P, and a second one that corresponds to the singly deamidated
substance P. Right: Combined isotopic distribution of both peaks (the
two isotopic distributions are partially overlapping) demonstrates the rel-
ative abundance of the unmodified and deamidated species. The inset
shows separate isotopic distributions for the two species that correspond
to the LC–MS of the 300 min sample. The m/z scale of the LC ESI LTQ
MS data shown was only externally calibrated (for doubly charged SP,
m/z : calcd: 674.37; found: 674.18).
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The reaction pathway that leads to peptide transamidation
with subsequent formation of dimers or polymers is also not
considered in Figure 1. Previous findings by Ferrndiz et al.
have shown that Gln5 serves as an indispensable tTGase
substrate and is more reactive as an acyl donor.[38] Thus, we
used the LC–MS/MS to investigate if both Gln residues can
be tTGase substrates and elucidate the possible reaction se-
quence as a function of time. Electron-capture dissociation
(ECD) was chosen as a tandem mass spectrometry method
mainly due to the efficient and easy-to-interpret fragmenta-
tion of substance P it induces. Furthermore, the specific
character of ECD allows one to distinguish amino acid iso-
merization that may occur during the enzymatic reaction
(vide supra). According to a study by Marinos group, sub-
stance P dimers should not be formed.[39] However, this find-
ing contrasts with the general understanding of tTGase cata-
lytic activity, which demonstrates a relatively good specifici-
ty for the peptidic sequence that contains the acyl donor
(Gln), but not for the acyl acceptor (Lys).[18]
We assume that transamidation, which can be thought of
as a competitive reaction with respect to deamidation, can
be promoted by increasing the probability of two substan-
ce P monomers to be recognized in rapid succession by the
enzyme. This result was achieved by using a high substrate
concentration. To accelerate the reaction and increase the
enzyme activity, we used higher substrate and tTGase con-
centrations and increased the temperature. Figure 2 shows
the total ion current (TIC) chromatogram of reaction prod-
ucts obtained after 5 h incubation of a solution of 222 mm SP
with 0.02 U of tTGase at 37 8C. The species of interest were
detected by LC FT-ICR MS (Figure 2, insets). The singly
deamidated SP elutes at retention time, tR=15 min, fol-
lowed by doubly deamidated SP at tR=16.2 min. The two
peaks at tR=16.4 and 17.2 min correspond to the truncated
forms, which lack the first two residues at the N terminus, of
singly and doubly deamidated SP, respectively. Degradation
of SP after the second residue is observed normally after in-
cubation for several hours at 37 8C and represents a cleavage
at the C-terminal side of proline residue. These species are
followed by three distinct peaks of lower intensity that cor-
respond to the three different populations of SP dimers
(tR=17.55, 17.75, and 18.1 min). Under these experimental
conditions, the reaction was completed without detection of
unreacted SP.
The substantially higher intensity of the peaks assigned to
deamidated SP compared to the cross-linked SP suggests
that the Lys residue of SP is not a preferred substrate for
the enzyme. A similar conclusion can be made by comparing
the reaction described here and the one between SP and the
primary amine monodansylcadaverine (MDC) (vide infra).
Selective deamidation of Glu5 and Glu6 : ECD mass spectra
collected for singly and doubly deamidated SP in the data-
dependent LC FT-ICR MS/MS experiment are shown in
Figure 3. The expected and almost complete sequence cover-
age is achieved in both cases. The absence of the c1
+/z10
+ or
c3
+/z8
+ ions is due to the ring structure of a proline residue,
which prohibits the formation of the corresponding ECD
product ions. The fragmentation patterns are similar to
those of nondeamidated SP.[50] The predominance of c-type
ions over z-type ions is, presumably, due to the position of
the charged residues close to the N terminus of the peptide.
ECD reveals that the singly deamidated SP has a single
Gln-to-Glu substitution that occurs exclusively at position 5
(Figure 3A). The inset in Figure 3A shows the presence of a
Figure 2. Reverse-phase HPLC separation of the tTGase-catalyzed sub-
stance-P deamidation and transamidation reaction products.
Figure 3. Tandem mass spectra of tTGase-catalyzed (top) singly and
(bottom) doubly deamidated substance P, acquired with LC ECD FT-
ICR MS.
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radical species, c5
+ ·, at the amount typically obtained in
ECD of the unmodified SP for c5
+ ions. Moreover, all the
heavier c-type ions, from c6
+ to c10
+ , show a 0.98 Da mass
shift in comparison to the corresponding ions of unmodified
SP, as demonstrated by c6
+ isotopic distribution (Figure 3A,
inset). The ECD mass spectrum of doubly deamidated SP
shown in Figure 3B correlates with the ECD pattern for the
singly deamidated SP species for c2
+ , c4
+ , and c5
+ ions. Con-
sistently, an additional 0.98 Da shift in mass is observed for
the rest of the cn
+ ion series, for n>5.
Importantly, no population of SP with a single deamida-
tion at position 6 is observed. Therefore, ECD FT-ICR MS
results, coupled with the intensity ratio of the TIC chroma-
tographic peaks for the two modified SP species, suggest
that either the deamidation of Gln5 is necessary for the sub-
sequent deamidation of Gln6, or that Gln6 is a much less
probable substrate for tTGase than the Gln5 residue.
Substance-P transamidation products : As displayed in
Figure 4, the three populations of SP dimers revealed by
LC–MS differ by a 0.98 Da mass shift, which corresponds to
a single deamidation event.
Calculation of the expected molecular weight of cross-
linked dimers from transamidation (twice molecular weight
of SP minus ammonia; 17.024 Da) indicates the three
dimers to be singly, doubly, and triply deamidated species.
Proposed sequences for each population inferred by the
measured m/z values are reported between the two isotopic
distributions for the two charge states, 4+ and 5+ , ob-
served in the broadband mass spectra (Figure 4). Note that
the intensities of the first two dimer populations are similar
and higher than the one of the third population, Figure 2.
ECD FT-ICR MS was performed on every isolated SP
dimer population by using the [M+4H]4+ ions as precursors
(Figure 5). The FT-MS was set to operate in a targeted
mode to isolate (isolation window of 5 Th) and fragment
species at m/z 670.10. In all three ECD mass spectra report-
ed in Figure 5, a total absence of c5
+ ion, that could origi-
nate from an SP monomer if cross-linked at position 6, is
observed. Therefore, only Gln5 is involved in the transami-
dation reaction. The low reactivity of Gln6 revealed by the
study of ECD mass spectra of the two deamidated forms of
monomeric SP (Figure 3) supports this conclusion. The re-
markably high abundance of c2
+ ions in comparison to other
product ions, specifically c4
+ ions, reflects the unique possi-
bility for both monomeric units that form the dimers to con-
tribute.
ECD product ions that contain the transamidation-reac-
tion-produced covalent bonding between an intact mono-
Figure 4. Isotopic distributions of the (left) quintuply and (right) quadru-
ply charged populations of (top) singly, (middle) doubly, and (bottom)
triply deamidated SP dimers formed by transamidation and observed by
LC FT-ICR MS. Insets show the corresponding suggested structures of
the dimers.
Figure 5. ECD FT-ICR MS of (top) singly, (middle) doubly, and (bottom)
triply deamidated dimers of substance P formed by tTGase-induced
transamidation (“m” indicates the monomeric form of SP). Tandem mass
spectra were acquired under standard operating conditions in the LC–
MS/MS experiment.
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meric SP and a c-type fragment of the second SP monomer
are assigned in Figure 5 as [m+cn]
k+ . The analysis of the
series of [m+cn]
k+ ions gives an important indication about
the position of deamidated residues. The ECD fragmenta-
tion pattern obtained from the singly deamidated SP dimer
population contains a characteristic [m+c5]
2+ ion that indi-
cates the deamidation of Glu5 (Figure 5A, inset). The first
deamidation of the Gln5 residue is further confirmed by the
fact that one of the two Gln5 residues in the dimer is in-
volved in the formation of the cross-linking bond, and a
population of [m+c5]
2+ ions without a corresponding mass
shift is not observed.
ECD mass spectra for the SP dimer population with two
deamidated residues is shown in Figure 5B. Depending on
both the position of the second Glu residue and the frag-
mentation site, two possible [m+c5]
2+ fragment ions can be
produced by ECD: one with the same m/z as observed for
the singly deamidated dimers, and a heavier one
(Scheme 2).
A partial overlap between the two product ion isotopic
distributions can be observed (Figure 5B, inset). Finally, as a
consequence of deamidation of all the three originally avail-
able Gln residues in the third population of SP dimers, a fur-
ther mass shift in the [m+c5]
2+ isotopic distribution is appar-
ent (Figure 5C and inset).
Substance-P cross-linking with MDC : The above-illustrated
results demonstrate that the tTGase-induced deamidation of
Glu6 can occur not only after the deamidation of Glu5, but
also after a cross-linking between Glu5 and a peptydil lysine.
To further investigate this process, a tTGase reaction with
SP was performed in the presence of a primary amine, mon-
odansylcadaverine (MDC).[38] The acyl-acceptor MDC was
used in a 10-fold excess amount to promote the transamida-
tion between SP and MDC in a competition with SP deami-
dation. Kinetics studies were performed by using the same
algorithm as for the SP-tTGase reaction described above.
We were able therefore to monitor both the formation of
transamidated SP-MDC complexes and the results of the
competition between deamidation and transamidation reac-
tions. In contrast to the previous reports on the kinetics of
SP interaction with tTGase, the reaction product analysis
described here did not take advantage of MDC fluorescent
properties but was obtained through LC–MS analysis.[38]
The advantage of the LC–MS method is in the detailed
characterization of peptide modifications, specifically, Gln
deamidation, on transamidated SP-MDC complexes. The
time-course analysis clearly indicates that the main reaction
product is the cross-linked MDC-SP (tR=11 min, m/z
833.439 for the doubly charged species, as displayed on the
left inset of Figure 6), in presence of both higher (right) and
lower (left) concentration of substrates. After approximately
one hour from the reaction start, the abundant peak of
MDC-SP complex is followed by a less abundant peak (tR=
11.2 min, m/z 833.931, doubly charged), which corresponds
to an MDC-SP with deamidated Gln6 (Figure 6, central
inset). Although the intensity of the latter peak increases
with time, it remains low. Nevertheless, the presence of this
peak demonstrates that the second glutamine of SP can be
deamidated also in presence of an isopeptidic bond on Gln5
side chain.
Abad and co-workers investigated the reactivity of Gln6
in SP during its tTGase-catalyzed reaction with MDC de-
tecting the reaction products by reverse-phase HPLC com-
bined with fluorescence spectroscopy.[38] They observed a
high propensity of SP to be cross-linked to both Gln5 and
Gln6 when the reaction is performed at 37 8C with an ap-
proximately 100-fold excess amount of MDC over SP. On
the contrary, we show that under our reaction conditions,
the formation of a doubly cross-linked SP ((MDC)2-SP) is
not favored and that this reaction product is probably unsta-
ble. After 60 min from the beginning of the reaction, a peak
related to (MDC)2-SP is detected for both reactions (tR=
Scheme 2. Possible deamidation and fragmentation sites of doubly deami-
dated SP dimers for obtaining [m+c5]
2+ ions (“m” indicates the mono-
meric form of SP); dashed lines indicate the lighter product ions, solid
lines the heavier ones. A) Dimer with both the deamidation on the same
monomer; B) dimer with deamidation on both SP monomers.
Figure 6. LC FT-ICR MS of a tTGase-catalyzed reaction between sub-
stance P and monodansylcadaverine (MDC) used in a 10-fold excess
amount. Left: 74 mm SP; right: 148 mm SP.
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13.3 min, m/z 992.508 for the doubly charged species; spec-
trum on Figure 6, right inset).
The reasons for the low abundance of (MDC)2-SP can be
found in the competition between deamidation and transa-
midation and in a possible hydrolytic activity of the enzyme
towards isopeptidic bonds, as reported by Sollid et al.[51] This
tTGase reaction could explain the absence of (MDC)2-SP
peak at the later reaction times.
Biochemical confirmation of substance-P deamidation : To
verify the data collected with LC–MS/MS, and to determine
possible modifications that occurred at SP as an effect of
side reactions of tTGase, we performed enzymatic digestion
of SP with endoproteinase Glu-C from Staphylococcus
aureus V8 (Figure 7).[52] Glu-C can selectively cleave the
peptidic bond on the C-terminal side of a glutamic acid resi-
due when used in ammonium bicarbonate 0.1m, pH 8.0. A
solid-phase-synthesized Glu5-SP variant was used to com-
pare its Glu-C digestion products with the ones obtained by
using the tTGase-deamidated SP as a substrate for the endo-
proteinase. In summary, the following substrates were com-
pared by the proteolitic digestion: SP after reaction with
tTGase, Glu5-SP after tTGase deamidation, and Glu5-SP
alone, without previous reaction with tTGase. All the sam-
ples were tested in the presence (positive control) and ab-
sence (negative control) of Ca2+ . Our enzymatic digestion
described before was carried out using the products of up-
scaled tTGase reactions (performed in 1 h with 0.05 units of
enzyme to prevent possible aggregation of the products that
could occur after many hours from the start) without inter-
mediate purification. The substrates for Glu-C were dis-
solved in a buffer that contained Tris-HCl to obtain the final
concentration in the new reaction mixture of around 110 mm.
The synthetic Glu5-SP was used for the reaction in presence
of the same concentration and composition of the buffer.
The detection of the digested peptides was performed by
LC–MS by using the linear trap quadrupole (LTQ) mass
spectrometer.
All the screened samples provided the expected frag-
ments: no cleavage for SP negative control, 2 main frag-
ments, SP [1–5] and SP [6–11], for the singly deamidated SP
(both enzymatically obtained from unmodified SP and a
synthetic modified peptide), and, more interestingly, the
same two fragments for the doubly deamidated SP, with a
shift in mass of 0.98 Da in the SP [6–11] fragment in com-
parison with the one obtained from singly deamidated SP.
This result, combined with the lack of detection of the SP
[1–6] or SP [7–11] fragment, reveals that Glu-C cleaves spe-
cifically only after the Glu5 residue (see Figure S1 in the
Supporting Information). Figure 7 illustrates the products
detected for the upscaled tTGase reaction of SP after 24 h.
The highly hydrophilic SP [1–5] peptide elutes very early,
and most probably it is partially undetected, whereas the
above-mentioned variants of the SP [6–11] fragment elute
after more than 9 min. Note that the second most abundant
species in the TIC is at m/z 724.12. We suggest that it corre-
sponds to the SP [6–11] fragment in which the N-terminal
Gln or Glu residue is converted into pyroglutamic acid
(pGlu) through a nucleophilic attack reaction of the free N-
terminal amine to the g-carboxylic group. The mass differ-
ence between this peak and the most abundant SP [6–11]
peptide is 17.1 Da. The formation of pGlu after proteolitic
cleavage of peptides and proteins has been previously re-
ported, but only for tryptic digestion.[53] The LC–MS data
alone is not sufficient to determine if only the N-terminal
Gln residue is converted into the pGlu or if the N-terminal
Glu of the second and less abundant SP [6–11] fragment
also contributes. Literature reports suggest that the pGlu
conversion is more favorable in the presence of an N-termi-
nal glutamine, which correlates here with the observation of
the more abundant of the two species.[54,55]
Conformational studies on substance P and singly deamidat-
ed substance P : To determine potential differences in the
conformation of unmodified SP and its singly deamidated
Glu5-SP variant in solution, circular dichroism (CD) spectra
were recorded for both peptides (Figure 8).
Both peptides in aqueous solution show CD spectra typi-
cal for a random coil conformation (Figure 8A) as reported
previously.[56–58] Apparently, a single amino acid substitution
as in the Glu5-SP variant does not induce the formation of a
stable secondary structure. However, it is known that SP can
acquire an ordered secondary structure when dissolved in
organic solvents or bound to detergent micelles. Figure 8B
and C represent SP (solid line) CD spectra in 50% 2,2,2-tri-
fluoroethanol (TFE) and 30 mm sodium dodecyl sulfate
(SDS), respectively. In the former case, the spectra collected
in 50% TFE are characterized by a minimum in ellipticity
at 205 nm and a maximum at 195 nm, thus indicating a b-
turn or mixed b-turn/a-helix structure.[57] Upon binding to
negatively charged SDS micelles, SP forms predominantly
Figure 7. LC–MS of Glu-C digestion of reaction products of substance P
with tTGase.
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an a-helical conformation in agreement with published
data.[57,59] The synthetic singly deamidated SP variant shows
a similar behavior (Figure 8C). The CD spectra of the two
peptides in the presence of 30 mm SDS are almost identical,
whereas in 50% TFE, Glu5-SP shows minor structure varia-
tions in comparison to the unmodified SP, in particular in
the 215–230 nm region.
Although peptide structure assignment based on the CD
spectra in SDS and TFE solution is not unambiguous, the
high similarity of the spectra trends for SP and Glu5-SP sug-
gests that the substitution at the fifth residue does not alter
the peptide structure in solution. Nevertheless, conclusive
indications with regards to Glu5-SP receptor binding charac-
teristics could not be derived from our CD data.
Receptor activation studies : To demonstrate the biological
relevance of our structural investigations further, we investi-
gated the capability of Glu5-SP to induce a cellular response
through binding to the neurokinin-1 receptor (NK1-R). For
these studies, HEK293 cells that stably expressed the NK1-
R were used. We employed the fluorescence assay based on
the signal transduction pathway, which is activated after the
binding of an agonist to NK1-R. This process leads to an in-
crease in the free cytosolic concentration of Ca2+ and subse-
quently to a fluorescent response mediated by Fluo-4 Ca2+
indicator dye.
First, a confocal microscopy-based analysis was carried
out to compare the cellular response to the two peptides
and the morphological changes induced by the potential
stimulation (Figure 9).[60]
As shown in Figure 9, the addition of Glu5-SP produces a
quick increase of fluorescence with the cellular response du-
ration, approximately 100 s, comparable with the reported
values[61,62] and those observed for SP (data not shown).
Moreover, the binding of SP to NK1-R eventually results in
the formation of blebs on the cell membrane.[63] The same
phenomenon is observed for Glu5-SP.
Figure 8. Circular dichroism spectra of SP (solid line) and Glu5-SP
(dashed line) in different solutions: A) water, B) 50% TFE–water,
C) 30 mm SDS in water.
Figure 9. Ca-ion concentration mobilization in HEK293 after the addition
of Glu5-SP. The confocal images show the fluorescence of the Ca-ion in-
dicator Fluo-4 inside of the HEK cells at A) 0 s, B) 30 s, and C) 110 s
after the addition of Glu5-SP to a final bulk concentration of 20 nm.
D) Time dependence of fluorescence intensity of Fluo-4.
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We subsequently compared the cellular Ca-ion responses
in a dose-dependent stimulation for the two agonists.[64]
Figure 10 shows the concentration-response curves that indi-
cate that Glu5-SP induces the intracellular response at slight-
ly lower concentrations than the unmodified counterpart.
The calculated EC50 values for the wild-type and deamidat-
ed SP are (2.90.5) and (1.30.2) nm, respectively. The
repetition of the experiment resulted in a substantial confir-
mation of the ratio between the EC50 values.
Discussion
The first biology-related question we addressed here by LC
FT-ICR MS/MS concerns tTGase activity on SP. Although it
is known that tTGase can catalyze two competitive reac-
tions, one that involves both glutamine and lysine (transami-
dation), the other glutamine and a water molecule (deami-
dation), the reactivity of lysine residues in SP is a source of
controversy in the literature. Whereas some reports claim
that no dimers could be detected[39] and that lysines preced-
ed by a proline are not good acyl acceptors, Pastor et al.
mentioned the detection of intermolecular cross-linking of
SP analogues, however, without delivering further informa-
tion.[49] Here we have shown that the reactivity of Lys3 is
low. We confirmed it first by the kinetic study on SP only,
which shows that the deamidation is much favored on this
substrate over transamidation, and second by the analysis of
SP–monodansylcadaverine reaction products, which on the
contrary highlight the strong propensity of tTGase for cross-
linking this primary amine to the neuropeptide.
However, we demonstrated that at the specific reaction
conditions, for instance, at an increased substrate concentra-
tion, tTGase efficiently produces SP dimers, although dea-
midated SP remains the main reaction product. Moreover,
tTGase can modify the structure of the monomers and
create different populations of intermolecularly cross-linked
SP. ECD FT-ICR MS analysis demonstrates the presence of
three different subpopulations of dimers that are distin-
guished by the number of deamidated glutamines they con-
tain, from 1 to 3 (three is the maximum number of Gln resi-
dues in SP dimer that may be modified after the formation
of one isopeptidic bond).
As indicated by previous studies[38] and confirmed here by
tandem mass spectrometry, in the case of SP, the two gluta-
mine residues can both act as substrates for tTGase, but
strictly sequentially. The Gln6 residue can be either deami-
dated or transamidated, but only after the modification of
the Gln5 residue. This conclusion is based on the observation
that, as displayed in Figure 2, in the attempt to force the
tTGase-mediated production of dimers, the main reaction
products are singly and doubly deamidated SP, and the
former of these species is deamidated at position 5 only.
This is revealed by the corresponding ECD mass spectra,
which present a c5
+ ion that corresponds to a Gln5-to-Glu5
substitution. The corresponding isotopic distribution is the
one expected for a c+ ion that terminates with Glu
(RPKPE) and not the one terminated with Gln (RPKPQ),
despite the presence of a radical species. The characteriza-
tion of the SP dimers by ECD reaffirms this conclusion.
ECD mass spectra show that the transamidation takes place
only at position 5 of the first SP monomer, and the first of
the three detected deamidations proceeds at Gln5 of the
second SP monomer. The Gln6 residue is modified only af-
terwards. Consistently, in the MDC–SP reaction, the Gln6
residue is deamidated only in doubly deamidated SP or in a
small population of MDC–SP dimers in which the acyl
donor for cross-linking remains Gln5.
The fact that the modification that occurs at Gln5 can be
either a deamidation or a transamidation suggests that the
probable reason for Gln6 to start acting as a substrate is not
the deamidation-induced local charge modulation (increase
of a negative charge upon conversion from glutamine to glu-
tamate). Although in the presence of two consecutive gluta-
mines in the primary structure the one closer to the C-termi-
nal end is normally less reactive than the other, this cannot
be considered to be a general rule.[15] Presumably, Gln6
starts to be reactive after a modification of Gln5 as a conse-
quence of a conformational change in the peptide that leads
to improved steric accessibility to the active site of tTGase.
Therefore, a modification at position 5 might also affect SP
properties in other binding processes. Generally, it is be-
lieved that SP assumes a partial a-helical conformation
when interacting with membranes and proteins such as re-
ceptors. The attainment of an a-helical secondary structure
has been previously indicated by CD experiments.[56, 57]
Recent NMR spectroscopic studies suggested that in a mem-
brane-bound form SP is organized with a central a-helix and
a flexible N-terminal end.[65] We confirmed the fact SP rear-
ranges itself in an a-helix by CD performed in 30 mm SDS,
a membrane-mimicking environment (see Figure 8). Not
Figure 10. Change of the intracellular Ca-ion concentration at different
bulk concentrations of SP (*) and Glu5-SP (&) obtained as described in
Figure 9. Lines are fits of the experimental data to the Hill equation. Ex-
perimental data are expressed as mean ( standard deviation) of four
measurements.
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surprisingly, the same behavior is retained also by Glu5-SP.
The activity of Glu5-SP was a subject of the studies reported
here due to the high rate of its formation by tTGase from
SP. The capability of SP analogues to reach an a-helical con-
formation despite single and even double sequence muta-
tions has been demonstrated by NMR spectroscopy.[65,66]
To reveal the capability of Glu5-SP to interact with a pro-
tein, we chose a calcium-ion signaling assay in live HEK293
cells that stably express the neurokinin-1 receptor (NK1-R),
the natural agonist of which is SP. We demonstrated that
Glu5-SP acts as an agonist for NK1-R, with an activity that
is even higher than that of unmodified SP. NMR spectro-
scopic studies conducted on polypeptides that represent the
predicted second and third extracellular loops (named EC2
and EC3, respectively) of NK1-R showed that both peptides
are involved in SP binding; specifically Gln5 is among those
SP residues that interact with EC3 and, presumably, that
maintains a solvent-accessible position.[67,68] This is in agree-
ment with the case of the NK2 receptor, which is very close-
ly related to the NK1-R, in which the binding site for ago-
nist and antagonist peptides has been localized with high
precision in living cells also at the extracellular side of the
receptor.[69,70] On the other hand, Perrine et al. demonstrat-
ed that in cells that express the rat NK1-R, the Gln5-to-Ala5
substitution only slightly reduces the capability of SP to
induce intracellular calcium-ion responses, thus suggesting
that the residue at the fifth position is involved in the bind-
ing to the receptor but is not essential for the activation of
the downstream signal transduction.[66] Nevertheless, the
latter study considers a nonconservative substitution, where-
as the tTGase-induced deamidation results in a less dramat-
ic modification. In the Gln-to-Glu substitution, the main
variation is associated with the introduction of a negative
charge into SP, whereas the steric hindrance of the two side
chains is similar. The results obtained here suggest that the
absence of the amide group in the lateral chain of glutamate
slightly alters the interaction of the fifth residue with both
the solvent and, more notably, the third extracellular loop of
the receptor without compromising at the same time the
general structure of the peptide. These findings offer the
prospect for further analysis directed toward the elucidation
in detail of the differences in the interaction of substance SP
and Glu5-SP with EC3.
Conclusion
By coupling reverse-phase liquid chromatography, for the
separation of tissue transglutaminase (tTGase) reaction
products, with online electron capture dissociation high-res-
olution mass spectrometry, we were able to unambiguously
determine the deamidation and transamidation sites on the
neuropeptide substance P (SP). The identification of these
sites on our model peptide was unambiguous even without
using traditionally employed strategies such as testing modi-
fied peptides that carry point mutations. In fact, ECD of-
fered a complete fragmentation pattern of both deamidated
and transamidated SP (without, in the latter case, cleavage
of the newly formed isopeptidic bond). Therefore our pro-
posed method has the potential of being used in the elucida-
tion of structural features of larger peptides and proteins,
for example, amyloid-beta peptide,[71] subjected to both en-
zymatic “zero-length” cross-linking and post-translational
modifications.
Taken together, this study shows that under different con-
ditions the major reaction products are always singly and
doubly deamidated SP, tereby highlighting the low propensi-
ty of Lys3 of SP to act as a substrate in a cross-linking reac-
tion. Moreover, ECD spectra have demonstrated that both
the two consecutive glutamine residues of the substrate
(Gln5 and Gln6) can be deamidated, but strictly sequentially,
and with Gln5 as a preferred substrate for tTGase. In fact,
when the reaction conditions allow the formation of SP
dimers, ECD reveals that the cross-linking site is on Gln5
only, whereas Gln6 can react the same but, again, only after
Gln5 modification (deamidation or transamidation). This re-
sults in the formation of three different dimers populations
with one, two, or three deamidated Gln residues, respective-
ly. With regards to the identification of the isomeric resi-
dues, for example, glutamate to g-glutamic acid isomeriza-
tion, the results reported here did not demonstrate the pres-
ence of characteristic product ions in ECD FT-ICR MS
specified by OConnor and co-workers.[48] Therefore, the re-
action catalyzed by tTGase indeed does not induce isomeri-
zation and deamidated SP species do not undergo spontane-
ous Glu isomerization after 5 h in solution at 37 8C. Finally,
we discovered that the cellular response of SP upon binding
to the natural receptor NK1-R is not decreased but, on the
contrary, slightly increased by a single deamidation event
that occurs at residue 5, as proven by an in vitro Ca2+ assay
with HEK293 cells that express the receptor.
Experimental Section
Samples and reagents : Water, acetonitrile (HPLC MS grade), NaCl, and
CaCl2 were purchased from Fluka analytical (Buchs, Switzerland).
Formic acid was obtained from Merck (Zug, Switzerland). Tris-HCl
buffer was purchased from Calbiochem (Nottingham, United Kingdom).
Guinea pig liver transglutaminase, endoprotease Glu-C from Staphylo-
coccus aureus V8, and substance P were purchased from Sigma–Aldrich
(Buchs, Switzerland). Dulbeccos modified Eagle medium (DMEM),
GlutaMAX medium, fetal calf serum (FCS), and Dulbecco phosphate-
buffered saline (D-PBS) were purchased from Invitrogen (Breda, Nether-
lands). Fluo-4 NW calcium assay kit was obtained from Invitrogen
(Carlsbad, CA, USA). Substance P variant modified at position 5 (E5-SP)
with the substitution of the glutamine residue by glutamic acid,
RPKPEQFFGLM-NH2, was produced by solid-phase synthesis (Protein
and Peptide Chemistry Facility, University of Lausanne, Switzerland). E5-
SP crude peptide was purified by reverse-phase HPLC chromatography,
whereas other reagents and samples were used without further purifica-
tion.
Transglutaminase-catalyzed reactions : In a typical reaction catalyzed by
Guinea pig liver transglutaminase (tTGase), the reaction mixture con-
tained 40 mm Tris-HCl (pH 7), 70 mm NaCl, and 2 mm CaCl2. For the ki-
netics studies of substance-P deamidation following interaction with
tTGase, tTGase (0.002 units) was mixed with a solution of substance P
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(74 mm) at an incubation temperature of 30 8C. In total, 7 fractions were
collected at the following time points: 5, 10, 15, 30, 60, 120, and 300 min.
For substance-P deamidation and transamidation, the peptide concentra-
tion was increased to 222 mm. For this reaction and those described
below, tTGase (0.02 units) was used at 37 8C unless otherwise stated. The
reaction was stopped after 24 h with fraction collection performed after
1, 2, and 5 h. For the monodansylcadaverine (MDC)–substance P cross-
linking reaction, substance P at two concentrations, 74 and 148 mm, was
used. A 10-fold excess amount of MDC was employed to yield the corre-
sponding final MDC concentrations of 740 and 1480 mm, respectively.
Several fractions were collected following the scheme used for substance-
P deamidation and transamidation. The enzymatic catalysis was always
quenched by immediately storing the liquid samples at 80 8C.
Liquid chromatography mass spectrometry (LC–MS): Analysis of the re-
action products was performed by liquid chromatography combined
online with high-resolution tandem mass spectrometry (LC–MS/MS). For
the reverse-phase liquid chromatography, a Surveyor LC pump (Thermo
Fisher Scientific, Bremen, Germany) was used. After a 1:2 dilution in
water, samples (10 mL) were loaded onto a silica-based Hypersil Gold
(1001 mm, 1.9 mm particle size) C18 resolving column (Thermo Fisher
Scientific, Bremen, Germany). Eluents consisted of 0.1% (v/v) formic
acid in water (mobile phase A) and 0.1% (v/v) formic acid in acetonitrile
(mobile phase B). The employed flow rate was 50 mLmin1 with an initial
flow of 5% B maintained for 2 min followed by a linear gradient up to
80% B in 20 min.
Tandem mass spectrometry analysis was performed using a linear-ion-
trap Fourier-transform ion-cyclotron-resonance mass spectrometers (LTQ
FT-ICR MS) equipped with a 7 and 12 T superconducting magnet
(Thermo Fisher Scientific). Eluting analytes were electrosprayed by using
a standard electrospray ion source (ESI). The LTQ FT-ICR MS were op-
erated in the data-dependent mode to automatically switch between
broadband MS and MS/MS acquisitions. Peptide cations of interest were
isolated in the LTQ (isolation window of 5 Th, target charge counts 5
105) according to a predefined mass list and then transferred to the ICR
ion trap for subsequent tandem mass spectrometry. Electron-capture dis-
sociation (ECD) was performed under standard experimental parame-
ters: selected precursor ions were irradiated with low-energy electrons
for approximately 50 ms before product ion excitation and detection. Ion
magnetron motion correction was taken into account by introducing an
appropriate delay prior to electron injection.[72] The minimum signal-to-
noise (S/N) ratio for selection of precursor ions was set to 500. Broad-
band MS spectra (m/z 500–800) were collected using transient recording
over 768 ms (a resolution of 100000 at m/z 400 for 7 T LTQ FT-ICR MS
configuration), whereas ECD was performed with transient recording
over 192 ms (a resolution of 25000 at m/z 400 for 7 T LTQ FTMS config-
uration) across an m/z window of 100–2000 Th. Reported ECD mass
spectra normally average 10 scans. Data analysis was performed using
Xcalibur software, version 2.0.7 (Thermo Fisher Scientific).
Proteolytic digestion with Glu-C : Endoproteinase Glu-C digestion was
carried out at 37 8C in 0.1m ammonium bicarbonate at pH 8.0 by using an
enzyme-to-substrate ratio of 3:100 (w/w). Reaction mixture aliquots were
collected after 6, 10, and 24 h. Different substrates were tested at 110 mm
concentration, including substance P with and without modifications:
wild-type substance P; reaction products of tTGase catalytic activity
(same conditions previously described except for the enzyme concentra-
tion, 0.05 U instead of 0.02) on substance P with and without Ca2+ ; reac-
tion products of tTGase on synthetic Glu5-SP (same conditions men-
tioned above) with or without Ca2+ ; synthetic Glu5-SP in the same Tris-
HCl final concentration of the previous sample, with and without Ca2+ .
The GPMAW tool (version 8.0, Lighthouse data, Odense, Denmark) was
used for generating a list of expected peptides from the enzymatic diges-
tion. Reactions were always quenched by immediate sample storing at
80 8C.
CD measurements : Far-UV circular dichroic spectra were collected using
a Jasco J-810 spectropolarimeter (Jasco Corporation, Japan) at 37 8C with
a cuvette with a path length of 0.1 cm. CD spectra were recorded be-
tween 190 and 250 nm, with 0.2 nm wavelength steps and a bandwidth of
1 nm. Samples (SP and Glu5-SP) were dissolved to a final concentration
of 50 mm in water, 50% 2,2,2-trifluoroethanol (TFE) and 30 mm sodium
dodecyl sulfate (SDS). For every reported spectrum, six scans were aver-
aged to improve signal-to-noise ratio. All spectra were corrected for the
buffer baseline.
Confocal imaging : Adherent HEK293 cells that stably expressed NK1 re-
ceptors[60] were grown in DMEM/F-12+GlutaMAX medium that con-
tained 10% FCS and Hygromycin B (100 mgmL1) in a humidified atmos-
phere with 5% CO2 at 37 8C. For confocal imaging, cells were seeded on
glass coverslips in six-well dishes in DMEM/FCS (2 mL). After 24 h, cells
were incubated at 37 8C for 30 min with 5 mm Fluo-4 AM (Invitrogen,
Carlsbad, CA, USA) in serum-free medium, followed by 30 min incuba-
tion with fresh medium that contained 10% FCS. Agonist-containing so-
lution was added to the selected well during the experiments. Cells were
imaged using confocal fluorescence microscopy with a Zeiss LSM510
confocal microscope equipped with a C-apochromat 63/1.2 water-im-
mersion objective (Zeiss, Germany). Excitation was at 488 nm (Ar laser)
and the Fluo-4 fluorescence was monitored using a 505 nm longpass
emission filter at a rate of 1 image every 2 s.
Calcium-signaling assay : For monitoring the receptor activation, HEK293
cells that stably expressed NK1 receptors were seeded in DMEM/FCS
into a clear-bottom 96-well plate for 24 h at 37 8C and 5% CO2. Growth
medium was removed and replaced with fluorescent Ca2+-indicator solu-
tion (Invitrogen, Carlsbad, CA, USA). Cells were subsequently incubated
for 30 min at 37 8C followed by another 30 min at room temperature
before the measurements, without removing the dye-loading solution.
The increase of fluorescence intensity upon addition of SP or Glu5-SP in
11 different concentrations (60, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.05, and
0.01 nm) in assay buffer (1 Hank’s balanced salt solution (HBS), 20 mm
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes)) was mea-
sured on a fluorescence plate reader (FLEX Station, Molecular Devices)
at room temperature. The fluorescence emission was recorded at (525
4.5) nm upon excitation at (4854.5) nm, and final values of Ca2+ re-
sponse were the result of averaging the measurements of 4 wells for each
peptide concentration. The EC50 for SP and Glu5-SP were obtained by
fitting a sigmoidal dose–response equation to the Hill equation [Eq. (1)]:
EL ¼ E0 þ ðEmaxE0Þ=ð1þ ðEC50=½LÞnH Þ ð1Þ
in which EL is the fluorescence intensity for a given ligand concentration
[L]; EC50 is the concentration that produces 50% of the maximal re-
sponse Emax; E0 is the baseline intensity in the absence of ligand; nH is
the Hill coefficient. Experimental data were fitted to the Hill equation
using Igor Pro software (WaveMetrics Inc., Lake Oswego, OR). Experi-
ments were performed in duplicate. To assess a possible statistical differ-
ence among the two dose–response curves, an F-test was performed,
whereas a t-test was used for the comparison of EC50 values.
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Glycan variability on a recombinant IgG
antibody transiently produced in HEK-
293E cells
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In this study, a recombinant monoclonal IgG antibody was produced by transient gene expression (TGE)
in suspension-adapted HEK-293E cells. The objective of the study was to determine the variation in
recombinant IgG yield and glycosylation in ten independent transfections. In a ten-day batch process,
the variation in transient IgG yield in the ten batches was less than 30% with the speciﬁc productivity
averaging 20.2  2.6 pg/cell/day. We characterized the N-glycosylation proﬁle of each batch of afﬁnity-
puriﬁed IgG by intact protein and bottom-up mass spectrometry. Four major glycans were identiﬁed at
Asn297 in the ten batches with the maximum relative deviation for a single glycoform being 2.5%. In
addition, within any single transfection there was little variation in glycoforms over the ten-day culture.
Our experimental data indicate that with TGE, the production of recombinant IgG with little batch-to-
batch variation in volumetric yield and protein glycosylation is feasible, even in a non-instrumented
cultivation system as described here.
Introduction
Two main strategies are available for the production of recombi-
nant therapeutic proteins in mammalian cells, stable (SGE) and
transient gene expression (TGE). The former is based on the
constitutive expression of the protein from a clonal recombinant
cell line having one or more integrated copies of the transgene and
is the method of choice for the large-scale production of recom-
binant therapeutic proteins for the commercial market [1,2]. TGE
is based on protein production from a pool of transiently trans-
fected cells and is mainly used to generate small amounts of
protein for research and/or for pre-clinical studies [3–5]. In con-
trast to SGE, TGE has not yet been used for the commercial
production of therapeutic proteins. One of the major concerns
with bioprocesses based on TGE is the batch-to-batch variability in
protein yield and quality, especially with regard to protein glyco-
sylation. The purpose of this study was to determine the batch-to-
batch variability in these two parameters for a transiently pro-
duced recombinant IgG antibody. The protein was produced in ten
independent batches of transiently transfected HEK-293E cells.
Afﬁnity-puriﬁed protein was analyzed by SDS–PAGE and size
exclusion chromatography (SEC). Mass spectrometry (MS) was
used for the identiﬁcation and relative quantitation of glycans.
Materials and methods
Cell culture and transfection
Four days before each transfection, one vial of frozen suspension-
adapted HEK-293E cells was thawed for two 150-mL transfections.
Cells were rinsed once with Ex-cell293 medium (SAFC, St. Louis,
MO) and resuspended at 0.4  106 cells/mL in Ex-cell293 medium
supplemented with 4 mM glutamine in an orbitally shaken 250-mL
glass bottle (SciLabware Ltd., Stone, United Kingdom). Cells were
incubated at 378C in the presence of 5% CO2 with orbital shaking
at 110 rpm (ISF-4-X incubator, Ku¨hner AG, Birsfelden, Switzer-
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land) [6]. After three days, the cells were resuspended at
1  106 cells/mL in a 1-L glass bottle in Ex-cell293 medium with
glutamine. Transfections were performed on the following day as
previously described with some modiﬁcations [7]. Brieﬂy, cells
were centrifuged before transfection and resuspended at
20  106 cells/mL in 7.5 mL RPMI 1640 medium (Lonza, Verviers,
Belgium) supplemented with 25 mM HEPES and 0.1% Pluronic F68
(Applichem GmbH, Darmstadt, Germany) and placed in 50-mL
glass bottles equipped with home-made vented caps with 1.5 cm
polyether sulfone membranes. To each bottle, 187.5 mg of plasmid
DNA (2% pEGFP-N1 (Clontech, Palo Alto, CA) and 98% pXLGCHO-
A2 by weight) and 600 mg of linear 25 kDa polyethylenimine (PEI;
1 mg/mL in H2O) (Polysciences, Eppenheim, Germany) were
added separately. The vector pEGFP-N1 carries the enhanced green
ﬂuorescent protein (EGFP) gene. Plasmid pXLGCHO-A2, a dual
expression vector for the production of a human anti-Rhesus D
IgG1 antibody, was constructed as described for pXLGCHO-A3 [8],
except that the expression cassettes for the light and heavy chain
genes were in a head-to-tail rather than a head-to-head orienta-
tion. After DNA and PEI addition, the cultures were incubated at
378C with agitation as before. After three hours the cells were
transferred to a 500-mL glass bottle with a vented cap and diluted
to a ﬁnal cell density of 1  106 cells/mL by addition of Ex-cell293
medium to a total volume of 150 mL. Valproic acid (VPA) (Sigma–
Aldrich, St. Louis, MO) was added to a ﬁnal concentration of
3.75 mM, and the cultures were incubated as before. The cell
density and viability were determined with the Trypan blue exclu-
sion method using a Neubauer hemocytometer. The recombinant
IgG concentration in the cell culture medium was determined by
ELISA as previously described [9].
IgG puriﬁcation and analysis by SDS–PAGE and size exclusion
chromatography
Recombinant IgG was puriﬁed from the cell culture medium using
Streamline Protein A according to the manufacturer’s instructions
(GE Healthcare, Uppsala, Sweden). Puriﬁed IgG was analyzed by
reducing SDS–PAGE either before or after treatment of the protein
with PNGase F for three hours at 378C (New England Biolabs,
Ipswich, MA). Analysis of puriﬁed IgG by SEC was performed on a
Superdex 200 10/30 GL column connected to an A¨kta system (GE
Healthcare). Before injection 50 mg of puriﬁed IgG was diluted in
100 mL of running buffer (50 mM K2HPO4 and 150 mM NaCl, pH
8.0). The protein was eluted with running buffer at a ﬂow rate of
0.4 mL/min and detected by UV absorbance. The IgG produced by
TGE was compared to a control IgG produced for clinical trials in a
stable Chinese hamster ovary (CHO) cell line that was kindly
provided by the authors of the study [10].
IgG sample preparation for mass spectrometry
For the bottom-up MS analysis, IgG samples were dried using a
SpeedVac system and resuspended (200 mL, 50 mg of protein) in
Tris–HCl buffer, pH 8.8 (Calbiochem-Merck, Darmstadt, Ger-
many). Protein aliquots were denatured and reduced in the pre-
sence of 4 M urea (Acros Organics, Thermo-Fischer Scientiﬁc, Geel,
Belgium) and 10 mM DTT (SAFC) at 378C for one hour with shaking
and subsequently alkylated by incubation with 40 mM iodoaceta-
mide (SAFC). Reduced and alkylated IgG was subjected to proteo-
lysis with trypsin (0.5 mg, substrate-to-enzyme ratio of 100:1, w/w)
(Promega AG, Du¨bendorf, Switzerland) at 378C for 18 hours. After
denaturation of trypsin by heating for 5 min to 908C, the samples
were aliquoted in four fractions containing 12.5 mg of peptides
each, dried, and stored at 808C.
Mass spectrometry of IgG
Measurements of the intact IgG were performed on a electrospray
ionization (ESI) – quadrupole time-of-ﬂight mass spectrometer
(MaXis qTOF MS, Bruker Daltonics, Bremen, Germany) operated
in positive ion mode at a resolution of 50,000 and on-line
coupled with a reverse phase liquid chromatography (RPLC) sys-
tem (HPLC 1200, Agilent, Santa Cara, CA) equipped with a C8
column for sample desalting. Mass spectra were smoothed and
deconvoluted with BioTools and Max Entropy (Bruker Daltonics).
Bottom-up analysis of the IgG tryptic digestions was performed
according to the following protocol. After resuspension in 35 mL of
water, 10 mL of a digested sample aliquot was loaded onto a porous
graphitized carbon column (Hypercarb column, Thermo Scienti-
ﬁc, Bremen, Germany) heated at 458C. Peptides were separated
over a binary gradient (from 100% to 55% mobile phase A in
36 min, followed by column wash and re-equilibration; mobile
phase A: 95% H2O, 4.9% acetonitrile (ACN, Fluka, Sigma–Aldrich)
and 0.1% formic acid; mobile phase B: 95% ACN, 4.9% H2O and
0.1% formic acid) at a ﬂow rate of 150 mL/min. Peptide cations
eluted from the column were ionized with a standard ESI source
and subsequently detected on a linear ion trap Fourier transform
ion cyclotron resonance (LTQ FT-ICR) mass spectrometer (Thermo
Scientiﬁc) equipped with a 12 T superconducting magnet (Oxford
Nanosciences, Oxon, UK). Broadband mass spectra were collected
in positive ion mode at a resolution of 25,000 at 400 m/z over a m/z
window of 700–2000. For the data analysis the Xcalibur software
version 2.0.7 (Thermo Scientiﬁc) was used.
Label-free quantitation of glycopeptides
Label-free quantitation of glycopeptides was performed by apply-
ing a previously described method [11] adapted here for liquid
chromatography (LC)–MS analysis. Brieﬂy, a list of tryptic glyco-
peptide ions was created by considering the IgG N-glycosylation
site (Asn297, Kabat numbering [12]) and a maximum of two trypsin
missed cleavages. Only biologically relevant oligosaccharidic
structures were chosen by browsing a glycopeptide database (Gly-
coPep DB software, http://hexose.chem.ku.edu/sugar.php) [13]
and other sources [14–17]. Glycopeptide masses were calculated
by adding to the peptide mass the different glycan masses. The
obtained masses were converted into protonated glycopeptide ion
m/z values (from 2+ to 4+; Table 1). These theoretical values were
used to validate the presence of glycopeptides in the sample
mixture by using a threshold of theoretical-to-experimental mass
accuracy of 3 ppm. For the relative quantitation of the detected
glycoforms, the intensity of the peaks corresponding to glycopep-
tides were extracted from a speciﬁc area of the chromatogram
(typically from 24 to 29 min) and transferred to Microsoft Excel.
The intensities of the ﬁrst four isotopic peaks were summed for
obtaining a single value of intensity for each glycopeptide ion. The
relative intensity of each ion was obtained by normalizing over the
total glycopeptide intensity, and the relative abundance of each
glycoform was calculated by summing the relative intensities of all
the related glycopeptide ions.
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Results and discussion
The variability of the TGE bioprocess was assessed in ten indepen-
dent transfections of 150 mL performed under the same condi-
tions. For the ten batches, the cell density and viability varied by
16–26% (Fig. 1a) and the recombinant antibody concentrations
varied by 24–30% over the ten-day culture (Fig. 1b). The calculated
cell speciﬁc productivity in the ten batches averaged 20.2  2.6 pg/
cell/day. The recombinant IgG was puriﬁed from cell-free super-
natants by afﬁnity chromatography with Protein A and analyzed
by SEC and SDS–PAGE. For each analysis, the IgG produced by TGE
was compared to a control IgG produced in a CHO cell line [10].
On the chromatograms, only one sharp protein peak was observed
at the same elution volume for all the samples, suggesting that the
ten batches produced a protein of the same size (Fig. 2a). No other
protein peak was observed, which indicated the IgG was pure and
did not contain degradation products. The two other peaks
observed at a later elution time represent salt peaks. For all samples
resolved by reducing SDS–PAGE, two bands were observed at
25 kDa and 55 kDa, corresponding to the IgG light and heavy
chains, respectively (Fig. 2b). Each IgG heavy chain had about the
same extent of N-linked glycosylation as determined by treatment
with PNGase F (Fig. 2b). No difference in the size was observed
between the IgG produced by TGE in HEK-293E cells and by SGE in
CHO cells (Fig. 2a,b). The higher peak intensities for the CHO-
produced antibody (Fig. 2a) can be explained by the fact that it was
stored at a different concentration in a different buffer than the
IgGs produced in HEK-293E cells.
To further analyze the variability of glycosylation among the ten
batches of transiently produced antibody, we employed high reso-
lution MS. First, analysis of intact IgG was performed by on-line LC–
electrospray quadrupole time-of-ﬂight (LC–ESI-qTOF) MS at a reso-
lution of 50,000. The deconvoluted mass spectra showed that each
IgG was composed of a complex mixture of several glycoforms with
MWs between 149,700 and 150,500 Da (Fig. 3a), which is in
agreement with the theoretical MW calculated on the basis of the
IgG light and heavy chain cDNA sequences. Moreover, the quali-
tative analysis of three selected batches clearly indicated that their
glycosylation pattern was conserved (Fig. 3a). We then applied a
label-free bottom-up methodology using FT-ICR MS coupled on-
line with LC. This method, adapted from Rebecchi et al. [11],
consisted in the LC–MS-based identiﬁcation of the glycopeptides
generated upon trypsin digestion of the intact IgG and their sub-
sequent quantitation after normalization over the total glycopep-
tide intensity (see Materials and methods for additional details).
This approach allowed us to identify both high mannose and
complex oligosaccharides. However, no sialic acid-containing
New Biotechnology Volume 29, Number 4 May 2012 RESEARCH PAPER
TABLE 1
List of glycopeptide ions detected by LC–FT-ICR MS
Glycoforma Peptide aa sequenceb Theoretical m/zc (monoisotopic) Charge state
EEQYNSTYR
TKPREEQYNSTYR
TKPREEQYNSTYR
TKPREEQYNSTYR
1398.5528
1639.7018
1093.4686
820.3537
2+
2+
3+
4+
EEQYNSTYR
TKPREEQYNSTYR
TKPREEQYNSTYR
1479.5794
1147.4875
860.8674
2+
3+
4+
EEQYNSTYR
TKPREEQYNSTYR
TKPREEQYNSTYR
TKPREEQYNSTYR
1317.5265
1558.6748
1039.4523
779.841
2+
2+
3+
4+
EEQYNSTYR
TKPREEQYNSTYR
1378.0397
810.0976
2+
4+
EEQYNSTYR 1203.4710 2+
EEQYNSTYR 1386.0371 2+
TKPREEQYNSTYR 1133.8120 3+
EEQYNSTYR 1446.5503 2+
EEQYNSTYR 1365.5239 2+
EEQYNSTYR 1215.9869 2+
EEQYNSTYR 1297.0133 2+
a ( ) N-Acetylglucosamine; ( ) mannose; ( ) galactose; ( ) fucose.
b Glycosylation site located on Asn297 (Kabat numbering [12]).
c Theoretical m/z values were calculated according to the procedure described in Materials and methods.
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glycopeptides were detected. This was probably due to their low
ionization efﬁciency in positive mode. Eleven different glycans were
detected, but four of these contributed 98  1% of the total glycan
amount (Table 1). These four species, represented in Fig. 3b with
their relative abundances averaged over the ten batches [order of
relative abundance: G1F (58.5%), G2F (20.8%), G0F (14.3%) and the
mixed complex form (4.1%)], were fucosylated (the nomenclature
used for the glycoforms is described in [18]). Fucosylation is impor-
tant for the activity of therapeutic antibodies as it can reduce their
antibody-dependent cytotoxicity [19]. It is noteworthy that the
relative ratio order of the four main glycans was maintained over
nine of the ten batches with the only exception being batch 8, where
G0F (21.3%) was slightly more abundant than G2F (17%) (Fig. 3c).
Despite the generally low ionization efﬁciency of glycopeptides, the
RESEARCH PAPER New Biotechnology  Volume 29, Number 4 May 2012
FIGURE 2
Analysis of the IgG produced in ten TGE batches and puriﬁed by afﬁnity to Protein A. The control refers to the same IgG produced for clinical trials in a stable CHO
cell line [10]. (a) SEC of puriﬁed IgGs. The buffer alone was used as a negative control. (b) Reducing SDS–PAGE of IgG either deglycosylated with PNGase F (+) or
not ().
FIGURE 1
Cell growth and IgG production in ten independent TGE batches. HEK-293E cells were transfected and cultivated for ten days as described in Materials and
methods. The data are expressed as the average of ten batches  s.d. At the times indicated the cell density (closed circles) and viability (open circles) were
measured by manual counting using the Trypan blue exclusion method (a) and the IgG concentration in the medium was measured by ELISA (b).
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maximum standard deviation over three technical replicates for
these glycoforms (with samples analyzed according to a random
sequence) was 9.1% and normally it remained below 6%. The
maximum relative deviation for a single glycoform among the
ten batches was only 2.5%.
Finally, to determine if the type and distribution of the glyco-
forms varied with time in cell culture, we compared the glycosyla-
tion proﬁle of one batch harvested at three, ﬁve, seven and ten
days after transfection. The results indicated that the ranking of
the four main glycoforms was constant from three days post-
transfection (Fig. 3d). This suggested that the N-linked glycans
were stable in cell culture despite the decrease in cell viability over
time (cf. Fig. 2a). The same observation has been reported for an
IgG produced by TGE in CHO cells [20].
In conclusion, the results presented here show that a TGE
process can be reproducible even in a non-instrumented cultiva-
tion system. As measured by LC–MS, the IgG produced by TGE in
HEK-293E cells had a glycosylation proﬁle which was reproducible
over ten batches and similar to glycosylation proﬁles reported in
the literature for human IgGs [21,22]. Therefore, this study
demonstrated that TGE processes, even when performed in simple,
non-instrumented bioreactors, can yield a protein with little
batch-to-batch variation in yield or quality. The relevance of sialic
acids in glycosilation patterns has not been overlooked in this
study; however, we focused here on the overall glycans detectable
by the positive mode of MS. Our future work will also address the
sialic acid content of recombinant proteins produced by TGE.
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Abstract Electron transfer dissociation (ETD)-based top-
down mass spectrometry (MS) is the method of choice for
in-depth structure characterization of large peptides, small-
and medium-sized proteins, and non-covalent protein com-
plexes. Here, we describe the performance of this approach for
structural analysis of intact proteins as large as the 80 kDa
serotransferrin. Current time-of-flight (TOF) MS technologies
ensure adequate resolution and mass accuracy to simulta-
neously analyze intact 30–80 kDa protein ions and the com-
plex mixture of their ETD product ions. Here, we show that
ETD TOF MS is efficient and may provide extensive se-
quence information for unfolded and highly charged (around
1 charge/kDa) proteins of ∼30 kDa and structural motifs
embedded in larger proteins. Sequence regions protected by
disulfide bonds within intact non-reduced proteins oftentimes
remain uncharacterized due to the low efficiency of their
fragmentation by ETD. For serotransferrin, reduction of S–S
bonds leads to significantly varied ETD fragmentation pattern
with higher sequence coverage of N- and C-terminal regions,
providing a complementary structural information to top-
down analysis of its oxidized form.
Keywords Electron transfer dissociation . ETD .
Electrospray . ESI . TandemMS .MS/MS . Time-of-flight
mass spectrometry . TOFMS . Top-down . Transferrin
Introduction
The term top-down mass spectrometry (TD MS) refers to the
structure analysis of intact protein ions by their fragmentation
in the gas phase [1]. When applied to a mixture of proteins
from different protein families or proteoforms of a single
protein family, TD MS translates into a top-down proteomics
(TDP). TDP presents several theoretical advantages over
bottom-up mass spectrometry-based proteomics (BUP),
which consists in the analysis of peptide mixtures derived
from proteolysis [2, 3]. In both TDP and BUP, the survey
scan (MS1 or simply MS) yields information about the total
mass of biomolecules, whereas the tandemMS (MS/MS) step
confirms the sequence of the selected precursor ion. TDP thus
identifies a specific proteoform, whereas BUP is typically
employed in identification of protein families [4].
TDMS and TDP analyses are technically more challenging
since proteins are generally more difficult to separate, ionize,
and fragment than peptides. In addition, the resulting MS/MS
spectra are convoluted and data interpretation is not trivial.
Recent introduction of novel in-solution protein fractionation
techniques, e.g., gel-eluted liquid fraction entrapment electro-
phoresis [5], or the adoption of new stationary phases for
liquid chromatography (LC) [6] have partially filled the gap
between peptide and protein fractionation and separation.
However, for MS data acquisition and analysis, new develop-
ments and improvements are needed. In terms of hardware,
only high-resolution instruments are capable of resolving and
distinguishing complex product ion clusters in MS/MS spec-
tra of proteins. In terms of software, specific data analysis
workflows have to be applied to efficiently reconstruct and
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combine the information from MS1 and, most importantly,
MS/MS.
Although all the common ion activation methods can be
applied to intact proteins, electron-based fragmentations, spe-
cifically electron capture dissociation (ECD) [7, 8] and elec-
tron transfer dissociation (ETD) [9], have been shown to
produce a higher sequence coverage than “slow-heating”
methods (such as collision-induced dissociation [10] or infra-
red multiphoton dissociation [11]) and also have the capability
of cleaving disulfide bridges [12]. Importantly, ECD and ETD
perform most efficiently (i.e., with low ion activation time
resulting in an extensive backbone fragmentation) with highly
charged precursors, which is the typical condition present
during TD MS or TDP where highly charged protein cations
are analyzed. Recently, developments in ultraviolet photodis-
sociation (UVPD) and surface-induced dissociation MS/MS
demonstrated intriguing capabilities specifically for intact
protein analysis [13].
Originally, radical-driven TD MS of large proteins was
introduced using MS/MS “in time” because the required high
resolution was only available for Fourier transform ion cyclo-
tron resonance mass spectrometers (FT-ICR MS) and the
ability to perform radical-induced fragmentation was only
available in ion traps, e.g., ICR ion trap or Paul ion trap [14,
15]. Beginning with comprehensive analysis of ∼10-kDa
model proteins, such as ubiquitin [16], the application range
of ECD-based TDMS was significantly expanded, delivering
a single-amino acid resolved structure of a 29 kDa carbonic
anhydrase [17, 18] and further analysis of proteins in the 50–
70 kDa range [19]. TD MS of proteins in these mass ranges
can be now performed on the time scale of on-line LC.
The quest for radical-driven fragmentation in the wide-
spread, low resolution quadrupole (q) mass analyzers and
product ion analysis in the high-resolution mass analyzers
led to the development of radical-driven top-down mass spec-
trometry “in space”. After numerous attempts, ECD was
efficiently implemented in a quadrupole mass analyzer that
could be coupled to a higher resolution time-of-flight mass
spectrometer (TOFMS) [20, 21]. However, the real revolution
in TDMS “in space” was made by implementing ETD first in
a linear ion trap and then in other quadrupole mass analyzers
[22]. Currently, the most successful implementations of ETD
specifically for protein analysis include ETD on hybrid qTOF
MS [23, 24], LTQ Orbitrap FTMS [25] and qFT-ICR MS
platforms [26]. These recent technologies have already shown
strong potential applications, including the structural analysis
of ∼150 kDa intact immunoglobulins G (IgG) on different
platforms [27, 28].
The ETD fragmentation and subsequent mass analysis
using a qTOF MS of bovine carbonic anhydrase and human
serotransferrin are presented herein. Carbonic anhydrase was
used as a model for medium-size proteins, which can be
analyzed without specifically designed sample preparation or
instrumental set-up. Serotransferrin was used to challenge the
instrument capabilities with a large protein and investigate the
performance of ion manipulation, fragmentation, and detec-
tion. Structural study of this protein is complicated in part
because its large MWand the presence of 19 disulfide bridges
hinders ion–ion interactions in ETD. This structural complex-
ity manifested itself by significant differences in the ETD
fragmentation patterns depending on serotransferrin oxidation
state. To characterize these proteins in detail we applied ded-
icated data analysis workflow based on the SNAP2 algorithm
(Bruker Daltonics, Bremen, Germany). Our results thus dem-
onstrate the current capabilities of high-resolution qTOF MS
in sequence analysis of large proteins by TD MS.
Experimental
Sample preparation Bovine carbonic anhydrase and human
serum transferrin (serotransferrin) were obtained commercially
(Sigma, Taufkirchen, Germany). For direct infusion experiment
of carbonic anhydrase and non-reduced serotransferrin, proteins
were dissolved in water/acetonitrile/formic acid (50:49.9:0.1,
v/v/v) to a final concentration of∼1μMand usedwithout further
purification. Transferrin reduction was obtained by dissolving
the lyophilized protein in 50 mM sodium carbonate buffer in
presence of 5 mM tris(2-carboxyethyl)phosphine (TCEP, Sig-
ma). Prior to infusion, the reduced protein was desalted by
centrifugation with microcentrifuge 10 kDa MW cut-off filters
(Millipore, Zug, Switzerland).
Time-of-flight tandem mass spectrometry Mass measure-
ments of intact protein ions and ETDMS/MS were performed
on a high-resolution, high-mass accuracy quadrupole time-of-
flight (qTOF) mass spectrometer (maXis UHR qTOF MS,
Bruker Daltonics GmbH, Bremen, Germany) equipped with
electrospray ion source. ETD MS/MS was performed as pre-
viously described [24]. The main steps in top-down ETD TOF
MS are schematically shown in Fig. 1. The differences in ETD
of high-mass proteins compared to smaller analytes are: (1)
prolonged cation accumulation and radical anion injection
times to ensure the accumulation of a sufficient number of
analyte ions and, at the same time, the possibility of efficiently
inducing ETD; (2) decreased ion–ion reaction time as ETD
proceeds faster when highly charged ions are used as precur-
sors. After optimization (see Supplementary Information), pre-
cursor ion accumulation time was increased up to 800 ms,
anion injection time was set to 100 ms, and additional ion–
ion interaction time to 40–50 ms. Product ions were transferred
to the ion cooler cell from the reaction cell and orthogonally
pushed to the TOF mass analyzer at the rate of 10 kHz. The
orthogonal acceleration potential was at 10 kV. Acquisition in a
broad m/z window (100–5,000 m/z) was performed with signal
digitization at 2 GHz, whereas higher resolution MS and MS/
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MS data were acquired at a faster digitization rate of 4 GHz for
narrower m/z range of 500–3,000 m/z. Intact protein and prod-
uct ion mass spectra were acquired in separate direct infusion
experiments. For the larger protein, data acquisition time of up
to 30 min was employed to average up to 1,000 MS/MS
spectra.
Data analysis The MS and MS/MS spectra were analyzed
using the dedicated top-down data analysis procedure. Briefly,
precursor and product ion mass spectra were summed over the
infusion time in each MS and MS/MS experiment with Data
Analysis software version 4.0 (Bruker Daltonics). Intact protein
mass spectra were submitted to the MaxEntropy deconvolution
procedure to yield heterogeneous distribution of neutral
(deprotonated) glycosylated proteoforms.
Before ETD data analysis, the SNAP 2 algorithm was used
to simulate MS/MS spectra with theoretical isotopic distribu-
tions of the peaks that matched the experimental mass spectra
with a correlation coefficient of 0.4 or better. Charge states and
monoisotopic masses were assigned automatically for the prod-
uct ion isotopic distributions in both the experimental and
theoretical mass spectra. Manual analysis considering both ex-
perimental and theoretical mass spectra was performed to assign
ETD-specific c-type and z-type product ions. Alternatively,
automatic data analysis was performed by deisotoping the sim-
ulated isotopic clusters, keeping only the monoisotopic masses.
Following charge state deconvolution, the obtained mass list of
product ions was searched against the known sequence of the
proteins to determine the product ion identity and the sequence
coverage. The results of both manual and automatic data anal-
ysis were compared and pooled to generate the verified protein
sequence coverage map. Internal product ions, formed by sec-
ondary fragmentation of the primary product ions, have not
been considered in the current work.
Results and discussion
Evaluation of ETD top-down mass spectrometry workflow The
complete workflow for TD MS includes: (1) sample prepara-
tion, (2) intact protein mass measurement in MS mode, (3)
sequence analysis in MS/MSmode, and (4) data analysis. The
present work employed a state-of-the-art, ETD-enabled high-
resolution qTOF mass spectrometer (Fig. 1). Some of its
figures of merits for intact protein analysis are: resolution up
to 50,000 over a wide m/z range in MS1, and up to 30,000–
40,000 for MS/MS (the resolution is influenced by the com-
plexity and the abundance of the product ion population); a
scan rate up to 20 Hz; mass accuracy of ∼1 ppm (for bothMS1
and MS/MS). Remarkably, TOF mass analyzers generally
have a higher dynamic range than FT-based instruments, and
this characteristic is particularly important for intact protein
analysis: for the ∼9-kDa ubiquitin the ratio between the mon-
oisotopic and the most abundant peaks is ∼10, but the same
reaction 
cell
10 kHz
n-CI source
product 
ions
precursor 
ions
reagent 
anions
Fig. 1 Sequence of top-down electron transfer dissociation tandem mass
spectrometry on a qTOF MS. Step 1: electrospray ionization of the
samples in the ion source and precursor ion accumulation in the reaction
cell (800 ms). Step 2: ETD reagent injection from the chemical ionization
source to the reaction cell (20–100 ms). Step 3: ion–ion reaction in the
reaction cell (20–100 ms). Step 4: ion–ion reaction product ions transfer
into the ion cooler. Step 5: ion extraction from the ion cooler into the
orthogonal acceleration region. Step 6: orthogonal ion extraction into the
time-of-flight tube with an iron mirror (10 kHz, 10 kV). Step 7: ion
detection at the multichannel plate with time to digital converter (2 or
4 GHz sampling rate)
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ratio increases to∼6E4 for ∼29 kDa carbonic anhydrase,∼E15
for ∼79 kDa transferrin, and up to ∼E32 for a ∼150-kDa IgG.
Figure 2 shows the ETD mass spectrum of 35+ precursor
ion of carbonic anhydrase. Most intense product ions are
shown in the expanded segments. Generally, the envelope of
the undissociated charge-reduced species (also referred to as
“ETnoD products”) in ETD TD MS of small to medium
proteins is positioned in the low m/z range (∼500–1,500 m/z)
therefore overlapping with typical product ions of ∼300–
1,400m/z. Here, three different intense ETnoD products (with
charge states 34+, 33+, and 32+) were detected, impeding the
product ion observation between ∼850 and 920 m/z.
The complexity of the product ion mixture for ETD TDMS
of carbonic anhydrase is illustrated in Fig. 3, top panel. Several
partially overlapping clusters of multiply charged ions can be
observed in an expanded 675–684m/zwindow. Due to the high
density of peaks, the first data analysis step is to filter the ion
clusters from noise or spurious peaks by matching the experi-
mentally obtained clusters with theoretical peaks (Fig. 3, middle
panel). For a successful noise filtration, high-mass accuracy and
resolution are needed. In addition, high signal-to-noise signal is
required to confidently identify the charge state and possibly the
monoisotopic peak of each ion cluster. For carbonic anhydrase,
the qTOF TDMS allowed the assignment of product ions of up
to 14+ charge state. Software parameters such as signal-to-noise
cut-off can bemanually selected to enhance peak identifications.
The SNAP2 algorithmmatches the experimental and theoretical
distributions applying a user-defined correlation coefficient.
Due to the complexity of product ion population for a 29 kDa
protein, this coefficient is usually set to 0.5 or higher (equivalent
to 50 % correlation), but this value can be reduced for larger
proteins, where generally the complexity of product ion mixture
is higher and the average signal-to-noise ratio is lower. Finally,
as illustrated in Fig. 3, bottom panel, the identified clusters are
deconvoluted and deisotoped, as only the monoisotopic masses
are used for the database search or, alternatively, for de novo
sequencing. In all our experiments, we imported the sequence of
the employed proteins in the software BioTools (Bruker
Daltonics) to reduce the time needed for a complete database
search.
Fig. 2 Top-down electron transfer dissociation (ETD)-based ESI qTOF
MS/MS of carbonic anhydrase (29 kDa). Prior to ETD, a single charge
state, [M+35H]35+, of carbonic anhydrase was selected with an isolation
window of 30 m/z. Efficient charge reduction upon electron transfer
resulted in electron transfer products without dissociation (ETnoD prod-
ucts), specifically [M+35H]34+•, [M+35H]33+••, and [M+35H]32+••• ions.
The insets show the expanded regions of the MS/MS mass spectra
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Top-down mass spectrometry of oxidized transferrin Mature
human serotransferrin (UniProt entry: P02787) is a 679 amino
acid-long protein, Scheme 1. First, the intact mass of non-
reduced transferrin was determined (Fig. 4, insets). The ob-
served charge state distribution was centered at ∼2,200 m/z
and included charge states 22–50+ with the most abundant
676 677 678 679 680 681 682 683 m/z
7+
676 677 678 679 680 681 682 683 m/z
7+
11+ 8+ 10+ 9+
deconvolution and de-isotoping 
isotopic cluster matching 
database or de novo sequencing
c41 7+
676 677 678 679 680 681 682 683 m/z
z40
7+
c66 11 +
c48 8+ c60 10 + c55 9+
Fig. 3 Top-down MS/MS data
analysis procedure. Example is
made for ETD qTOF MS/MS of
29 kDa carbonic anhydrase
protein, m/z=675–684 (Fig. 2).
Step 1: raw data file analysis and
matching of theoretical and
experimental isotopic clusters.
Step 2: deconvolution and
deisotoping of the selected
theoretical isotopic clusters. Step
3: protein theoretical product ion
database search and/or de novo
sequencing based on the
monoisotopic masses and charge
states data (product ion
assignment)
Scheme 1 Fragmentation map of
intact transferrin after ETD-based
ESI qTOF MS/MS. Backbone
cleavage sites identified uniquely
for the oxidized form of
serotransferrin are indicated in
black, whereas cleavages
characteristic of the reduced form
are indicated in red. Common
cleavage sites are shown in green.
Disulfide bridges are indicated by
purple dotted lines
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charge states at 35–38+. This corresponded to a charge density
of only 1 proton/2.1 kDa. The relatively low protonation level
can be presumably explained by the compact conformation
retained by the protein in the liquid as well as in the gas phase
due to the constraints from S–S bridges, which limit the
accessibility of potential protonation sites. The deconvoluted
mass spectrum showed a main peak at ∼79.5 kDa (Fig. 4), left
inset. Intact protein mass measurements showed the presence
of additional, less abundant, proteoforms, presumably due to
protein glycosylation. Although the proteoform characteriza-
tion is beyond the scope of this work, it might be useful to
recall that the capabilities of qTOF MS in determining with
high mass accuracy protein glycoforms have already been
demonstrated for 150 kDa intact IgGs (see Electronic Supple-
mentary Material, Fig. S1 of reference [27]).
One of the most intense precursor ions, the [M+38H]38+
ion, was selected for ETD TOF MS/MS. Fragmentation pa-
rameters, specifically (1) cation accumulation time, (2) ion–
ion interaction time and (3) radical anion injection time were
optimized to maximize the protein fragmentation efficiency.
The optimum transferrin cation accumulation time was found
to be at ∼800 ms, which ensured a sufficient precursor ion
population. A similar value was previously applied also to the
ETD of ∼150 kDa IgG [27]. The ion–ion interaction time was
found to be optimal for ETD of transferrin between 40 and
50 ms. At these interaction times, ETD process resulted in the
formation of a significant product ion population without
excessive internal fragment production, and incomplete dis-
sociation of the charge-reduced species (Fig. S1, Electronic
Supplementary Material). The radical anion reaction time can
deeply influence the ETD efficiency as it determines the final
reagent anion number involved in ETD. For a fixed ion–ion
interaction time, a low anion injection time impedes ETD, and
conversely at too long injection times the occurrence of mul-
tiple, consecutive electron transfer events is highly enhanced,
so that many charge-reduced species, low-charged product
ions and internal fragments are produced. The final applied
valuewas 100ms (Fig. S2, Electronic SupplementaryMaterial).
The ETD mass spectrum of oxidized transferrin is shown
in Fig. 4, bottom. Charge-reduced species (particularly,
[M+38H]37+•, [M+38H]36+••, and [M+38H]35+••• ions) domi-
nated the mass spectrum in the high m/z region, whereas the
product ions were grouped and centered at ∼1,000m/z. Notably,
in contrast to what is typically observed for a smaller protein,
e.g., carbonic anhydrase, the highly abundant ETnoD products
were positioned above 2,000 m/z, thus they did not interfere
with the product ion detection and analysis. Most product ions
were located below ∼1,700 m/z.
An expanded view of the ETDmass spectrum of transferrin
containing most of the product ions is presented in Fig. 5. The
top panel illustrates the capabilities of the qTOF mass spec-
trometer to isotopically resolve multiply charged product ions
Fig. 4 Top-down electron transfer dissociation (ETD)-based ESI qTOF
MS/MS of transferrin (79 kDa). The insets show ESI qTOF MS of intact
transferrin with and without deconvolution. Prior to ETD, a single charge
state, [M+38H]38+, of transferrin was selected with an isolation window
of 30m/z. Efficient charge reduction upon electron transfer resulted in
electron transfer products without dissociation (ETnoD products),
specifically [M+38H]37+•, [M+38H]36+••, and [M+38H]35+••• ions. Prod-
uct ions are observed as a group primarily in the m/z=700–1,600 region.
Due to their high charge state and lower abundance compared to the
ETnoD charge-reduced precursor ions these ions are not resolved. There
are no product ions detected above 2,500m/z
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present in complex mixture. The assignment of the most
abundant product ions shown in the bottom panel indicates
that at the applied ETD conditions product ions up to 14+ in
charge state were detected, with charge states primarily
between 5+ and 8+. Almost all identified product ions
were c-type, containing information about the N-terminus of
the protein. The relative position of the disulfide bridges may
explain the fragmentation pattern observed. Close to the
C-terminus, two Cys residues (Cys665 and Cys674) are located.
These are believed to be involved in the formation of
distal S–S bridges with Cys474 and Cys402, respectively. The
entire C-terminal portion of serotransferrin is folded in a tight
conformation by a number of additional S–S bonds present
between Cys402 and Cys674. The extent of disulfide-protected
sequence is therefore most likely responsible for the formation
of only few z-type ions. Particularly, most z-ions identified
derived from backbone cleavages occurring at the C-terminal
side of Cys665 (i.e., with no need of cleaving a disulfide bond,
but only the peptide bond for product ion formation), with the
notable exceptions of z18, z75 and z99.
Conversely, at the N-terminus there was a 69-residue loop
completely disulfide-free (between Ile49 and Ser117), which
Fig. 5 Expanded views on ETD
product ions of transferrin
obtained on a qTOF MS.
(Bottom) expanded segment,
m/z=700–1,500, shows ETD
product ions that are assigned to
be mainly c-type product ions of
transferrin in charge states from
5+ to 14+. Product ions c69 and
c56 are particularly abundant and
present in a number of charge
states. (Top) expanded segment,
m/z=975–1,015, shows efficient
separation and baseline resolution
of multiply charged ETD product
ions. For example, the inset
shows a well-resolved isotopic
distribution of c55
6+ product ion at
∼1,000m/z. The annotated here
MS/MS peaks are included into
the protein sequence coverage
summary presented in Scheme 1
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interconnects the first disulfide-protected area (from Cys9 to
Cys48, with two S–S bonds) to the following one (starting
from Cys118, which is linked to Cys194). As expected, most of
the identified backbone cleavages arose from the unprotected
linker, which was almost fully sequenced, and the small N-
terminal sequence preceding Cys9. Only four cleavages in the
first disulfide-protected area were identified (i.e., ions c28, c37,
c43, and c44), and no product ions derived from the second area
were observed. Overall, we identified 62 c-ions and 11 z-ions,
for a total sequence coverage of ∼11 % (Table 1).
The capability of ETD (and, more generally, radical-driven
ion activation methods) to cleave disulfide bonds has been
confirmed to some extent in these experiments with transfer-
rin, in addition to those reported earlier for IgGs. Of 73
backbone cleavages reported for the oxidized serotransferrin,
13 derived from disulfide-protected regions, and were mainly
located towards the C-terminus. However, recent results by
Ganisl and Breuker suggest that, at least when applied to
proteins, ECD does not preferentially nor frequently cleaves
S–S bonds rather than peptide backbone ones [29], as reported
in the past for peptides [12, 30]. Nevertheless, the controversy
may be limited to the term “preferential”, as backbone cleav-
ages from S–S bond-protected regions for many of the inves-
tigated proteins were reported. The authors explain these
cleavages as resulting from a contribution from either vibra-
tional fragmentation prior to ECD, or secondary radical frag-
mentation in ECD. Due to the differences in ETD and ECD
processes, especially for what concerns the pressure of the ion
traps where ion activation and fragmentation take place, fur-
ther studies are needed to address this interesting question in
relation specifically to ETD.
Top-down mass spectrometry of reduced transferrin Top-
down experiment on disulfide-reduced serotransferrin was
performed by direct infusion of a protein sample treated
overnight with TCEP (Fig. 6). As expected, the reduction of
S–S bonds induced the exposure of protonation sites not
accessible to the acidic solvent in the oxidized protein. As a
result, the charge state envelope of the reduced intact protein is
significantly shifted towards lowerm/z in respect to that of the
oxidized counterpart. A large number of high charge state ions
were detected (Fig. 6, right inset). Specifically, the charge state
distribution included charge states from 40+ to 100+, with the
most intense transferrin ions located around 900m/z and car-
rying 83–88 protons.
To maximize the fragmentation efficiency in radical-driven
mass spectrometry, high charge state precursors are usually
preferred. Nevertheless, positioning the precursor isolation
window around 1,000m/z resulted in a partial overlapping
between the ETnoD products and the heavy product ions.
An intensity difference was observed between the charge-
reduced species and dissociation products. This impeded the
identification of fragments above 1,000m/z, therefore we
opted for a 300m/z isolation window centered at 1,285m/z,
to include a number of charge states of the precursor (from 56+
to 70+) (Fig. S3, Electronic Supplementary Material). These
precursor ions ensured improved fragmentation efficiency and
the presence of ETnoD products in a region of the mass
spectrum not occupied by product ions, beyond 1,400m/z.
Different from the oxidized transferrin, the ETD mass spec-
trum of the reduced protein showed a large m/z distribution of
the product ions, which were not grouped in a specific, limited
region but instead spread between ∼200 and 1,300m/z, with a
variation of intensity that generally is not higher than two- to
three-folds over the wholem/z range (Fig. 6, left insets). Since
the same ETD fragmentation parameters (injection and inter-
action times) were applied for both the lower charge states
oxidized, and higher charge state reduced forms, it is likely
that for reduced transferrin analysis multiple electron transfer
events occurred on already formed product ions, reducing
their charge state and increasing their final mass-to-charge
ratio. This is supported by the identification and assignment
of several z+1 ions, generally not detected for the oxidized
protein, and presumably obtained through a charge reduction
event by secondary electron transfer on a primary product ion.
As summarized in Scheme 1, the distribution of the
assigned product ions for ETD of reduced serotransferrin
was more balanced between c- and z-type ions. Regarding
the N-terminal fragments, the backbone cleavages observed
were complementary to those previously identified for the
oxidized transferrin. Specifically, the protein motif comprised
between Cys9 and Cys48 was highly sequenced (18/30 back-
bone cleavages assigned). On the contrary, the loop between
Cys48 and Cys118 was poorly sequenced. The number of z-
type ions was increased, with good sequence coverage in the
region between Cys620 and the C-terminus. This motif includ-
ed also Cys637, which is linked to Cys418 in the oxidized
protein; a non-complete reduction of this bond might explain
the poor or absent sequence coverage for the sequence pre-
ceding Cys637. In general, for the reduced protein the average
size of assigned product ions was smaller than for the oxidized
counterpart, likely because of a modified conformation and
charge location. Here, the only “high-mass” product ions
assigned were c101, c102 and c104 (which were still lighter than
Table 1 Summary of the assigned unique backbone cleavages for oxi-
dized or reduced transferrin, and for the combination of the two datasets.
Serotransferrin
form
N-terminal
fragments
C-terminal
fragments
Total sequence
coverage (%)
Oxidized 62 (4)a 11 (9)a 10.7
Reduced 34 39 10.7
Combined 82 41 18.1
a For the oxidized form, the number of backbone cleavages from disul-
fide-protected regions is indicated within parenthesis
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other c-ions assigned for the oxidized transferrin). In total, for
the reduced form we report 34 c-type ions and 39 z-type ions
(Table 1). Similarly to the previous experiments on IgG frag-
mentation, no complementary fragments for the same back-
bone cleavage have been identified.
Conclusions
Our previous results reported for the analysis of immunoglob-
ulin G (IgG) had already shown light on the new possibilities
open by high-resolution TOF mass spectrometry for the top-
down analysis of large proteins. Here, we focused our attention
on electron transfer dissociation-based TDMS characterization,
for stressing the current possibilities offered by this experimen-
tal set-up and further investigating the dependence of protein
sequence coverage on the protein structure/conformation and
its disulfide bond connectivity. The comparison between oxi-
dized and reduced transferrin clarifies, despite the use of a
different precursor charge state for the ETD reaction, that the
presence or absence of S–S bonds redistribute entirely the
fragmentation channels (see Scheme 1, where the backbone
cleavages in common between oxidized and reduced precur-
sors, signed in green, are a minority). Not only the disulfide-
protected regions need two bond cleavages to be sequenced,
but also the different charge localization and local conformation
can play an important role in this scenario. Moreover, the
comparison between the fragmentation maps of transferrin
and IgG represents incontrovertible evidence that ETD is pri-
marily directed to the disulfide-free loops interconnecting con-
secutive disulfide-protected domains when the proteins are
analyzed in non-reduced forms [27]. On the other hand, for
these two protein forms the product ion populations are distrib-
uted very differently in their ETD mass spectra (a single-
maximum distribution for transferrin versus a double-
maximum distribution for the IgG), indicating that also the
primary structure of the protein influences the final outcome
(see Fig. 1 and Schemes 1 and 2 in Ref. [27]). Serotransferrin
presents a much more complicated S–S bond connectivity in
comparison to the IgG, and this might explain the limited
sequence coverage for the C-terminus of its oxidized form, as
well as the smaller size of assigned fragments when compared
to the IgG. The analysis of the reduced transferrin, indeed,
complemented the results obtained for the oxidized form very
well: although the extent of fragmentation obtained in each
single experiment (i.e., for the oxidized or reduced protein) is
the same, the combination of the two increases the final se-
quence coverage by ∼70 % (from 10.7 to 18.1 %, Table 1).
Achieved ETD TD MS performance shall extend the appli-
cation range of protein–drug binding characterization to larger
proteins, compared to the current level of ubiquitin (8.6 kDa)-
size proteins [31, 32]. However, further enhancement in (1)
Fig. 6 Top-down electron transfer dissociation (ETD)-based ESI qTOF
MS/MS of disulfide bond reduced serotransferrin (79 kDa). The right
inset shows ESI qTOF MS data of intact S–S bond reduced transferrin
without deconvolution demonstrating a significant shift in precursor ion
charge states toward increased protein charging. Prior to ETD, a number
of transferrin precursor ions in different charge states, from about
[M+56H]56+ to [M+70H]70+, were selected with an isolation window
of ±150m/z around m/z 1,285. Efficient charge reduction upon electron
transfer resulted in electron transfer products without dissociation
(ETnoD products). The observed product ions occupy the m/z region
from charge-reduced precursor ions to the lowest m/z detected
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sensitivity of detection of multiply charged product ions (to
reach high signal-to-noise by averaging a lower number of
scans); (2) dissociation of charge-reduced species, which are
constantly dominant over the product ions in all the reported
mass spectra; (3) detection of complementary heavy product
ions as well as (4) internal product ions from secondary frag-
mentation will be needed to increase the overall capabilities of
ETD-based TDMS and TDP on the qTOF and alternative, e.g.,
Orbitrap FTMS, platforms.
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With the inception of new protein engineering technologies,monoclonal antibodies, once deemed “magic bullets,” are
again gaining popularity as an eﬀective therapeutic tool against
various diseases, including cancer. As a result, monoclonal
antibodies in general and immunoglobulins in particular cur-
rently constitute an important number of therapeutic drugs (also
called biologicals) under development in the biopharmaceutical
industry.1 Immunoglobulins play an essential role in the immune
systems and can be found in the blood of vertebrates. Among the
diﬀerent classes of immunoglobulins, secreted immunoglobulins
G (IgGs) are the most abundant.2 A schematic representation of
the Y-shaped structure of IgGs is shown in Scheme S1, which is
given in the Supporting Information. All IgG antibodies have two
identical light chains and two identical heavy chains. Each chain
consists of constant and variable regions, the latter being
responsible for the recognition and binding of antigens. The
identiﬁcation of the intact mass and sequencing of the constant
and variable domains of the IgGs is important for the quality
control of recombinant antibodies to be used as drugs.3 There-
fore, mass spectrometry (MS) and tandem mass spectrometry
(MS/MS) play an important role in the qualitative and quanti-
tative characterization of IgGs.4 Speciﬁcally, mass spectrometric
analysis is used to conﬁrm the stability of IgGs in processing
and storage, to identify and quantify their often highly hetero-
geneous post-translational modiﬁcation (PTM) proﬁles, and to
provide in-depth information on PTMs location and structure.
MS/MS techniques are primarily used in the so-called bottom-up
MS approach, in which IgGs are enzymatically cleaved in solution
prior to ionization and MS/MS analysis. Similarly, speciﬁc PTM
analysis may involve an enzymatic digestion that, in turn, may
lead to the loss of PTMs (e.g., carbohydrates) prior to MS and
MS/MS analysis.5 Prolonged digestion at relatively high (37 C)
temperature, which is required for complete enzymatic action,
can produce the artifacts and, particularly for IgGs, lead to an
increased rate of deamidation and oxidation, preventing the
correct identiﬁcation of certain PTMs, such as Asp isomerization.2
Top-down mass spectrometry refers to mass spectrometric
monitoring of the gas-phase fragmentation of biomolecular ions
of any size.68 A growing number of protein and RNA char-
acterization experiments performed by top-down mass spectro-
metry in both direct infusion and coupled with online protein
mixture puriﬁcation and separation has been reported.918
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ABSTRACT: Improving qualitative and quantitative character-
ization of monoclonal antibodies is essential, because of their
increasing popularity as therapeutic drug targets. Electron
transfer dissociation (ETD)-based top-down mass spectrome-
try (MS) is the method of choice for in-depth characterization
of post-translationally modiﬁed large peptides, small- and
medium-sized proteins, and noncovalent protein complexes.
Here, we describe the performance of ETD-based top-down
mass spectrometry for structural analysis of intact 150 kDa
monoclonal antibodies, immunoglobulins G (IgGs). Simultaneous mass analysis of intact IgGs as well as a complex mixture of ETD
product ions at suﬃciently high resolution and mass accuracy in a wide m/z range became possible because of recent advances in
state-of-the-art time-of-ﬂight (TOF) mass spectrometry. High-resolution ETD TOF MS performed on IgG1-kappa from murine
myeloma cells and human anti-Rhesus D IgG1 resulted in extensive sequence coverage of both light and heavy chains of IgGs and
revealed information on their variable domains. Results are superior and complementary to those previously generated by collision-
induced dissociation. However, numerous disulﬁde bonds drastically reduce the eﬃciency of top-down ETD fragmentation within
the protected sequence regions, leaving glycosylation uncharacterized. Further increases in the experiment sensitivity and
improvement of ion activation before and after ETD reaction are needed to target SS bond-protected sequence regions and
post-translational modiﬁcations.
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Direct mass spectrometric analysis of intact IgGs has several
advantages over the bottom-up approach, including quantitative
diﬀerentiation of heterogeneously modiﬁed proteins and direct
indication of N-terminal and C-terminal truncation.19 Top-down
MS/MS characterization of intact IgGs can potentially allow
direct assignment of protein sequence fragments with multiple
amino acid variations, even if the mutations occur within a
distance of several amino acids. Furthermore, top-down mass
spectrometry has found an important application in detecting the
diﬀerences in protein splicing variants (isoforms), as highlighted
in a recent work by Ge and co-workers on extensive troponin
T protein characterization.20 Finally, bottom-up analysis gen-
erally requires a higher amount of sample than the top-down
approach.2
To date, the fragmentation of intact proteins of the size of
intact monoclonal antibodies in the gas phase has been at-
tempted with collision-induced dissociation (CID), either in
the dedicated CID cell or directly in the ion source region.21,22
However, CID-generated sequence coverage, particularly from
IgGs, has been limited. Electron capture dissociation (ECD)2325
and electron transfer dissociation (ETD)26 mass spectrometry of
large proteins occupies a signiﬁcant niche in top-down MS ana-
lysis, because of the speciﬁc advantages of these radical-driven
MS/MS techniques, compared to slow-heating fragmentation
methods, such as CID and infrared multiphoton dissociation
(IRMPD). Advantages include more extensive sequence cover-
age obtained on large proteins and eﬃcient rupture of disulﬁde
bonds.27,28 However, the signiﬁcant advantage of ECD/ETD
over CID/IRMPD in the characterization of labile PTMs on
peptides29 is less pronounced on proteins, where vibrational
energy distribution over a large number of degrees of freedom
increases the chance for labile PTMs to remain intact during the
rupture of protein backbone bonds in CID/IRMPD.30,31 As the
current state-of-the-art in ECD-based top-down mass spectro-
metry “in time”, Ge and co-workers identiﬁed 36 c-type ions and
23 z-type ions (59 cleavages) of 142 kDa cardiac myosin binding
protein C (cMyBP-C).32 Further increases in protein molecular
weight for top-downmass spectrometry “in time” await the imple-
mentation of ECD on Fourier transform ion cyclotron resonance
(FT-ICR)MS platforms equipped with superconducting magnets
with strengths of 1521 T.33
The reported here work became possible because of the
newest addition to the family of tandem mass spectrometry “in
space” instruments, particularly ETD-enabled state-of-the-art
high-resolution quadrupole time-of-ﬂight (qTOF) MS.34 Speci-
ﬁc features of a particular importance for the top-down mass
spectrometry of intact proteins on the high resolution qTOFMS
platform include the following: a resolution of up to 50 000 over a
widem/z range is achieved for intact protein analysis (see Figure
S1 in the Supporting Information), a resolution of up to
30 00040 000 over a wide m/z range is achieved for product
ion analysis (resolution depends on the complexity of the
product ion mixture and on the abundances of the product
ions), a mass accuracy of∼1 ppm exists in both MS andMS/MS
modes, and a mass spectra acquisition rate of up to 20 per second
is observed. The tandem mass spectra acquisition rate is depen-
dent on the time required for the fragmentation reaction and will
be discussed below. Particular advantages of top-down mass
spectrometry of TOFMS platforms include larger dynamic range
than the high-resolution Orbitrap and FT-ICR MS instruments
and single-ion counting versus the ion package accumulation re-
quired for Fourier transformmass spectroscopy (FTMS) platforms.35
Therefore, we present the top-down characterization of two
intact recombinant monoclonal antibodies, murine and human
IgGs, performed with the above ETD-enabled state-of-the-art
qTOF MS platform.
’METHODS
Sample Preparation. Glycosylated monoclonal antibodies,
specifically immunoglobulins G, were obtained commercially or
produced in house. Proteins were dissolved in water to a final
concentration of ∼1 μM. Purified IgG1-kappa from murine
myeloma (clone number MOPC 21) was purchased from Sigma
(Taufkirchen, Germany) and used without further purification.36
In-house produced human anti-Rhesus D IgG1 was transiently
expressed in HEK293 cells. Transfection of HEK293 cells in
suspension for the expression of human anti-Rhesus D IgG
was conducted as previously reported (see the Supporting
Information).37,38 Protein purification was performed following
standard protocols to yield a nondetectable level of impurities
(e.g., IgG fragments).39
Liquid Chromatography. Online protein purification and
concentration for intact protein measurements was performed
using an Agilent 1200 HPLC system with reversed phase
cartridges (Zorbax SB C8 3.5 μm, 2.1 mm i.d. 30 mm, Agilent,
Waldbronn, Germany) at 70 C and a flow rate of 300 μL/min.
The applied gradient was 100% phase A (0.1% formic acid in
water) for 3 min, followed by a linear gradient to 100% phase B
(0.1% formic acid in acetonitrile) in 7 min. For ETD experi-
ments, a capillary liquid chromatography (LC) setup (Dionex
Ultimate 3000) with monolithic columns heated to 60 C
(PepSwift PSDVB, 200 μm i.d.  50 mm, 5 mm trapping
column; Dionex, Germering, Germany) was used. To obtain
protein elution time from the LC column of∼510 min, a long
and shallow gradient (3%-80% phase B in 30min at 2 μL/min) in
combination with intentionally overloading the column was
applied (see Figure S2, top inset, in the Supporting Information).
Protein injection volume was 1 μL per each injection to provide
∼1 pmol of protein per injection.
Time-of-Flight Tandem Mass Spectrometry. Intact protein
mass measurements and ETD MS/MS were performed on a
high-resolution and high-mass-accuracy quadrupole time-of-
flight (qTOF) mass spectrometer (maXis UHR qTOF MS,
Bruker Daltonics GmbH, Bremen, Germany). ETD MS was
performed as previously described.34 The specific difference in
ETD applied to high mass proteins is in the increased precursor
ion accumulation time (up to 800 ms) prior to radical anion
(azuline) injection for electron transfer reaction. Typical anion
injection time was 40 ms, and additional ionion interaction
time was normally set to 60 ms. Product ions were transferred to
the ion cooler cell from the reaction cell and orthogonally pushed
to the TOF mass analyzer at the rate of 10 kHz. The orthogonal
acceleration potential was at 10 kV. Acquisition in a broad m/z
window (1005000m/z) was performed with signal digitization
at 2 GHz, whereas higher-resolution MS and MS/MS data were
acquired at a faster digitization rate of 4 GHz for narrower m/z
range of 5003000m/z. Intact protein MS data and product ion
MS/MS data were acquired in separate LC runs to allow
sufficient time for data acquisition during protein elution from
the chromatographic column.
Data Analysis. The LC-MS and LC-MS/MS data were ana-
lyzed using the standard top-down data analysis procedure (Bruker
Daltonics).40 (See the Supporting Information for more details.)
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Briefly, precursor and product ion mass spectra were summed
over the elution time of a protein in each LC-MS and
LC-MS/MS run with Data Analysis software version 4.0
(Bruker Daltonics). Intact protein MS data were directly sub-
mitted to the MaxEntropy deconvolution procedure to yield a
heterogeneous distribution of neutral (deprotonated) glycosy-
lated protein isoforms (see Figure S1 in the Supporting
Information). Protein glycosylated forms were assigned using
the built-in post-translational modification calculator. Internal
product ions, formed by secondary fragmentation of the primary
product ions, have not been considered in the current work and
will be analyzed in a separate study. To increase the signal-
to-noise level of the product ions, up to 10 LC-MS/MS runs
were summed.
’RESULTS
Intact Protein Molecular Weight and Distribution of Gly-
coforms. Electrospray ionization time-of-flight (TOF) mass
spectra of both MOPC 21 and HEK293 cell derived monoclonal
antibodies (“HEK IgG”) show broad charge-state distributions
from approximately +30 to +60 (see Figure S1, panels A and B,
respectively, in the Supporting Information). Deconvolution of
the charge states toward the neutral protein mass distribution
allows the estimation of the intact protein molecular weight
(MW) and the differentiation of a number of glycosylated
protein isoforms (see Figure S1, panels C and D, respectively,
in the Supporting Information). Knowledge of the intact pro-
tein mass indicates any potential modification of the protein,
including N-terminal and C-terminal truncations, which are
common for monoclonal antibodies. Importantly, information
on the terminal truncations may be lost when performing
bottom-up mass spectrometry. Figure S1 in the Supporting
Information suggests protein molecular weights (MWs), with-
out modifications, of ∼147 kDa for MOPC 21 IgG and
∼149 kDa for HEK IgG (see the Supporting Information for
more details). Finally, intact protein mass spectrometry results
presented in Figure S1 in the Supporting Information allow
direct quantification of the relative abundances of the different
glycoforms, whereas relative quantification of protein glyco-
forms by bottom-up mass spectrometry is typically performed
on one or several enzymatically derived peptides that contain
these glycoforms.39,41
Top-Down Mass Spectrometry of Murine IgG. To increase
the performance of protein fragmentation by ETD in a single
LC-MS experiment we explored the possibility that the LC-MS
system might provide a substantially long protein elution time.
Therefore, we have not attempted to optimize the separation
efficiency. Total ion chromatogram showing the elution profile of
the MOPC 21 IgG indicates protein elution time of ∼5 min for
the experimental setup employed (see Figure S2, top inset, in the
Supporting Information).
Although top-down analysis of large peptides and small
proteins typically relies on the isolation of a single charge state,
we isolated three charge states simultaneously for the online LC-
puriﬁed proteins of 150 kDa. Indeed, online puriﬁed and
separated proteins of such high m/z values, as in electrospray
ionization mass spectrometry (EI-MS) of IgGs, dominate the
Figure 1. Top-down electron transfer dissociation (ETD)-based LC electrospray ionization (ESI) quadrupole time-of-ﬂight (qTOF) MS/MS of
MOPC 21 IgG. Inset: expanded segment, m/z = 250950, shows ETD product ions that are assigned to be mainly z-type product ions containing the
C-terminal part of the heavy chain of MOPC 21 IgG. The inset shows a typical isotopic distribution of doubly charged product ion demonstrating high
resolving power and true isotope relative abundances achieved. To increase the conﬁdence in ETD product ion assignment, the demonstrated here
tandem mass spectrum was obtained by summation of the data from 10 consecutive LC MS/MS runs.
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precursor ion distribution in the isolation window for the
samples studied in the current work. Figure 1 and Figure S2 in
the Supporting Information show the result of the top-down
ETD qTOF MS approach applied to the online LC-puriﬁed
MOPC 21 IgG (1 pmol on a column per injection). The isolation
window was m/z 100 and covered precursor ion charge states
+49, +50, and +51. Electron transfer from the reagent radical
anions resulted in an eﬃcient charge state neutralization of the
precursor protein ions, as evidenced by the abundant protein
peaks for charge states +48, +47, and +46. The extent of the
reaction, shown by the intensity of the charge-reduced peaks and
the value of the remaining charge, is a function of the injection
time of radical anions and ionion reaction time. Suﬃciently
long injection and interaction times can reduce the precursor and
charge-reduced ion amounts to undetectable levels. More eﬃ-
cient charge state neutralization and reduced species fragmenta-
tion can be achieved by increasing protein ion internal energy,
similar to the supplemental activation.42,43 For the experimental
setup here, the supplemental activation can be provided by more
energetic product ion transfer from the reaction cell to the ion
cooler cell (by setting higher potential drop).
ETDMS/MS of MOPC 21 IgG shows abundant product ions
grouped around m/z 500 and m/z1500 , Figure 1. Interestingly,
there are no product ions in the large m/z area preceding
precursor and charge-neutralized ion region. Closer analysis
of product ions in the regionm/z∼500 demonstrates primarily
light (∼12 kDa) product ions with few charges (Figure 1, top
inset). The data demonstrate the suﬃcient capacity of the
employed high-resolution qTOF MS to resolve the isotopic
distributions and the overlapping product ions in thism/z range
for the given MS/MS spectrum complexity. Expanded seg-
ments of the ETD mass spectrum at m/z ≈ 1500 show the
presence of heavier (up to 1015 kDa) product ions that are
more highly charged (see Figure 2). Despite a much higher
complexity of the MS/MS spectrum, the employed mass
spectrometer allows eﬃcient separation of the isotopic and
overlapping peaks. The results of ETD product ion identiﬁca-
tion are summarized in Scheme 1 for both light (Scheme 1, top)
and heavy (Scheme 1, bottom) chains of murine IgG. In total,
we report 69 c-ions (33 fragments for light chain and 36 for
heavy chain) and 73 z-ions (9 fragments for light chain and
64 for heavy chain) identiﬁed from the ETD mass spectra
Figure 2. Medium-size product ions from a tandem mass spectrum of MOPC 21 IgG acquired with ETD-based LC ESI qTOF MS/MS, as shown in
Figure 1. In the bottom image, the expanded segment,m/z = 13701460, showsmultiply charged product ions from the center part of the heavy chain of
MOPC 21 IgG, variable domain of the light chain, and other parts of the IgG. In the top image, the expanded segment, m/z = 14081443, shows the
typically obtained resolved isotopic clusters of ETD product ions. To increase the conﬁdence in ETD product ion assignment, the tandem mass
spectrum demonstrated here was obtained by summation of the data from 10 consecutive LC MS/MS runs.
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of murine MOPC 21 IgG (Table 1). All 142 product ions
correspond to unique backbone cleavages out of 657 possible
cleavage sites (see Scheme 1 for details). Therefore, the overall
sequence coverage obtained is about 21%. The overall sequence
coverage calculated for fragmentation of SS unprotected
regions of the sequence, shown in Scheme 1 in black, increases
to ∼48%. Sequence coverage of the constant domain CH3 of
the heavy chain (see Scheme S1 for details) is the highest
and is ∼85% (only SS unprotected regions are taken into
consideration).
Top-Down Mass Spectrometry of Human IgG. Application
of ETD qTOFMS/MS to another monoclonal antibody, human
anti-Rhesus D IgG, was similar to theMOPC 21 IgG efficiency of
precursor ion neutralization and fragmentation. However, the
observed product ion distribution indicates some differences
(see Figure 3). Note that only the product ion region of the MS/
MS data is shown in Figure 3, following data acquisition with a 4
GHz sampling rate. Interestingly, the distinction between the
light and heavy product ion groups is less pronounced than for
ETD of MOPC 21 IgG, whereas the region between the heavy
product ion group and the charge-neutralized precursor ions is
still empty (data not shown). ETD mass spectra assignment
results show a similar to murine IgG sequence coverage formed
by product ions belonging to both light and heavy chains
of human IgG (see Scheme 2). In total, we report 32 c-ions
(21 fragments for light chain and 11 for heavy chain) and 77 z-
ions (15 fragments for light chain and 62 for heavy chain)
identified from ETD mass spectra of human anti-Rhesus D
IgG (see Table 1). The 109 product ions correspond to 103
unique backbone cleavages out of 669 possible cleavage sites
(see Scheme 2 for details). Therefore, the overall sequence
coverage obtained is ∼15%. Compared to ETD of murine IgG,
fewer c-type product ions in ETD of human IgG were identified,
most likely due to the structural differences between these two
antibodies and lower purity of the sample employed. Sequence
coverage distribution over the SS protected and unprotected
regions, as well as increased sequence coverage of the constant
domain CH3, are similar to the ETD of murine IgG.
’DISCUSSION
Typically, ECD/ETD-based top-down mass spectrometry has
been applied to 1050 kDa proteins. The resulting ECD/ETD
patterns demonstrate almost symmetrical distributions of
product ions around the isolated precursor protein charge state,
which is them/z≈ 1000 region for proteins of that size.28,44,45 In
contrast, here, the ETD mass spectra of 150 kDa proteins in
charge states below 50 exhibit a signiﬁcant product-ion-free
region between charge-reduced precursor ions (centered at
m/z≈ 3000) and abundant product ions (centered at m/z≈ 1000).
Interestingly, the product ions occupy similarm/z space as in the
ECD/ETD of 1050 kDa proteins, presumably demonstrating
protein structure related preference toward the formation of
product ions of a given size and charge state, as well as the
product ion charge-state dependent eﬃciency of the secondary
fragmentation and charge neutralization reactions in ETD.
Furthermore, diﬀerences in protein sequence and high-order
structure organization between human and murine IgGs (e.g.,
the number of disulﬁde bonds between the heavy chains) are also
responsible for the substantially higher ETD eﬃciency for the
fragmentation of the N-terminal regions of both heavy and light
chains in themurine IgG (see Scheme 1, compared to Scheme 2),
as manifested also by the more-abundant and numerous light
product ions in Figure 1, compared to Figure 3.
For intact IgGs, the formation of several distinct product ion
clusters can be explained by the speciﬁc structural organization of
these covalently bound protein complexes (see Scheme S1 in the
Supporting Information for details). IgGs employed in the
current work are formed by two heavy chains of ∼50 kDa each
(443 amino acids for murineMOPC 21 IgG and 455 amino acids
for human anti-Rhesus D IgG) and two light chains of∼25 kDa
each (214 amino acids for both murine MOPC 21 IgG and
human anti-Rhesus D IgG). These are covalently linked by
interchain disulﬁde bonds between each heavy and light chain,
as well as between the heavy chains. Observation of C-terminal
product ions from light chains (see Schemes 1 and 2) indicates a
possible rupture of interchain disulﬁde bonds upon electron
absorption by precursor ions, which leads to the separation of
heavy and light chains (Scheme S1 in the Supporting In-
formation). As a result, fragmentation patterns are formed
following the ETD fragmentation rules for 25 kDa and 50 kDa
proteins, corresponding to isolated light and heavy chains. If
the interchain SS bonds remain intact, extensive fragmenta-
tion of N-terminal and C-terminal regions of heavy chains of IgG
and N-terminal regions of light chains can occur. We note that
the complementary product ions to either light or heavy product
Scheme 1. MOPC 21 IgG Sequence Coverage Obtained by
ETD-Based LC ESI qTOFMS/MS for (Top) Light Chain and
(Bottom) Heavy Chain of the Proteina
aThe anticipated intra-chain disulﬁde bonds are shownwith the red lines
that connect Cys residues. Glycosylation is not shown.
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ions would be positioned in the region around the charge-
reduced precursor ions in the m/z ≈ 3000 region. However,
these complementary product ions are not shown with suﬃcient
abundance and resolving power to be identiﬁed. Similarly, ion
signals corresponding to the entire heavy or light chains follow-
ing the possible interchain disulﬁde bond rupture have not been
detected.
Fragmentation of monoclonal antibodies using CID of re-
duced and alkylated proteins previously yielded 26 b-ions and 20
y-ions (43 unique cleavages) for the isolated heavy chain and 24
b-ions and 32 y-ions (54 unique cleavages) for the isolated light
chain for IgG2.4 Collision-induced in-source fragmentation of
intact IgG2 has produced eﬃcient fragmentation of the variable
domains of both heavy and light chains, leaving the constant
domains almost intact.3 Therefore, the top-down ETD data
presented here for fragmentation of intact antibodies is superior
to the CID performed on the separated heavy and light chains
and in-source CID performed on the entire IgG. Amore-detailed
comparison of the CID fragmentation patterns reported by
Bondarenko and co-workers in Figure 6 of ref 4, with the ETD
fragmentation patterns reported in Schemes 1 and 2 of the
current work (Table 1), demonstrates a signiﬁcant diﬀerence in
the number of cleavages speciﬁcally in the C-terminal part of the
protein (i.e., CH2 and CH3 domains) between the two activa-
tion/dissociation techniques, with ETD being more eﬃcient
than CID. The number of ETD-generated z-ions produced in
CH2 and CH3 domains is twice that of the CID-generated y-ions,
despite the fact that ETD experiments were performed on the
nonreduced IgGs, whereas CID was done on the reduced and
alkylated proteins and it is known that CH2 and CH3 domains are
highly stable in the native folding. On the other hand, the
sequence coverage obtained at the N-terminal parts of all three
Figure 3. Expanded segment, m/z = 2502500, of ETD-based LC ESI qTOF tandem mass spectrum of human anti-Rhesus D IgG transiently
expressed inHEK293 cells. Only product ions due to the backbone cleavages in the IgG heavy chain are shown. Note the abundant product ions, e.g., z86,
z93, z97, and z106, present in many charge states and presumably indicate a structure-related facile backbone rupture within the IgG heavy chain. To
increase the conﬁdence in ETD product ion assignment, the tandem mass spectrum demonstrated here was obtained by summation of the data from
10 consecutive LC MS/MS runs. The inset shows schematic representation of a generic IgG monoclonal antibody (see Scheme S1 in the Supporting
Information for a detailed description).
Table 1. Sequence Information Obtained by Tandem Mass Spectrometry from Diﬀerent Immunoglobulins G, IgGsa
Sequence Information Containing N-terminus Sequence Information Containing C-terminus
muIgG11 huIgG12 huIgG23 muIgG11 huIgG12 huIgG23
# c-ions # c-ions # b-ions # z-ions # z-ions # y-ions
light chain 33 21 24 9 15 32
heavy chain 36 11 26 64 62 20
total 69 32 50 73 77 52
aResults are presented for ETD MS/MS performed on (superscript 1) murine IgG1 (muIgG1) used in this work, in its non-reduced form and
(superscript 2) human IgG1 (huIgG1) used in this work, in its non-reduced form; and for CID MS/MS performed on (superscript 3) human IgG2
(huIgG2), in its reduced and alkylated form, as reported by Bondarenko et al.4
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proteins studied is substantially less extensive. Neither ETD no
CID suﬃciently cover the biologically signiﬁcant complemen-
tary determining regions (CDRs), especially those identiﬁed as
CDR1 and CDR2, which are located in the variable domains of
both light and heavy chains. Finally, a diﬀerence in the number of
N-terminal fragments can be noted for the murine and the
human IgGs used in this work, which reﬂects a variation in
ETD eﬃciency, which is possibly due to either primary, second-
ary, and tertiary structures between IgGs of diﬀerent species. The
diﬀerent states of the proteins used (reduced or not reduced),
combined with their diﬀerent sequence and structure, make
deﬁnitive conclusions diﬃcult; however, we can speculate that
the sequence coverage achievable by ETD MS could be further
improved by reducing and alkylating the IgGs, gaining an
additional advantage over CID in terms of total sequence
coverage. Nevertheless, due to the natural diﬀerences between
ETD and CID, e.g., diﬀerent method behavior toward cleaving at
the N-terminal side of Pro, complementary information can be
still obtained from the combined data.
The particular power and attraction of top-down mass spec-
trometry is that post-translational modiﬁcations can be charac-
terized without the use of enzymatic interaction with the
product.6 Whereas intact protein mass spectrometry clearly
demonstrated the heterogeneous glycosylation patterns of the
employed IgGs (see Figure S1 in the Supporting Information),
ETD-based top-down mass spectrometry is not yet capable of
locating these modiﬁcations. The reasons for this failure in top-
down mass spectrometry, as presented here, are the speciﬁc
structural organization of IgGs, where the single glycosylation
site is located in a middle of 50 kDa heavy chains and is pro-
tected by disulﬁde bonds. In addition to the overall MS/MS
performance increase, top-down mass spectrometry performance
for post-translational modiﬁcation analysis could be further im-
proved through increases in the signal-to-noise ratio of product
ions through summation of data from more than 10 LC-MS/MS
runs and extensive use of ion activation before and after ETD
reaction.42,43 Further increase in sequence coverage can be
envisioned from an increased rate of MS/MS data acquisition,
which would translate to a higher number of spectra per LC MS/
MS run.46 Therefore, the use of CO2 laser-based infrared multi-
photon-induced ion activation should be considered.47
In addition to peptide and protein sequencing, ECD and ETD
have been suggested to reﬂect the secondary and tertiary
structures of peptides and proteins. It is believed that hydrogen
bonding networks in the gaseous biomolecular ions modulate
the site-speciﬁc eﬃciency of ECD/ETD peptide backbone
cleavages.4850 Therefore, the structural organization of amino
acids intoα-helical, random coil, or beta strands may ﬁnd speciﬁc
signatures in the fragmentation pattern through distinct product
ion abundance (PIA) distributions.51 For example, ECD of
amphipathic peptides produces sequence-speciﬁc periodic dis-
tribution of PIAs that may reﬂect a strong preference by
amphipathic peptides for α-helical organization.52 Similar ob-
servations of speciﬁc ECD PIA distributions have been reported
for larger systems, including proteins consisting of a bundle of 3
α-helix segments.53 Interestingly, Figures 13 also reveal very
distinct preferential ETD fragmentation of intact IgGs.46 For
example, Figure 3 shows abundant z86, z93, z97, z106, and other
product ions that are present in many charge states and clearly
dominate the ETD PIA distribution. Presumably, these product
ions indicate a structure-related facile backbone rupture within
the IgG heavy chain. Indeed, these preferential cleavage sites are
located between two highly structured, disulﬁde-protected do-
mains of the heavy chain.46
’CONCLUSIONS
Recent advances in high-resolution time-of-ﬂight mass spec-
trometry (TOF-MS) made it possible to extend the upper mass
limit of electron transfer dissociation (ETD)-based top-down
mass spectrometry to 150 kDa intact monoclonal antibodies,
speciﬁcally immunoglobulins G (IgGs). The number of identi-
ﬁed product ions and the corresponding unique cleavages in
ETD of IgGs reported here is double that of the electron capture
dissociation (ECD) of a similarly sized (142 kDa) protein
previously reported. Compatible with online puriﬁcation and
separation by high-performance liquid chromatography (HPLC),
ETD-based top-down mass spectroscopy (MS) can now be
eﬃciently applied to large intact proteins and protein complexes.
The extent of protein sequence coverage is protein-structure-
dependent and governed by disulﬁde bond connectivity and
complex organization. The sequence coverage of IgGs achieved
in this study is superior and complementary to the results of the
previous attempts made with slow-heating fragmentation techniques
such as collision-induced dissociation (CID) in a dedicated
collisional cell or ion source region of a mass spectrometer.3,4
Importantly, ETD-generated sequence tags provide valuable
structural information on variable domains of both light and
heavy chains. On the other hand, failure of the current imple-
mentation of ETD to locate and characterize glycosylation on the
IgGs should be addressed by increasing the method sensitivity
and adding eﬃcient ion activation techniques. Despite the assign-
ment of the most peaks in the ETDmass spectra, a number of the
Scheme 2. Transiently Expressed in HEK293 Cells Human
Anti-Rhesus D IgG Sequence Coverage Obtained by ETD-
Based LC ESI qTOF MS/MS for (Top) Light Chain and
(Bottom) Heavy Chain of the Proteina
aThe anticipated intra-chain disulﬁde bonds are shownwith the red lines
that connect Cys residues. Glycosylation is not shown.
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unassigned isotopic clusters are still present. We estimate this
number to be at least 20% of the total number of the isotopic
clusters. Considering internal product ions and other peptide
backbone cleavage products (e.g., y-ions and a-ions) should further
enhance the sequence coverage and conﬁdence in product ion
assignment. The unambiguous assignment of all the unknown
peaks is especially important for the characterization of anti-
bodies in the biopharmaceutical industry and, thus, must be con-
sidered in the future data analysis work. Taking into account all
product ions will allow the total eﬃciency of ETD to be estimated
in this experimental setup. However, it is expected that the ETD
eﬃciency of highly charged large protein ions shall be above 50%
if all the neutral loss-produced product ions, as well as both
primary and secondary (internal) product ions, are considered.
Suﬃciently long ionion interaction periods allow one to deplete
the precursor and charge-neutralized ion populations completely,
especially when assisted by supplemental activation (data not
shown). The high complexity of the fragmentation pattern also
demands further (at least 23 fold) resolution increase in a wide
m/z range. Further improvement in the conﬁdence and speed of
complex top-down data analysis is also needed to account for the
vast number of heterogeneously charged product ions formed
and to increase the eﬃciency of pooling data from diﬀerent
charge states of precursor ions and experimental conditions (e.g.,
ionion interaction time).54,55 Finally, further investigation of
the abundant ions present in the product ion region is needed to
conﬁrm the assignment of these ions to the preferential ETD
products or an eventual CID-based fragmentation. However, recent
investigations suggest the ETD-based nature of these ions;46
therefore, a study into the preferential fragmentation in ETD is
needed to relate the observed preferential dissociations channels
with the high-order structural features of these large proteins
and to contribute to the general understanding of ECD/ETD
mechanisms.
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Analysis of Intact Monoclonal Antibody IgG1
by Electron Transfer Dissociation Orbitrap
FTMS*□S
Luca Fornelli‡, Eugen Damoc§, Paul M. Thomas¶, Neil L. Kelleher¶,
Konstantin Aizikov§, Eduard Denisov§, Alexander Makarov§, and Yury O. Tsybin‡
The primary structural information of proteins employed
as biotherapeutics is essential if one wishes to under-
stand their structure–function relationship, as well as in
the rational design of new therapeutics and for quality
control. Given both the large size (around 150 kDa) and
the structural complexity of intact immunoglobulin G
(IgG), which includes a variable number of disulfide
bridges, its extensive fragmentation and subsequent se-
quence determination by means of tandem mass spec-
trometry (MS) are challenging. Here, we applied electron
transfer dissociation (ETD), implemented on a hybrid
Orbitrap Fourier transform mass spectrometer (FTMS),
to analyze a commercial recombinant IgG in a liquid
chromatography (LC)-tandem mass spectrometry (MS/
MS) top-down experiment. The lack of sensitivity typi-
cally observed during the top-down MS of large proteins
was addressed by averaging time-domain transients re-
corded in different LC-MS/MS experiments before per-
forming Fourier transform signal processing. The results
demonstrate that an improved signal-to-noise ratio,
along with the higher resolution and mass accuracy
provided by Orbitrap FTMS (relative to previous appli-
cations of top-down ETD-based proteomics on IgG), is
essential for comprehensive analysis. Specifically, ETD
on Orbitrap FTMS produced about 33% sequence cov-
erage of an intact IgG, signifying an almost 2-fold in-
crease in IgG sequence coverage relative to prior ETD-
based analysis of intact monoclonal antibodies of a
similar subclass. These results suggest the potential
application of the developed methodology to other
classes of large proteins and biomolecules. Molecular
& Cellular Proteomics 11: 10.1074/mcp.M112.019620,
1758–1767, 2012.
Top-down mass spectrometry (MS)1 (1–3) has continued to
demonstrate its particular advantages over traditionally em-
ployed bottom-up MS strategies (4). Specifically, top-down
MS allows the characterization of specific protein isoforms
originating from the alternative splicing of mRNA that code
single nucleotide polymorphisms and/or post-translational
modifications (PTMs) of protein species (5). Intact protein
molecular weight (MW) determination and subsequent gas-
phase fragmentation of selected multiply charged protein ions
(referred to as tandem MS or MS/MS) theoretically might
result in complete protein sequence coverage and precise
assignment of the type and position of PTMs, amino acid
substitutions, and C- or N-terminal truncations (6), whereas
the bottom-up MS approach allows only the identification of a
certain protein family when few or redundant peptides are
found for a particular protein isoform. At a practical level,
however, top-down MS-based proteomics struggles not only
with the single- or multi-dimensional separation of undigested
proteins, which demonstrates lower reproducibility and re-
peatability than for peptides, but also with technical limita-
tions present in even state-of-the-art mass spectrometers.
The outcome of a top-down MS experiment depends indeed
on the balance between the applied resolution of the mass
spectrometer and its sensitivity. The former is required for
unambiguous assignment of ion isotopic clusters in both sur-
vey and MS/MS scans, whereas the latter is ultimately de-
pendent on the scan speed of the mass analyzer, which
determines the number of scans that can be accumulated for
a given analyte ion on the liquid chromatography (LC) times-
cale to enhance the resulting signal-to-noise ratio (SNR). Until
recently, the instrument of choice for top-down MS has been
the Fourier transform ion cyclotron resonance (FT-ICR) mass
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spectrometer, primarily because of its superior resolving
power and the availability of electron capture dissociation for
the efficient MS/MS of large biomolecules (7, 8). However, this
solution has been shown to have some limitations in the
analysis of large proteins (9). The main issue, as described by
Compton et al. (10), is that the SNR in Fourier transform mass
spectrometry (FTMS) is inversely proportional to the width of
the isotopic and charge state distributions (11), which both
increase as a function of MW. Particularly, the SNR dramati-
cally decreases with MW under standard on-line LC-MS/MS
operating conditions if isotopic resolution is required. It is
noteworthy that such SNR reduction can affect not only intact
mass measurements, but also the subsequent MS/MS
performance.
The most widely employed solution for improving top-down
analysis is thus a substantial reduction of the protein mixture
complexity, for example, through off-line sample prefraction-
ation (12). Furthermore, when the MW exceeds 100 kDa,
proteins are often analyzed via direct infusion after off-line
purification of the single isoform or species of interest (13).
Overall, these strategies aim to improve the quality of mass
spectra, specifically their SNR, by increasing the number of
scans dedicated to each selected isoform or species. How-
ever, off-line intact protein analysis has limitations, including
sample degradation and modification (e.g., oxidation during
long off-line measurements and sample storage). The time
required for multistep LC-based protein purification can also
be substantial.
Electron capture dissociation (ECD) (14, 15) and electron
transfer dissociation (ETD) (16) are ion activation techniques
that allow polypeptide fragmentation with reduced PTM
losses (17, 18). Nevertheless, ECD and ETD generally provide
larger sequence coverage for intact proteins than slow-heat-
ing activation methods such as collision induced dissociation
(CID) and infrared multiple photon dissociation (19, 20). Fur-
thermore, ECD and ETD are known to cleave disulfide bonds,
a fundamental feature for the analysis of proteins in their
native state (i.e., without cysteine reduction and alkylation)
(21–23).
The structural analysis of high MW intact proteins with MS
has garnered much recent attention in the literature (24, 25),
mainly because of the improved capabilities offered by rapidly
developing sample preparation, protein separation, and mass
spectrometric methods and techniques. Immunoglobulin G
(IgG) proteins are antibodies with an MW of about 150 kDa
that are composed of two identical sets of light and glycosy-
lated heavy chains with both intra- and intermolecular disul-
fide bridges (Fig. 1) (26). IgGs represent an attractive target for
structural analysis method development, given their high im-
portance as biotherapeutics (27). A unit-mass resolution mass
spectrum demonstrating an isotopic distribution of an isolated
charge state of a 148 kDa IgG1 has been recently achieved
with FT-ICR MS equipped with 9.4 T superconducting magnet
and a statically harmonized ICR cell (24). However, further
analytical improvements are needed to achieve routine and
reproducible MS operation at the required level of resolution
and sensitivity.
Fragmentation of intact antibodies in the gas phase follow-
ing the top-down MS approach has been previously at-
tempted without precursor ion charge state isolation by
means of nozzle-skimmer CID on a linear trap quadrupole
(LTQ)-Orbitrap™ (28, 29) and with precursor ion isolation via
ETD on a high resolution quadrupole time-of-flight (qTOF)
mass spectrometer (25). Relative to the results previously
obtained with slow-heating MS/MS methods, the ETD qTOF
MS/MS demonstrated substantially higher sequence cover-
age, reaching 15% for human and 21% for murine IgGs.
Important for future top-down proteomics development for
complex protein mixtures, the ETD qTOF MS/MS results were
obtained on the LC timescale. To increase the sequence
coverage and confidence in product ion assignment, a sub-
stantial increase in SNR was achieved by averaging MS/MS
data from up to 10 identical LC-MS/MS experiments. The high
complexity of the product ion population reduced the effec-
tive resolution to about 30,000, presumably limiting the as-
signment of overlapping high charge state product ions in the
1000–2000 m/z range. Even higher peak complexity was ob-
served in the region of charge reduced species and comple-
mentary heavy product ions, above 3000 m/z. Finally, numer-
ous disulfide bonds drastically reduced MS/MS efficiency in
the disulfide bond-protected regions.
Asn297Asn297
FIG. 1. Schematic representation of IgG1. Two identical light
(blue) and two identical heavy (fucsia) chains form the intact IgG. The
light chain is composed of a variable domain (VL) and a constant
domain (CL), whereas the heavy chain comprises one variable domain
(VH) and three constant domains (CH1–3). Each domain contains an
intramolecular disulfide bridge (in red); intermolecular disulfide
bridges link the heavy chains to each other (two bonds) and each
heavy chain to one light chain (one bond). Each heavy chain includes
an N-glycosylation site (located at Asn297; here, a G0F/G0F glycosy-
lation is shown).
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Here we demonstrate that ETD-enabled hybrid linear ion
trap Orbitrap FTMS allows us to further improve the top-down
ETD-based LC-MS/MS of monoclonal antibodies, introduced
earlier for TOF-based MS. To fully take advantage of the high
resolving power of Orbitrap MS/MS for increasing both the
number of assigned product ions and the confidence of the
assignments, maintaining an LC-MS/MS setup useful in a
general proteomics workflow for protein desalting and sepa-
ration, we averaged time-domain transients (derived from
separated LC-MS/MS runs) before Fourier transform signal
processing.
EXPERIMENTAL PROCEDURES
Sample Preparation—Humira monoclonal IgG1, kappa, was kindly
provided by Abbott Laboratories (Abbott Park, IL, USA). The protein,
originally stored in a buffer solution (sodium phosphate/sodium cit-
rate/polysorbate 80, with the addition of NaCl), was dissolved in water
at a concentration of 10 M and used without further purification.
Liquid Chromatography—Protein desalting and preconcentration
for subsequent on-line MS/MS analysis was performed with reverse
phase high performance LC (Surveyor MS Pump Plus with Micro
Autosampler, Thermo Fisher Scientific, San Jose, CA, USA). For each
chromatographic run, 20 pmol (2 uL) of IgG was loaded onto a
BioBasic-4 column of 1 mm i.d. and 100 mm length with a 5 m
particle size (Thermo Fisher Scientific, Runkorn, UK). A linear gradient
from 20% to 80% of acetonitrile with 0.1% formic acid at a 100 l/min
flow rate was applied to ensure an IgG elution time of 5 min. The
total run time, including column wash and re-equilibration, was about
15 min.
MS and Tandem MS—An ETD-enabled hybrid linear ion trap Or-
bitrap FTMS (Orbitrap Velos Pro, Thermo Scientific, Bremen, Ger-
many) with an IonMAX ion source was employed for both IgG intact
mass measurement and fragmentation, in separate experiments. For
ETD MS/MS, precursor ions were isolated at either 2750  50 m/z
(hereinafter referred to as the “narrow isolation window”) or 2900 
300 m/z (hereinafter referred to as the “wide isolation window”) in the
high pressure LTQ. Fluoranthene radical anions were introduced into
the LTQ over 40 to 50 ms and were allowed to interact with multiply
charged cations of IgG for 10 or 25 ms. Product ions were transferred
to the Orbitrap FTMS, which was operated with a charge target value
(automatic gain control) set to 1 million. Precursor and product ion
detection were performed in the Orbitrap mass analyzer over a 200–
4000 m/z range. The resolving power was set at 15,000 (at 400 m/z)
for MS experiments and at 100,000 (at 400 m/z) for ETD MS/MS. The
precursor ion target was set to 1  106 for all experiments, and
the target for fluoranthene anions was set to 2  106. To optimize the
SNR improvement as a function of single scan number, 10 micros-
cans were averaged for each scan in all the experiments. The S-lens
rf level was set to the maximum (70), and the transfer tube tempera-
ture was set to 350 °C. Sheath gas was set to 20, and auxiliary to 10.
The Orbitrap FTMS was calibrated for the high (2000–4000 m/z) mass
range, keeping mass accuracy for the low (50–2000 m/z) mass range
at the acceptable level.
Tandem MS Data Processing and Analysis—For each ETD LC-
MS/MS experiment, Orbitrap FTMS time-domain transients were re-
corded in MIDAS .dat format (30) for additional signal processing. A
dedicated routine was developed in-house for recording and adding
the transients. Briefly, transient recording can be performed either
directly by the Orbitrap FTMS on-board computer or through an
additional oscilloscope connected to the preamplifier outputs, as
described elsewhere (31). Transient processing was performed fol-
lowing standard methods developed for FT-ICR MS, taking advan-
tage of the Orbitrap FTMS transient MIDAS format’s being fully com-
patible with the available FT-ICR MS data analysis freeware (32).
Importantly, all transient signals originating from separate LC-MS/MS
experiments were summed in the time domain prior to Fourier trans-
form (FT) signal processing. In the current work, the following num-
bers of summed transients were realized: (i) 18 scans (corresponding
to 180 microscans) from a single LC-MS/MS run with an ETD duration
of 10 or 25 ms; (ii) 180 scans (1800 microscans) from 10 LC-MS/MS
runs with either 10 or 25 ms ETD; (iii) 360 scans (3600 microscans)
from 20 LC-MS/MS runs, with equal numbers of 10 and 25 ms ETD
experiments; and (iv) 1000 scans (10,000 microscans) from 40 LC-
MS/MS runs, with 10 and 25 ms ETD combined.
For the SNR estimation, the noise in the ETD mass spectra was first
calculated point by point (in a 45 m/z unit-large portion of the mass
spectra, always the same for all of the ones considered), and after that
the abundance of the peak at 772 m/z (taken as a reference for the
light product ion population) was divided over the obtained noise
value. Mass spectral deconvolution was performed with ProMass
software (Thermo Scientific), and comprehensive analysis of fragmen-
tation patterns was performed with the dedicated top-down MS
analysis software ProSight PC 2.0 (Thermo Scientific) (33). In the
ProSightPC analysis, searches were performed against a custom
protein warehouse incorporating the known sequences of both light
and heavy chains of Humira in both oxidized and reduced forms (both
chains) and with both cyclized and uncyclized isoforms of the heavy
chain. Data were searched in two ways: first at 15 ppm fragment
tolerance, and finally at 4.2 Da fragment tolerance. Fragments
matching the first search were considered valid without further in-
spection. Data acquired in the second search were all manually
validated. The large search tolerance required for these analyses
arises from two separate phenomena: first, peak picking algorithms
can mismatch the isotopic distribution, and second, electron-based
fragmentations are known to undergo hydrogen atom migration (34,
35). Both of these processes can shift the observed mass by 1 or
more Da (1.0033 Da in the former, 1.0078 Da in the latter). Spurious
matches were removed as false positives in this analysis.
RESULTS
Intact Protein MS—Fig. 2 shows the results of a single
LC-MS experiment, without fragmentation, on the human,
recombinant Humira IgG1. Over the selected gradient, the
elution time of the IgG from the column was 5 min (Fig. 2A).
The gradient, in combination with the relatively high quantity
of IgG injected, maximized the elution time and allowed for
efficient desalting. The charge state distribution is centered
on the 52 protein cation, and charge states observed
ranged from 38 to 80 (Fig. 2B). After the deconvolution of
broadband MS data, several potential glycoforms were iden-
tified (Fig. 2C). The peak at 148,080.3 Da can be attributed to
two G0F oligosaccharidic chains (often referred to as G0F/
G0F glycoform (36)), whereas the remaining two glycoforms
can be considered, respectively, as a G0F/G1F glycoform
(considered the mass difference of 162 Da, corresponding to
the addition of a hexose to one of the oligosaccharides) and
G1F/G1F (or possibly, but less likely, G0F/G2F). Considering
the known sequence of the IgG, which corresponds to an
average mass of 145,465.5 Da, the mass accuracy error for
the first glycan combination is 0.3 Da, corresponding to 2
ppm. The wide charge state envelope (from 38 to 80) en-
sured good statistics for the deconvolution operation. The
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inferred glycosylation pattern for the Humira IgG1 produced
by intact protein mass measurements is consistent with what
reported in the literature for similarly produced antibodies (36,
37). Moreover, the intact mass measurements confirmed that
no truncation was observed at either the N- or the C-terminus
of the analyte.
Typically, qualitative and quantitative analysis of the glyco-
sylation profile are performed in a bottom-up fashion—for
instance, by quantifying tryptic glycopeptides (38). However,
and more commonly, in order to reduce the high complexity of
all possible combinations of different glycans that can be
found on recombinant IgGs, glycans are released via enzy-
matic reaction with PNGase F (39), with or without combina-
tion with physical methods such as microwave-assisted di-
gestion (40), for both qualitative and quantitative analysis.
Top-down MS Method Optimization—As previously men-
tioned, the main performance limitation in the LC-based top-
down MS and MS/MS of large proteins is the relatively low
SNR provided by averaging a limited number of scans ac-
quired during rapid protein elution in a single LC-MS/MS
experiment. To increase the SNR of the MS/MS data and to
maximize the number of confidently identified product ions,
summing of Orbitrap MS/MS transients coming from a num-
ber of distinct LC-MS/MS experiments could be implemented
before performing FT for time-to-frequency conversion. Fig. 3
displays expanded segments of ETD mass spectra resulting
from analysis of a different numbers of transients acquired for
two ion–ion interaction periods (10 ms and 25 ms) and two
isolation windows (narrow and wide). Figs. 3A–3E show the
results of experiments performed with a 2700–2800 m/z pre-
cursor ion isolation window in the LTQ, the narrow isolation
window, comprising precursor ions from 53 to 55 charge
states. The ETD mass spectrum shown in Fig. 3F was ob-
tained for the 2600–3200 m/z precursor ion isolation window,
the wide isolation window, comprising precursor ions from
47 to 57 charge states. For a 10 ms ion–ion interaction
period (ETD duration), the main product ion population is
centered at about 1600 m/z, and a second group of less
abundant, lighter product ions is located below 1000 m/z (Fig.
3A). The experiment with a longer (25 ms) ETD duration shows
(A) (C)
(B)
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FIG. 2. Results of intact IgG LC-MS analysis in the Orbitrap FTMS acquired at 15,000 resolution (at m/z 400). A, base peak
chromatogram displaying the 5 min elution of the analyzed IgG1. B, charge state distribution of the Humira IgG, from 38 to 80. C,
Deconvoluted mass spectrum showing distinct IgG glycoforms; the first peak represents a G0F/G0F glycoform, and the second and third peaks
are G0F/G1F and G1F/G1F, respectively.
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a clear mass shift toward higher m/z values, with the final
result being that the main product ion population is centered
at 2000 m/z (Fig. 3B). A longer ETD duration presumably
causes secondary electron transfer and product ion fragmen-
tation. A greater number of different product ions with low
masses is present in Fig. 3B than in Fig. 3A. Under both
experimental conditions, the precursor ions and the corre-
sponding charge-reduced species were barely detectable.
This contrasts with our previous ETD MS/MS analysis of a
human IgG conducted on a qTOF MS (for a comparison, see
Fig. 1 of Ref. (25)). Figs. 3C and 3D show ETD mass spectra
obtained by summing 180 scans from 10 and 25 ms ETD
LC-MS/MS experiments, respectively. Here, the lack of de-
tected IgG charge-reduced species is even more apparent.
Finally, Figs. 3E and 3F display mass spectra combining
scans from both 10 and 25 ms ETD MS/MS, with the former
resulting from the sum of 360 scans and the latter 1000 scans
coming from ETD experiments in which a wide isolation win-
dow was used. These two ETD mass spectra present a bi-
modal product ion distribution character. Note that in addition
to the increase in SNR for mass spectra gained by summing
experiments with ETD interaction times of 10 ms and 25 ms,
it is believed that higher sequence coverage may be obtained
by adding potentially different product ions produced at a
different degree of secondary fragmentation.
To estimate the sensitivity (or SNR) gain achieved by sum-
ming time domain transients before FT, we calculated SNR
values for each of the ETD mass spectra presented in Fig. 3
FIG. 3. Comparison of ETD mass spectra resulting from the addition of different numbers of transients and acquired under different
ETD conditions. Precursor ion isolation window for panels A–E was 2750  50 m/z, whereas for panel F a wider isolation window of 600 m/z
units centered at 2900 m/z was employed. A, ETD mass spectra obtained by summing 18 scans (corresponding to 180 microscans) acquired
in a typical single ETD LC-MS/MS experiment with 10 ms ETD duration. B, single LC-MS/MS with 25 ms ETD duration. C, ETD mass spectra
obtained by summing 180 transients (corresponding to 1800 microscans) collected in 10 LC-MS/MS experiments with 10 ms ETD duration.
D, 10 LC-MS/MS runs with 25 ms ETD duration. E, ETD mass spectrum resulting from the sum of 360 transients, coming equally from 10 ms
and 25 ms ETD duration experiments, equivalent to 20 LC-MS/MS runs. F, ETD mass spectrum resulting from the sum of 1000 transients
(10,000 microscans in total), coming equally from 10 ms and 25 ms ETD duration experiments.
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using the abundance of the 772 m/z ion peak as a reference
(see insets in Fig. 3). The reference peak was selected for its
presence in both the 10 ms and 25 ms ETD experiments and
its location in a spectral region with low interference from
other peaks. Although the abundance of the 772 m/z ion peak
relative to that of the base peak changes between the 10 ms
and 25 ms datasets, it is clear that the measured SNR is
roughly tripled when the number of scans increases from 18
to 180, as expected (the SNR goes from 18.8 to 60.8 and from
28.4 to 88.8 in 10 ms and 25 ms experiments, respectively).
For ETD mass spectra combining an equal number of scans
from the two types of ETD experiments, the gain in SNR is
more difficult to determine, but by considering an averaged
value for the initial SNR at 18 scans (that is, (18.8  28.4)/2 
23.6) we can assume an increment of more than 4 times for
the ETD mass spectrum in Fig. 3E relative to the result of a
single LC-MS/MS experiment. The same calculation returns
an almost 9-fold increment for the 1000-scans averaged ETD
mass spectrum, which results from the use of different ETD
precursor ions due to a wider isolation window and thus is not
fully comparable with the preceding examples. A further in-
crease in SNR obtained by adding more LC-MS/MS runs is
feasible, although the envisioned SNR gain might not be
justified by the increased sample consumption and experi-
ment duration. Therefore, other ways of improving SNR in a
single LC-MS/MS experiment are to be explored, including (i)
activated ion-ETD (35, 41), (ii) protein ion supercharging (42–
45), (iii) an increased number of precursor ions obtained
through multiple fills of the ETD reaction cell, (iv) improved
product ion transmission to the Orbitrap mass analyzer from
the ETD reaction cell, and (v) an increased number of scans
acquired per LC-MS/MS experiment via super-resolution-
method-based signal processing applied complementary to
the FT signal processing (46).
The complexity of high SNR ETD mass spectra can be
appreciated in Fig. 4, which emphasizes the importance of the
employed high resolution acquisition (100,000 at 400 m/z) in
the MS/MS mode. Particularly, the overlapping isotopic dis-
tributions of multiply charged product ion clusters are re-
solved, allowing one to determine their charge state with high
confidence. Although the high resolution employed in this
work profoundly contributed to the identification of IgG back-
bone cleavage sites (vide infra), it must be stressed that the
increase in SNR achieved with the addition of transients taken
from different LC-MS/MS experiments (see supplemental Fig.
S1) is currently the most important factor for the successful
analysis of populations of large, multiply charged product ions
via FTMS.
ETD-based Top-down MS: Narrow Isolation Window—The
mass spectra obtained by summing 360 and 1000 ETD
MS/MS scans were subjected to data analysis with ProSight
PC (see “Experimental” section for more details). The ob-
tained fragmentation map is represented in Fig. 5. A summary
of identified N- and C-terminal end-containing ions for both
light and heavy chains is presented in Table I. The ETD mass
spectrum obtained from 360 scans with simultaneous frag-
mentation of three different IgG precursor ions (charge states
53, 54, and 55) shows 46 c-ions, 31 z●-ions, and 23
y-ions for the light chain, corresponding to 72 unique back-
bone cleavages, and 48 c-ions, 35 z●-ions, and 21 y-ions,
equivalent to 90 unique backbone cleavages, for the heavy
chain (Fig. 5, black bars). In the heavy chain, the Glu1 residue
was observed to be also in pyroglutamic acid (pyroGlu) form,
as highlighted in purple in Fig. 5. The total number of 162
identified unique backbone cleavages obtained via ETD of the
three charge states of IgG precursor ions, taking into account
the 214 residues of the light and 451 residues of the heavy
chain (altogether resulting in 663 potential backbone cleavage
sites), corresponds to 24.4% sequence coverage. Note the
cleavages at both sides of proline residues (whose N–C bond
cleavage in ETD would not result in separated product ions).
Furthermore, although most of the assigned cleavage sites
are located in the disulfide-bond-free regions, 22 backbone
c162+
z81+
z142+
z294+
z142+ z81+
z223+
°
°
°
°
∗
∗
∗
∗
y81+
°
z1078+
y1078+c1249+
c1108+
c967+
c1249+
c977+
z1078+
Heavy chain
Light chain
FIG. 4. Expanded segments of ETD mass spectrum obtained by
averaging 1000 scans (mass spectrum shown in Fig. 3F). Upper
panel, low m/z region; the importance of the high resolution in dis-
criminating between z14
2 and z8
1 (heavy chain) is confirmed in the
inset. Bottom panel, expanded segment of an ETD mass spectrum
with highly charged and partially overlapping product ion clusters; the
isotopic distribution of z107
8 is shown in the inset.
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cleavages for the light chain and 10 for the heavy chain are
notably located in disulfide-protected portions of the polypep-
tide sequence. Finally, it is noteworthy that the central portion
of the light chain, comprising parts of both variable and con-
stant domains, has been extensively sequenced, with most of
the backbone cleavages confirmed by the identification of
fragments containing information about the N terminus (c-
ions) and the C terminus (z●- and/or y-ions). However, the
central portion of the heavy chain (including the glycosylation
site) was not sequenced at all.
ETD-based Top-down MS: Wide Isolation Window—The
wider ion isolation window (600 m/z units, including precursor
ions from 47 to 57 charge states), which might open new
dissociation channels, was employed in order to further im-
prove the ETD sequence coverage. Indeed, ETD of precursor
FIG. 5. Fragmentation map of light (top) and heavy (bottom)
chains of Humira IgG. Cleavage sites identified for experiments
conducted with isolation windows of 100 m/z (narrow window, cen-
tered at 2750m/z) or 600m/z (wide window, centered at 2900m/z) are
indicated in black and red, respectively. Cysteine residues are repre-
sented in orange, and intermolecular disulfide bonds are indicated by
the blue dashed lines. On the heavy chain, the detected pyroGlu1
mutation is highlighted in purple.
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ions from the wide isolation window generated 63 and 117
unique backbone cleavages from the light and heavy chains,
respectively (Fig. 5, red bars). The total number of thus-ob-
tained unique cleavage sites (180) corresponds to 27.1%
sequence coverage. Relative to the ETD results obtained with
the narrow isolation window, the C-terminal portion of the
light chain presents a lower number of assigned backbone
cleavages, whereas the sequence coverage of the region
between the second and third constant domains (CH2 and
CH3) and the C-terminal part of the heavy chain is substan-
tially improved. The outlined difference in fragmentation pat-
terns is apparent in the branching ratios of product ions
formed. Indeed, the total number of product ions containing
information on the C terminus, namely, z●- and y-type ions,
was 56 in ETD with the narrow isolation window, whereas it
reached 71 for ETD with the wide isolation window for the
heavy chain (Table I). Conversely, for the light chain, the same
number decreased from 54 for the former to 43 for the latter
ion selection conditions. Considering the good SNR charac-
terizing both analyzed mass spectra, the observed differences
in sequence coverage at the C terminus are most likely due to
the use of different ETD precursor ions for the two experimen-
tal sequences.
To adequately evaluate the progress made by employing
Orbitrap ETD MS/MS for the structural analysis of intact and
S–S bond reduced IgG, a comparison with previous work
employing ETD MS/MS on a qTOF MS (see Scheme 2 in Ref.
(25)) and CID MS/MS on an Orbitrap FTMS (29) can be done
(Table I). Note that CID experiments were performed on re-
duced and alkylated IgG of a different subclass (IgG2, not
IgG1). For ETD experiments, the analyzed human IgGs were
different only in the variable domains, as they belonged to the
same subclass and had the same kappa-type light chain. An
appreciable increase in sequence coverage provided by ETD
on Orbitrap FTMS is apparent (Table I). After we combined the
results of narrow and wide isolation window ETD Orbitrap
FTMS experiments, the final number of unique backbone
cleavage sites rose to 217, representing 32.7% sequence
coverage. A detailed investigation of the dependence of se-
quence coverage on the number of scans has yet to be
addressed.
DISCUSSION
Given their multimeric structure comprising two heavy and
two light chains, complex intra- and intermolecular disulfide
connectivity, and heterogeneous glycosylation on heavy
chains and their high molecular weight (150 kDa), the full
characterization of intact IgGs represents a difficult challenge
for any MS platform. The state-of-the-art high resolution Or-
bitrap FTMS allows LC-timescale-compatible intact IgG ioni-
zation, charge state selection in a range up to 4000 m/z, and
fragmentation by both slow-heating methods (e.g., CID and
higher energy collisional dissociation) and radical chemistry-
based dissociation (e.g., ETD). It also supports the detection
of isotopically resolved, multiply charged product ions pres-
ent in a complex mixture, enabling a top-down MS approach
for the structural analysis of intact IgGs. Here, we have dem-
onstrated that time-domain transient signal averaging from a
number of consecutive LC-MS/MS experiments before FT
signal processing and peak picking significantly improves the
performance of Orbitrap FTMS-based top-down MS. We note
that although state-of-the-art top-down proteomics of 10 to
50 kDa proteins is already performed with on-line nanoLCMS,
the analysis of intact proteins heavier than 50 kDa is often
performed after off-line LC-based protein purification fol-
lowed by off-line nanospray-MS. We opted for an on-line
LC-MS/MS approach here because it is more universal than
the off-line approach in terms of the types of samples to be
addressed, as well as its suitability for automated quality
control workflows. Indeed, the near-future goal of the top-
down proteomics is to perform analyses of complex protein
mixtures that contain heavy proteins as large as 150 to 200
kDa. With an increase in MS sensitivity and speed of high
resolution data acquisition, substantially fewer LC-MS/MS
runs will be required for protein characterization.
In the current work, the observed increase in SNR rose as
expected with the square root of the number of scans; spe-
cifically, we estimated a roughly 4-fold to 8-fold gain in SNR
from a single LC-MS/MS experiment to the final mass spec-
tra. Furthermore, to maximize the number of assigned unique
cleavage sites, we not only averaged 1000 scans, but we also
used a large (600 m/z) precursor ion isolation window. As a
result, the data presented here demonstrate a 2-fold higher
sequence coverage than was obtained on a similar human
IgG1 in a prior ETD implementation for top-down MS analysis
of IgGs. In addition, we report the partial cyclization of Glu1 to
pyroGlu1 on the IgG heavy chain. We note that significant
structural differences between IgG variants considered in Ta-
ble I certainly influence ETD MS/MS performance. Further
work should be dedicated to comparing similar IgG sub-
classes. Also, information about the ETD preference for a
particular IgG sequence or higher order structure provides an
additional source of information on the ETD fundamentals.
The novelty of the results presented here for ETD-based
top-down MS is primarily in the substantially improved ana-
lytical characteristics of the employed experimental set-up
that increase the overall capabilities of the method and allow
an important step to be taken toward its routine application.
Although previous work demonstrated the proof-of-principle
implementation, it also demonstrated the corresponding lim-
itations, specifically in terms of the mass resolving power. The
large number of laboratories equipped nowadays with high-
resolution Orbitrap FTMS instrumentation suggests a high
impact of the results described here. Nevertheless, similar to
previously reported results, we were not able to sequence
long portions of the constant domains of light chains or the
entire central portion of the heavy chain, presumably because
of a combination of disulfide-bond networks and the partial
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retention of the secondary and tertiary structures of the IgG in
the gas phase, which would explain the almost complete
sequence coverage obtained for the flexible, unstructured
loops connecting consecutive domains in the light and heavy
chains (see Fig. 5). We are currently addressing these issues
by implementing ion activation before and after ETD reaction,
unfolding IgG via the partial reduction of disulfide bonds, and
increasing the number of protonated sites via precursor ion
supercharging. Future improvements in instrumentation—for
example, the use of a compact high-field Orbitrap mass an-
alyzer or Orbitrap Elite FTMS instrument or improved ion
transfer and trapping—are expected to increase substantially
the speed of analysis and reduce the number of scans re-
quired for top-down analysis.
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(Abstract) 
The increasing importance of immunoglobulins G (IgGs) as biotherapeutics 
calls for improved analytical methods of in-depth structural characterization of 
these large (~150 kDa) macromolecules. Required methods have to be rapid, 
robust, and with minimal sample preparation. In a previous work we showed 
the potential of Orbitrap Fourier transform mass spectrometry (FTMS) 
combined with electron transfer dissociation (ETD) for the top-down 
investigation of an intact IgG1, resulting in ~30% sequence coverage. Here, we 
describe top-down analysis of IgGs1 (Adalimumab, Trastuzumab) and IgG2 
(Panitumumab) performed with ETD on the higher field Orbitrap mass 
analyzer. For two different IgGs1, sequence coverage comparable to the 
previous results was achieved in a two-fold reduced number of averaged 
transients, which corresponds, taken together with the increased acquisition 
rate of the high-field Orbitrap, to ~six-fold improvement in analysis time. 
Furthermore, we compared the ETD process performed on the same IgG with 
different ion-ion interaction times and the top-down fragmentation patterns 
obtained for IgGs1 with that of an IgG2 (Panitumumab), which presents 
structural differences. These results reinforce the hypothesis that portions of 
the IgG chains remaining unsequenced are those retaining structural 
constraints in the gas phase. 
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1. Introduction 
Monoclonal antibodies (mAbs) are an effective therapeutic tool in a variety of 
indications such as cancer and inflammatory disease.[1] These large 
glycoproteins constitute, with presently more than 40 approved products and 
30 others in advanced clinical investigations, the fastest growing class of 
therapeutics.[2] The main class of antibodies employed as biotherapeutics is 
immunoglobulin G (IgG). IgGs are large (~150 kDa) biomolecules with a 
quaternary structure made of two ~25 kDa light and two ~50 kDa heavy 
chains, identical among themselves, with the latter being N-glycosylated, Fig. 
1. The four chains are interconnected and their tertiary/quaternary structure 
is reinforced by inter- and intra-molecular disulfide bridges. Heavy chains can 
be translated from different genes, and their sequence determines the so-called 
IgG isotype (or subclass). In the pharmaceutical industry, three of the four IgG 
isotypes are of interest: IgG1, IgG2, and IgG4. Although all isotypes share 
~90% of homology in their amino acid sequences, the structure of their hinge 
regions and the disulfide bond connectivity are significantly different. IgG1 and 
IgG4 contain 16 disulfide bridges, two in the hinge linking the heavy chains, 
one disulfide bridge linking each light chain to the heavy chain and 12 
intramolecular bridges (2 and 4 for each light and heavy chain, respectively). 
IgG2 contains 18 disulfide bonds with four in the hinge region linking the two 
heavy chains together.[3] Figure 1 compares the structures of an IgG1 and an 
IgG2. Note that the C-terminal cysteine of the light chain is linked to the third 
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cysteine of the heavy chain in IgG2 (and also IgG4) whereas in IgG1 it is linked 
to the fifth cysteine.  
Due to their bioproduct nature, high-throughput extensive 
characterization of IgGs structure is needed.[4] Mass spectrometry (MS) plays a 
pivotal role in structure analysis of IgGs. MS-based methods have been 
developed and implemented across all stages of mAb production.[3] The basic 
workflow may include intact IgG mass measurement, IgG fragment (reduced 
light and heavy chains or papain-produced fragments) mass measurement 
(referred to as middle-up MS approach),[5] middle-down[6] and bottom-up 
MS.[2, 7] Although bottom-up approaches provide the most structural 
information today, they suffer a number of drawbacks such as artifact 
introduction and lengthy sample preparation.[8-10] Top-down mass 
spectrometry (TD MS) refers to the gas-phase dissociation of intact 
biomolecules and subsequent mass measurement of the reaction products.[11] 
In this perspective, TD MS of intact IgGs is a convenient way to obtain primary 
structure information while keeping the connectivity between light and heavy 
chains. Furthermore, this approach generally allows access to sequence 
confirmation of terminal regions as well as variable domains. It also allows the 
identification and localization of major modifications and the characterization 
of major glycoforms. It has the advantage of implicating limited sample 
preparation and therefore minimal artifact introduction due to sample 
processing. Despite these advantages, TD MS is not yet widely used for the 
characterization of mAbs, primarily due to the large number of highly charged 
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products yielded by IgG fragmentation which requires high-resolution MS and 
substantial acquisition time for improved sensitivity.[12]  
Electron capture dissociation (ECD)[13, 14] and electron transfer 
dissociation (ETD)[15] of proteins usually generate larger sequence coverage 
than slow-heating activation methods (such as collision-induced dissociation, 
CID).[16] ECD and ETD MS/MS are also known as powerful methods for 
characterization of labile post-translational modifications, e.g., 
glycosylation.[17, 18] Fourier transform ion cyclotron resonance (FT-ICR) MS 
provides the highest resolution and might be hyphenated with ECD making it, 
until recently, the technique of choice for TD MS experiments.[19-21] Notably, 
Mao et al. achieved 25% sequence coverage of IgG1 using qFT-ICR MS and 
ECD when isolating a single charge state in a direct infusion ionization mode. 
They increased the sequence coverage to ~33% with a broadband tandem mass 
spectrometry (MS/MS), e.g., using all the IgG1 ions present in the charge state 
envelope as precursors for ECD.[22] However, the general use of FT-ICR MS 
instruments for IgG characterization is rare,[3] presumably due to their limited 
presence in biopharmaceutical laboratories owing to the tedious maintenance 
and operational costs.  
With the advent of ETD efficiently performed in an external ion trap with 
product ion detection in a high-resolution mass analyzer, e.g., Orbitrap 
FTMS[23] or time-of-flight (TOF) MS,[24, 25] the performance of TD MS has 
improved. Particularly, TD MS of proteins on-line separated with reversed 
phase liquid chromatography (LC) prior to electrospray ionization (ESI) became 
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possible routinely.[26, 27] We have previously described the use of ETD with a 
high-resolution qTOF MS reporting the overall sequence coverage of 21% for 
mouse IgG1 and 15% for human IgG1 which provided structural information 
on variable domains of both the heavy and the light chain.[28] As a result of a 
more extensive investigation, we achieved 33% sequence coverage of a human 
IgG1 using ETD with a hybrid linear ion trap (LTQ) Orbitrap FTMS (considering 
c-, z- and y-type product ions). The results obtained with narrow (i.e., 100 Th) 
and large (i.e., 600 Th) isolation windows for precursor ions were combined to 
increase the final number of identified product ions.[29] In all the 
aforementioned TD MS studies, over one thousand scans (or transients, in the 
case of FTMS) were averaged to achieve maximum sequence coverage.[22, 28, 
29] Naturally, a number of LC MS/MS runs were acquired followed by time-
domain data averaging to provide the required number of scans in the LC-
MS/MS approach of TD MS. The current state of the art in TD MS, however, 
does not enable the sequencing of the disulfide bond protected domains of both 
light and heavy chains, neither it allows the direct localization of the 
glycosylation site in the CH2 domain of the heavy chain. This is due to the 
compact protein structure and its disulfide bond network (see Fig. 1), which 
constitute the major limitation in IgG TD MS characterization. Overall, the 
performance of all three approaches, using ETD on a qTOF MS or on LTQ 
Orbitrap FTMS, as well as ECD on FT-ICR MS, provide comparable results.  
Here we investigated the potential of ETD implemented on a high-field 
Orbitrap FTMS[30] for faster top-down characterization of three therapeutic 
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mAbs: Adalimumab and Trastuzumab (both of the IgG1 subclass), and the 
IgG2 Panitumumab. The high-field Orbitrap mass analyzer is characterized by 
a higher frequency of ion oscillations along the central electrode compared to 
the prior generation of Orbitrap mass analyzers.[31] Increased frequency of ion 
oscillations leads to the corresponding enhancement of the resolving power 
over a fixed acquisition time. Moreover the implementation of FT absorption 
mode of spectral representation (known as “eFT” algorithm) allows a further 
gain (of up to two-fold) in acquisition rate at a constant resolution.[32] In 
addition to the advantages of the employed mass analyzer, we optimized 
precursor ion isolation and product ion transfer between the LTQ and the 
Orbitrap to increase the efficiency of ETD-based TD MS. Finally, IgG TD MS 
was performed under the optimized conditions with a two-stage ion activation 
method, a combination of ETD and higher-energy collision dissociation 
(HCD)[33] termed EThcD, which previously was shown to be beneficial for 
extending peptide sequence coverage.[34, 35] 
 
2. Materials and methods 
2.1 Chemicals. Water, acetonitrile (ACN), methanol (MeOH), formic acid (FA) 
and trifluoroethanol (TFE) were obtained in LC-MS purity grade. Water, ACN 
and MeOH were purchased from Fluka Analytical (Buchs, Switzerland). FA was 
obtained from Merck (Zug, Switzerland), and TFE from Acros Organics (Geel, 
Belgium).  
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2.2 Sample preparation. Therapeutic monoclonal antibodies of the IgG1 
class, namely Adalimumab (Humira, Abbot Laboratories) and Trastuzumab 
(Herceptin, Genentech), as well as the IgG2 Panitumumab (Vectibix, Amgen) 
are the European Medicines Agency approved versions and formulations, 
available commercially to a general public. Prior to direct infusion analysis, all 
antibodies were buffer exchanged against a 150 mM ammonium acetate 
solution pH 6.7 using microspin desalting columns (Zeba 75 µL, Thermo 
Scientific, Zug, Switzerland).  
 
2.3 Sample delivery and ionization. The antibodies were injected into the 
mass spectrometer either by on-line coupled LC or by direct infusion in a 
positive ion mode of ESI. In the former case, we employed an Ultimate 3000 LC 
system (Thermo Scientific, Amsterdam, The Netherlands) equipped with a 
reversed phase C4 column (Hypersil gold, 1x100 mm, 5 µm particle size, 
Thermo Scientific, Runkorn, UK), applying a gradient of ACN from 5 to 80% in 
20 min, in presence of 0.1% FA, and a flow rate of 100 µl/min generated by the 
loading pump. 1.5 µg of antibody (~10 pmol), diluted in 20% ACN and 0.1% FA, 
were typically loaded in each injection, resulting in ~2 min elution of the IgG. 
The microESI source (IonMax ion source, Thermo Scientific, Bremen, Germany) 
was operated at 3.7 kV, with sheath gas set to 20 and auxiliary gas to 10 
arbitrary units. In the latter case, the antibody, buffer exchanged as described 
above, was diluted in 50% ACN and 0.1% FA to a final concentration of ~10 µM; 
6 µl of this IgG solution were loaded in a 20 µl loop connected to the injection 
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valve of the LC system and infused through a silica capillary to the nanoESI 
source (Nanospray Flex ion source, Thermo Scientific) equipped with a metallic 
emitter to which a 2.4 kV voltage was applied. The composition of the solution 
used to push the IgG from the loop to the source was 39.9% water, 30% ACN, 
20% MeOH, 10% TFE, and 0.1% FA. The flow rate generated by the nanopump 
of the LC system was 0.6 µl/min.  
 
2.4 Mass spectrometry. All experiments were performed on a hybrid dual 
linear ion trap high-field Orbitrap FT mass spectrometer (LTQ Orbitrap Elite, 
Thermo Scientific, Bremen, Germany) equipped with ETD and HCD. Similarly 
to our previous report,[29] the S-lens RF level was set to 70% and the 
temperature of heated transfer capillary was 350° C. Broadband mass spectra of 
intact IgGs and tandem mass spectra of the same molecules were recorded in 
separate experiments using ion detection in the Orbitrap FTMS (m/z 200-
4000). All Orbitrap FTMS scans were recorded averaging 10 microscans to 
improve the SNR. Orbitrap FTMS was calibrated in the high mass range (m/z 
2000-4000) using ion at 2021.93954 m/z of commercial LTQ Velos Calmix 
(Thermo Scientific). Intact mass measurements of IgGs were performed at 
15’000 resolution at 400 m/z with a target value of charges (automatic gain 
control, AGC) of 1 million. For ETD experiments, precursor ions were isolated 
between m/z 2400 and 2900 in the high pressure LTQ and subsequently 
subjected to ETD reaction. The AGC value for fluoranthene radical anions was 
set to 2 million charges, anion maximum injection time was set to 50 ms and 
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ETD duration (i.e., ion-ion interaction time) was set to 10 or 25 ms. Product ion 
detection in the Orbitrap mass analyzer was performed with 120’000 resolution 
(at 400 m/z, eFT enabled) and an AGC of 1 million charges.  
For both intact mass measurements and tandem mass spectrometry, the 
gas (N2) “delta pressure” in the Orbitrap mass analyzer region, calculated as the 
difference between the pressure in presence of gas flow into the HCD cell and 
when the gas is completely shut down, was of 0.1E-10 torr. The typical value of 
this pressure difference for bottom-up proteomics (smaller size ions) is ~0.35E-
10 torr. To further improve ion transmission to the high-resolution mass 
analyzer from the LTQ, ions ejected from the LTQ were first trapped and stored 
in the HCD cell (known as “HCD trapping”), then transferred backward to the 
C-trap, and finally injected into the Orbitrap as previously described.[36]  
EThcD experiments were performed as follows. After ETD with 10 ms 
duration, all ETD products, including both charge-reduced species and product 
ions (precursors are generally completely consumed in ETD under the applied 
conditions), were transferred from the LTQ to the HCD cell. Here the collision 
energy was set to 25 or 40 eV, so that instead of ion capture and relaxation a 
second fragmentation event could occur. Finally, ions were transferred back to 
the C-trap and further into the Orbitrap for detection.  
 
2.5 FTMS data processing and analysis. The data processing routine for 
obtaining high SNR tandem mass spectra was performed as previously 
described.[29] Briefly, in both LC-MS/MS and direct infusion MS/MS 
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experiments, Orbitrap FTMS time-domain transients were recorded in MIDAS 
.dat format[37] and underwent averaging before being processed with the 
standard FT procedure for time-to-frequency conversion. In this way it was 
possible to average scans derived from separate LC runs or distinct direct 
infusion experiments. The eFT signal processing was not applied to the 
averaged transients, whereas it should be feasible in principle. The averaged 
transients were then converted into standard Thermo .RAW files for further 
viewing and processing with XCalibur software (Thermo Scientific), as well as 
data analysis (vide infra). Final ETD mass spectra were derived from summed 
transients recorded for 10 and 25 ms ETD duration experiments. For an in-
depth evaluation of the effect of ETD duration on IgG fragmentation, 10 and 25 
ms ETD datasets were also analyzed separately. 
Previously, the combination of deconvolution software Xtract and product 
ion assignment software ProSight PC 3.0 (both from Thermo Scientific) was 
successfully employed for IgG TD MS data analysis.[30] Here, we evaluated the 
performance of a recently developed workflow combining a deconvolution 
software MS-Deconv and product ion assignment software MS-Align+ (both 
developed at University of California San Diego, San Diego, CA, USA).[38] A 
comparison between results produced by MS-Deconv/MS-Align+ and by 
Xtract/ProSight PC is presented in Fig. S1, Supporting Information. Both the 
data analysis packages led to comparable results, with MS-Deconv/MS-Align+ 
being faster to use (less manual intervention). Briefly, the MS-Deconv/MS-
Align+ analyses were realized according to the following steps: (i) ReAdW was 
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used to convert .RAW files into centroided mzXML files; (ii) a customized 
version of MS Deconv was used to deconvolute the mzXML files using a SNR 
cutoff of 3. The custom version of MS Deconv was written to process the data 
sets containing MS/MS information only, whereas the standard version of MS-
Deconv requires both MS and the directly corresponding to it MS/MS data 
sets; (iii) MS-Align+ was used for product ion identification, considering c- and 
z·- type ions for ETD experiments and c-, z·-, b- and y-type ions for EThcD 
data. Cysteine residues were considered as not modified and all the mass 
tolerances were set to 20 ppm. Manual validation was performed for cleavage 
sites identified from product ions present only in a single charge state. 
 
2.6 Product ion abundance analysis (PIA). Abundances of identified product 
ions were derived from MS-Align+ analysis. For each cleavage site, all the 
related product ions were considered and grouped. Final abundances were 
obtained by dividing the abundance values reported for each product ion over 
the ion charge state, and summing all the resulting charge-normalized 
abundance values of product ions generated from a single cleavage site. For 
plotting together product ion abundance (PIA) analysis results of different sets 
of data, the abundances were expressed as relative percentage of the most 
abundant product ion cluster (i.e., the group of all the z-type ions, with 
different charge state, derived from a single cleavage site) in each data set.  
 
 
164 
 
3. Results and discussion 
3.1 Optimization of ETD MS/MS of IgG. To maximize the ETD efficiency, we 
sought to optimize precursor cation selection and product ion transfer. In the 
former work based on a hybrid LTQ Velos Pro Orbitrap FTMS we isolated 
precursor ions around m/z 2750 (isolation window width: 100 Th, precursor 
ions from 53+ to 55+) or 2900 (isolation window width: 600 Th, precursor ions 
from 47+ to 57+). Considered the charge state envelope obtained with the 
current LC-MS setting on the LTQ Orbitrap Elite for the intact IgG1 
Adalimumab, we centered the isolation window at m/z 2700, with a width of 
600 Th, thus including precursors from 50+ to 61+ (Fig. S2, Supporting 
Information). Higher charge state precursor ions are supposed to increase the 
fragmentation efficiency in ETD and facilitate the separation of obtained 
product ions bound by non-covalent bonds. Furthermore, cleavage preferences 
within protein structure shift as a function of charge location. In regard to 
product ion transfer, we applied a combination of reduction of the gas pressure 
in the HCD cell and the “HCD trapping”, vide supra. The gas pressure 
reduction improves SNR of large product ions by improving their transmission 
from LTQ into the HCD cell and further in the Orbitrap analyzer. Trapping of 
ions in the HCD cell (and not in the C-trap) favors the transmission also of 
lighter ions, counterbalancing the reduced damping effect in the C-trap 
resulting from the lower gas pressure (Fig. S3, Supporting Information).  
Overall, the implementation of these settings allowed for SNR increase in 
the MS/MS mode for high m/z ions, which resulted in a reduced number of 
165 
 
transients needed to be averaged for obtaining high-quality mass spectra in 
comparison to our previous work, vide infra. Each ETD mass spectrum derived 
from a combination of transients was obtained applying two different ion-ion 
interaction times, 10 and 25 ms, Fig. 2. Increasing ETD duration enhanced the 
formation of product ions with a reduced charge state, likely because of the 
occurrence of multiple electron transfer and consequent charge reduction 
events. Nevertheless, the separate analysis of mass spectra obtained with 10 or 
25 ms ETD duration revealed that most of the identified cleavage sites are 
shared between the two experiments (see product ion abundance analysis 
results below), suggesting that ETD is primarily limited by the retention of a 
compact conformation of the IgG in the gas phase. Summing transients from 
these two experimental sets, though, increased the confidence in the 
assignment of cleavage sites, as product ions obtained by the same backbone 
cleavage are identified in multiple charge states. 
 
3.2 ETD and EThcD MS/MS of intact human IgG1. The analysis of product 
ions obtained by ETD MS/MS was conducted for two IgG1 mAbs, Adalimumab 
and Trastuzumab. These share more than 92% of their sequences, the 
differences being almost entirely concentrated in the complementarity 
determining regions (CDRs), involved in the antigen binding. Fig. 3A displays 
the ETD fragmentation map of Adalimumab, with the typical fragmentation 
pattern expected for this IgG isotype: extensive fragmentation is achieved on 
the heavy chain for the loop interconnecting VH and CH1, the loop between CH2 
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and CH3 and part of the CH3 domain; on the light chain, the characterized 
region is represented by the loop between VL and CL. For both chains, 
therefore, the sequenced areas are mainly disulfide bond-free loops exposed to 
the solvent. The results of ETD MS/MS application to Trastuzumab are nearly 
identical to those for Adalimumab (Fig. S4, Supporting Information). For both 
the IgGs only the CDR3 domains of light and heavy chains are fully sequenced, 
and only a few product ions positioned on CDR2 of heavy and light chain have 
been assigned for Trastuzumab (which shows slightly higher sequence 
coverage). As summarized in Table 1, 310 ETD MS/MS scans (which 
corresponds to 3100 transients) were summed to result in 23.8% and 26.5% 
sequence coverage for Adalimumab and Trastuzumab, respectively. Notably, 
from the comparison of these results and the previously reported ones it is 
apparent how, although the total sequence coverage (i.e., sum of cleavages in 
light and heavy chains) is similar, the distribution of identified cleavage sites 
between the two chains is changed, with the heavy chain being more 
sequenced in the present report than in the previous one. For Trastuzumab we 
reached 29% sequence coverage which represents the highest value obtained 
so far for the heavy chain of an intact IgG1 by ETD TD MS. On the other hand, 
the light chain has been less sequenced with the new settings and data 
analysis routine than in the past. Manual inspection of MS/MS spectra reveals 
that the missing product ions are mainly those arising from cleavage sites 
located at the two termini of the light chain: these are light, lowly charged ions 
that presumably were not favorably transmitted with the newly employed 
167 
 
settings (Fig. S3 Supporting Information). The fully sequenced region in the 
light chain, corresponding to the loop between VL and CL, as mentioned above, 
remained the same between the two studies, and it is equal between 
Adalimumab and Trastuzumab (both of which often show complementary c- 
and z-type ions for the same cleavage site). Cleavages outside this area do not 
follow any clear pattern and seem randomly distributed. 
To improve the sequence coverage of the IgG1 and, specifically, of the 
light chain, we applied EThcD on Adalimumab. We summed transients 
obtained with EThcD (i.e., both product ions and charge-reduced species) 
performed at both 25 and 40 eV collision energy. As shown in Figure 3B, 
EThcD produced fragmentation mainly in the same areas previously covered by 
ETD, but also induced new cleavages at the N-terminus of both light and heavy 
chain, and provided b- and y-type ions from the N-terminal side of proline that 
could not be previously identified from ETD data. The sequence coverage for 
the heavy chain of Adalimumab is lower than for ETD, but it passed from ~19% 
to ~28% for the light chain, as reported in Table 1. Overall, the combination of 
310 ETD scans and 260 EThcD scans, for a total of 570 scans, produced 
30.5% sequence coverage, which is the same result obtained by averaging 1360 
scans in our previous work based on the Orbitrap Velos Pro. In addition to the 
reduced number of scans, a two-fold scan speed improvement due to the 
implementation of the high-field Orbitrap mass analyzer and a further two-fold 
improvement potentially granted by the application of eFT substantially 
decreased the required experimental time. In particular, at 120’000 resolution 
168 
 
(at 400 m/z) and under LC-MS/MS conditions, 120 transients (microscans) 
could be recorded per minute of IgG elution on the Orbitrap Elite FTMS versus 
the previous 40 transients (microscans) on the Orbitrap Velos Pro (note, that 
the ETD MS/MS experimental sequence, including cation accumulation, anion 
injection and subsequent cation/anion interaction largely contributes to the 
duty cycle, partially counterbalancing the time gain in FTMS data acquisition 
due to combination of high-field Orbitrap and eFT).  
Finally, from the comparison of the ETD TD MS results obtained with 
different ion transfer parameters (especially the pressure conditions in the HCD 
cell), those reported here and in the previous work, it seems beneficial to 
acquire ETD TD MS data with both conditions and pooling the data together.  
Indeed, results reported in Fig. S5 (Supplementary Information) show that the 
sequence coverage for ETD MS/MS of Adalimumab with only c and z-ions is 
increased to 41.3% and 34.7% for light and heavy chain, respectively, with a 
total sequence coverage of 36.8%. 
 
3.3 Product ion abundance (PIA) analysis of ETD MS/MS of IgGs1. A PIA 
analysis was conducted on ETD MS/MS data for the C-terminal portions of the 
almost completely sequenced heavy chains of the investigated IgGs1. Fig. 4 
shows a comparison between the relative abundances of z-ions from 10 ms 
ETD of Adalimumab, as well as 10 ms and 25 ms ETD of Trastuzumab. Note, 
that the two IgGs share identical sequence in the analyzed area. For all the 
three data sets, the average abundance of product ions generated by the 
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disulfide-free loop connecting CH2 and CH3 is ~40% of the maximum, and 
global maxima are all located there. Conversely, ions derived from the disulfide-
protected area of CH3, as well as those from the disulfide-free C-terminal end 
(which is, structurally speaking, a part of the CH3 domain), have generally an 
abundance lower than 10% of the corresponding maximum. Furthermore, the 
global maxima for the two 10 ms ETD data sets are both located at the cleavage 
site between K105 and G106 (which results in z106 ions). Other local maxima 
correspond to the formation of z96, z93, and z86 ions. The 25 ms data set shows 
a similar trend, with z106 still abundant but surpassed by z93, z91, and z86. 
Therefore, the ETD results are conditioned by the secondary and tertiary 
structures of the gaseous protein. Moreover, similarly to ECD MS/MS,[39] the 
ETD radical process seems to be affected by the electron transfer site, as the 
presence of basic residues at one side of the cleavage maxima would suggest. 
Finally, the shift in maxima occurring when passing from 10 to 25 ms ETD 
might be explained by the increased probability of secondary electron transfer 
events when the ETD duration is prolonged. The occurrence of secondary 
electron transfer and consequent charge neutralization events might be 
confirmed by the reduced average charge state of the product ions identified for 
25 ms ETD in comparison to 10 ms ETD experiments (Table S1, Supporting 
Information). The data suggests that these events are most prominent at the 
flexible loop and with a CH3 domain in a compact conformation. Therefore, 
despite the second fragmentation event the abundance of product ions 
originated within the sequence of the CH3 domain is not higher than for the 10 
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ms experiments. Instead, we observe the shift between z106 and z86 as maxima 
in the disulfide-free region. Visually, this is represented in Fig. 5 through a 
color-coded map based on crystal structure of Trastuzumab (image elaborated 
with The PyMol Molecular Graphics System, version 1.3, Schrodinger, LLC). 
The passage from 10 ms to 25 ms ETD duration induces the translation of 
highly frequent cleavage sites (represented in red) towards the C-terminus, but 
still in solvent accessible positions. On the contrary, the compact 
“immunoglobulin-like domain” corresponding to CH3, which resemble the 
structure of a beta barrel, and contains an intra-molecular disulfide bridge, 
remains poorly sequenced (and thus represented in black-blue). These results 
reinforce the hypothesis that such large proteins as IgGs retain a relatively 
compact high-order structure in the gas phase, even under denaturing 
ionization conditions. 
 
3.4 ETD MS/MS of intact human IgG2. ETD MS/MS was performed on 
Panitumumab, an IgG2, to provide a confirmation to our hypothesis that 
limitations in achieved sequence coverage for IgGs1 have mainly to be 
attributed to gas-phase retention of a structured, compact conformation by the 
protein. As displayed in Fig. 6, identified product ions for this IgG are localized 
in the areas sequenced in the experiments involving Adalimumab and 
Trastuzumab, e.g., the solvent accessible loops interconnecting consecutive 
disulfide-protected domains and the CH3 domain. In-depth analysis reveals 
that the C-terminal portion of the heavy chain is highly sequenced, with 83 
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assigned z-type ions versus 82 z-ions identified for Trastuzumab, which has 
overall the highest sequence coverage for its heavy chain (Table 1). 
Nevertheless, given that, in accordance to what is observed for IgGs1, the hinge 
region is not sequenced also in the case of Panitumumab, differences between 
the two IgG isotypes are present in the loop interconnecting VH and CH1. In the 
case of IgGs1, this loop was fully sequenced, whereas for Panitumumab only 
partial sequencing was achieved. This can be explained by the presence in the 
loop of the IgG2 of Cys133, involved in an inter-molecular disulfide bridge 
connecting the heavy with the light chain. Notably, most of the identified c-type 
product ions are located to the N-terminus of C133. Further studies are needed 
to determine whether ETD cleavages were primarily impeded in the portion of 
the loop at the C-terminal side of C133 or, conversely, cleavages occurred but 
primarily produced product ions with portions of the light chain still present 
and therefore not identifiable by the present version of the data analysis 
approach. Finally, Panitumumab’s light chain has been sequenced in its 
central area (i.e., disulfide-free loop between VL and CL), similarly to IgGs1, but 
its incomplete sequencing and, importantly, the limited number of identified z-
ions (9, corresponding to only ~50-30% of those assigned in the other 
experiments), could indicate that the inter-molecular disulfide bridge with the 
heavy chain is less efficiently cleaved in IgG2 than in IgG1.  
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4. Concluding remarks 
Recent developments in Orbitrap FTMS technology mark a substantial 
improvement in high-resolution MS data acquisition rate. Specifically, around 
three-fold faster acquisition of IgG ETD data under optimized conditions in the 
Orbitrap Elite FTMS (high-field compact Orbitrap) combined with a two-fold 
reduction in the number of transients to be averaged resulted in about six 
times reduced acquisition time in the present study relative to the analysis 
with the Orbitrap Velos Pro FTMS (standard field Orbitrap). Particularly, 
selection of higher charged precursors, optimization of product ion transfer 
from the ETD reaction cell to the high-resolution mass analyzer by reduction of 
HCD gas pressure, combination of experiments conducted with different ion-
ion reaction times, and use of EThcD with two different collisional energy 
values all contributed to the reduction of number of scans needed for high 
quality TD MS analysis. Nevertheless, the previously determined limit in 
sequence coverage, ~30%, could not be overcome. The primary cause for the 
limited sequence coverage is the gas-phase retention of highly structured areas 
in the IgG, mainly in correspondence of the immunoglobulin-like domains.  
Extending the sequence coverage in TD MS of IgGs may be provided from 
improved ETD reaction cell,[40] chemical ionization source for front-end ETD 
on Orbitrap FTMS,[41] and the use of ion activation methods alternative to 
ETD, e.g., ultraviolet photodissociation.[42] Furthermore, improved sequence 
coverage shall be achieved by combining ETD experimental data acquired with 
high HCD gas pressure (i.e., maximizing light product ion transmission), and 
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low gas pressure (i.e., maximizing heavy product ion transmission), as it 
results from the combination of present data with those acquired in standard 
operational conditions with the LTQ Orbitrap Velos Pro FTMS. Finally, the 
probable presence of internal products and product ions retaining parts of both 
light and heavy chains bonded by inter-molecular disulfide bridges will require 
developments in the data analysis tailoring this specific class of proteins. 
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Figure caption 
 
Figure 1. Comparative schematics of the IgG1 (Adalimumab and Trastuzumab) 
and IgG2 (Panitumumab). The differences are related to a disposition of inter-
molecular disulfide bridges (connecting either heavy and light chain, or the two 
heavy chains). IgG1 has the C-terminal Cys of light chain connected to the fifth 
Cys residue of the heavy chain, whereas the C-terminal Cys of light chain in 
IgG2 is connected to the third Cys of the heavy chain. The hinge region of IgG1 
has 2 disulfide bridges between heavy chains, whereas IgG2 contains 4 S-S 
bonds there.  
 
Figure 2. Top-down ETD Orbitrap FTMS of IgG1 (Adalimumab) with ion-ion 
interaction time of 10 and 25 ms. (A) Combined mass spectrum including 
transients from 10 and 25 ms, with product ion population arising from the 
former experiment highlighted in blue, and from the latter indicated in red. (B) 
and (C) Expanded views of the two product ion populations, with assigned 
product ions derived from the heavy chain. Note the difference in the average 
charge state of the product ions of the two populations. 
 
Figure 3. Fragmentation map of Adalimumab by top-down Orbitrap FTMS. (A) 
ETD MS/MS. (B) EThcD MS/MS. The heavy chain is position on top, light chain 
at the bottom. 
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Figure 4. Product ion abundance analysis of ETD top-down MS of Adalimumab 
with 10 ms ETD duration and Trastuzumab with 10 and 25 ms duration. 
 
Figure 5. Color-coded representation of ETD PIA results for the C-terminus of 
the heavy chain of Trastuzumab. (A) 10 ms ETD. (B) 25 ms ETD. The displayed 
image is based on X-ray crystallography data (PDB entry: 3D6G). 
 
Figure 6. Fragmentation map of Panitumumab (IgG2) obtained with top-down 
ETD Orbitrap FTMS. 
 
Table 1. Sequence coverage obtained for different IgGs1 and IgG2 by top-down 
ETD Orbitrap FTMS. Indicated scans consist of 10 microscans each. Note, only 
c- and z-type ions were considered for ETD MS (for both “high-field” and 
“standard” Orbitrap data), whereas also b- and y-type ions were included in 
EThcD MS analysis. 
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Table 1. 
 
 
  
Number of 
scans
N-terminal 
product ions
C-terminal 
product ions
Unique 
cleavage sites
Sequence 
coverage
N-terminal 
product ions
C-terminal 
product ions
Unique 
cleavage sites
Sequence 
coverage
high-field Orbitrap
Adalimumab ETD 310 34 19 41 19.2% 39 78 117 26.0% 23.8%
Adalimumab EThcD 260 45 29 59 27.7% 22 58 80 17.8% 21.0%
Adalimumab combined 570 50 32 67 31.5% 53 82 135 30.0% 30.5%
Trastuzumab ETD 310 37 19 45 21.1% 55 75 130 29.0% 26.5%
Panitumumab ETD 300 34 9 34 15.9% 23 83 106 23.9% 21.3%
standard Orbitrap
Adalimumab combined 1360 54 59 84 39.4% 60 79 119 26.4% 30.6%
Light chain Heavy chain
Total sequence 
coverage
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Figure S1. Fragmentation map obtained with MS-Deconv/MS-Align+ (right) 
and Xtract/ProSight PC (left) for ETD MS of Adalimumab performed on the LTQ 
Orbitrap Velos Pro FTMS (data set from Ref. [30], so-called “wide isolation 
window”). This data set represents the first test bed for assessing the 
capabilities of MS-Deconv/MS-Align+ for product ion assignment of TD MS of 
IgGs.  
The combination of Xtract/ProSight PC used for the data analysis 
presented in Ref. [30] works efficiently, as shown in the left panel of the figure, 
with 60 and 112 unique cleavage sites for light and heavy chain respectively, 
identified by searching for c- and z-type ions. Results were achieved through a 
two-step search, with a first group of ions identified “automatically” under 
stringent mass tolerance settings (i.e., 20 ppm), and a second group manually 
validated after a 4.2 Da tolerance was set. The large tolerance allowed the 
assignment of product ions after hydrogen transfer (i.e., z+1 and, eventually, 
c+1 ions), or even ions with monoisotopic peak misassigned during 
deconvolution by Xtract (with a mass shift of 1.003 Da). Notably, automated 
assignment within the 20 ppm mass tolerance returned 27 and 59 unique 
cleavage sites for light and heavy chain, respectively, whereas the remaining 
product ions were assigned after manual validation-supported enlarging the 
mass tolerance to 4.2 Da. 
The comparison of the results with MS-Deconv/MS-Align+ shows that 
this combination produces results similar to Xtract/ProSight PC for what 
concerns the heavy chain, whereas some discrepancies are noticed in regard to 
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the light chain, with lower sequence coverage obtained with MS-Deconv/MS-
Align+. Importantly, MS-Deconv/MS-Align+ results are fully automated, and 
the manual validation is limited to those cleavage sites identified by a single ion 
and to the removal of eventual cleavage sites at the N-terminus of Pro. 
Furthermore, disulfide-free loops of both heavy and light chains show a highly 
similar sequence coverage with both software packages, although no manual 
ion assignment was needed in the case of MS-Deconv/MS-Align+. Note, other 
data sets acquired with Orbitrap Elite (such as some EThcD mass spectra) 
show slight advantage in favor of MS-Deconv/MS-Align+ even after the second 
search step in ProSight PC (data not shown), but most importantly they show 
good accordance between the cleavage sites identified by the two algorithms.  
A possible explanation of the lower number of identified unique cleavage 
sites in fully-automatic search with Xtract/ProSight PC relative to MS-
Deconv/MS-Align+ might derive from the differences in the product ion 
“envelope selection” procedure adopted by Xtract and MS-Deconv: the former 
selects iteratively the highest scoring envelopes whereas the latter uses a 
dedicated algorithm to determine a “heaviest path” in an envelope graph 
(comprising all the calculated theoretical envelopes) which finally results in 
optimized selection of product ion envelopes for highly convoluted MS/MS 
spectra with overlapping  product ion clusters, like those produced by 
ETD/EThcD MS/MS of IgGs. Moreover, differently from MS-Deconv, Xtract 
combines close monoisotopic masses derived from distinct envelopes into a 
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unique monoisotopic mass, which might be limiting for highly convoluted 
MS/MS data of very large proteins. 
As manual validation is a very time-consuming and operator-dependent 
procedure, after the tests MS-Deconv/MS-Align+ combination was chosen for 
the analysis of the data sets presented in this paper for a reason of the overall 
higher analysis speed and good reliability of identified ions, especially highly 
charged ones. We cannot exclude, nevertheless, that manual validation of data 
for finding additional product ions could lead to the discovery of additional 
cleavage sites, particularly those represented by product ions affected by 
hydrogen transfer, as efficiently demonstrated by the analysis with ProSight PC 
under large mass tolerance settings. 
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Figure S2. Mass spectra of intact IgGs. A, broadband spectrum of 
Adalimumab. Indicated in red are the maximum and minimum charge states 
included in the isolation window chosen for ETD MS/MS, 2400-3000 m/z. B, 
zoomed-in view of 56+ charge state of Adalimumab, showing baseline-resolved 
glycoforms. C-D, zoomed-in views of selected charge states of Trastuzumab and 
Panitumumab with indicated glycoforms. Mass spectra acquired with resolution 
15’000 at m/z 400. 
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Figure S3. Evaluation of ETD MS/MS of 24+ precursor of horse myoglobin, 2 
ms duration, at different HCD gas pressures. Each panel shows on top the 
results achieved with ∆p=0.35E-10 torr (“high” pressure, or standard ∆p 
condition), and on bottom with ∆p=0.1E-10 torr (“low” pressure). A, broadband 
view. With high pressure the base peak in the spectrum is a product ion, 
whereas with low pressure remaining precursor and charge reduced species are 
dominating. Panels B-D: expanded views on selected ions. It is apparent how, at 
low m/z and for light, singly-charged ions, the signal-to-noise ratio (SNR) is 
similar between the two pressure conditions, and slightly higher when the 
pressure is high. Panel D shows that, on the contrary, heavier ions are 
preferentially transmitted when the pressure in the C-trap is lowered. All the 
displayed mass spectra are single scans, with each scan composed of 10 
microscans. The MS/MS AGC was set to 1E6, similarly to the case of the IgG. 
Nevertheless, the IgG is 10 times heavier than myoglobin, and the largest 
identified IgG product ion exceeds in mass that of intact myoglobin. ETD of IgG 
produces many heavy, highly charged product ions which compete with low 
product ions for being transferred from LTQ to Orbitrap. In the case of 
myoglobin, using HCD trapping brings back the SNR of light ions to the levels 
normally achieved under high pressure condition (e.g., z3+ has SNR of ~9.5 with 
HCD trapping enabled). 
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Figure S4. Fragmentation map of top-down ETD MS/MS of Trastuzumab 
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Figure S5. Combination of ETD fragmentation maps of Adalimumab achieved 
in the present work and in the previous study based on the LTQ Orbitrap Velos 
Pro (i.e., standard Orbitrap). To the product ions assigned in the current study, 
signed in red, those derived from the old study were added (only where not 
already present), and signed in black. Note, that only c- and z-type ions were 
considered. Both light and heavy chain show primarily black product ions (i.e., 
from the Velos Pro data) located at the termini. 
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Table S1. Charge states of product ions identified at the C-terminus (z-ions) of 
Adalimumab and Trastuzumab for 10 and 25 ms ETD MS/MS. The reported 
values include: average charge state of all C-terminal product ions; average 
charge state of product ions belonging only to the disulfide-free loop connecting 
CH2 and CH3; highest charge state of an assigned product ion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adalimumab 
10 ms ETD
Trastuzumab 
10 ms ETD
Trastuzumab 
25 ms ETD
Average, C-term 6.2 6.2 5.3
Average, loop 6.9 6.9 5.7
Maximum 12 12 9
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(Abstract) 
The rapid growth of approved biotherapeutics, e.g., monoclonal antibodies or 
immunoglobulins G (IgGs), demands improved techniques for their quality 
control. Traditionally, proteolysis-based bottom-up mass spectrometry (MS) 
has been employed. However, the long, multi-step sample preparation protocols 
required for bottom-up MS are known to potentially introduce artifacts in the 
original sample. For this reason, a top-down MS approach would be preferable. 
The current performance of top-down MS of intact monoclonal IgGs, though, 
enables reaching only up to ~30% sequence coverage, with incomplete 
sequencing of the complementarity determining regions which are fundamental 
for IgG’s antigen binding. Here, we describe a middle-down MS protocol based 
on the use of immunoglobulin G-degrading enzyme of Streptococcus pyogenes 
(IdeS), which is capable of digesting IgGs in only 30 minutes. After chemical 
reduction, the obtained ~25 kDa proteolytic fragments were analyzed by 
reversed phase liquid chromatography (LC) coupled on-line with an electron 
transfer dissociation (ETD)-enabled hybrid Orbitrap Fourier transform mass 
spectrometer (Orbitrap EliteTM FTMS). Upon optimization of ETD and product 
ion transfer parameters, results show that up to ~50% sequence coverage for 
selected IgG fragments is reached in a single LC run, and up to ~70% when 
data obtained by distinct LC-MS runs are averaged. Importantly, we 
demonstrate the potential of this middle-down approach in the identification of 
oxidized methionine residues. The described approach shows a particular 
potential for the analysis of IgG mixtures. 
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Introduction 
With the tremendous progress in the development of protein engineering 
technologies, the use of recombinant protein therapeutics has expanded 
significantly in recent years with monoclonal antibodies (mAbs) becoming the 
fastest growing class of human therapeutics.1 Currently, there are more than 
40 approved mAbs and mAbs derivative products and 30 others in advanced 
clinical investigations. MAbs are indicated for the treatment of a variety of 
diseases including cancer.2 The success of mAbs as therapeutics is mainly 
attributed to their specificity to targets and their favorable pharmacokinetics. 
All approved therapeutic mAbs for clinical use belong to the immunoglobulin G 
(IgG) class. IgGs are tetrameric glycoproteins with molecular weights near 150 
kDa. They consist of four polypeptide chains: two heavy chains (Hc) of ~50 kDa 
each and two light chains (Lc) of ~25 kDa each, linked together by disulfide 
bonds to form the characteristic Y-shaped complex.3 
MAbs are required to be well characterized structurally to ensure their 
safety, efficiency, batch-to-batch consistency, and stability. With some 
approved therapeutic mAbs coming off patents, biosimilar antibodies are 
starting to be filed for approval. Biosimilar antibodies are “generic” versions of 
“innovator” (or “originator”) antibodies produced through different 
manufacturing processes and from different clones.4 For a biosimilar to be 
approved by the regulation agencies, it has to prove similar physicochemical 
characteristics, functional properties, and clinical efficiency to those of the 
innovator product.5 One of the most important criteria required is for the 
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amino-acid sequence to be strictly identical.6 Bottom–up liquid 
chromatography – tandem mass spectrometry (LC-MS/MS) sequencing of mAbs 
is widely used in pharmaceutical laboratories. Although bottom-up methods 
provide the most structural information, they suffer a number of drawbacks 
such as artifact introduction and lengthy sample preparation.7,8 Top-down MS 
sequencing constitutes an interesting alternative and might become a method 
of choice as it is a fast and convenient way to obtain useful protein sequence 
information.9-11 It has the advantage of implying limited sample preparation 
and therefore minimal artifact introduction due to sample processing. The 
advent of high resolution MS instruments coupled to electron transfer 
dissociation (ETD)12 or electron capture dissociation (ECD)13,14 enabled easier 
access to top-down analysis. In recent papers our team and others showed that 
top-down MS allows the sequencing of IgG terminal regions as well as variable 
domains and the characterization of major glycoforms.15-17 Up to 30% sequence 
coverage was achieved using ETD or ECD fragmentation on Orbitrap17 and ion 
cyclotron resonance (ICR)16 Fourier transform (FT) instruments, respectively. 
However, the current state of the art does not allow overcoming this 30% limit 
primarily due to the gas phase retention of highly structured areas in the IgG, 
mainly in correspondence of the immunoglobulin-like domains and the 
disulfide bond protected areas.  
By analogy to top-down and bottom-up approaches, the terms middle-up 
and middle-down were introduced.18 Middle-up refers to the mass 
measurement of large fragments or subunits of a protein after limited 
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proteolysis while middle-down also includes the MS/MS-based sequencing of 
these subunits.6,18 The terms top-down and middle-down are sometimes 
misused in the literature when referring to mass measurements of intact IgG or 
protease generated IgG subunits respectively, without performing MS/MS. 
Subunits of mAbs can be obtained through the chemical reduction of disulfide 
bonds thus yielding free heavy chains (50 kDa) and light chains (25 kDa), or by 
limited proteolysis in non-denaturing conditions with cleavage of the hinge 
region of the heavy chain yielding Fab (~50 kDa) or (Fab)’2  (~100 kDa) and Fc 
(~50 kDa) fragments, Figure 1. Chemical reduction in denaturing conditions of 
these proteolysis-generated subunits results in three ~25 kDa fragments: the 
light chain and two half heavy chains (the Fc/2 and the Fd). These 25 kDa 
fragments better match the performance characteristics of the state-of-the-art 
LC-MS/MS methods and techniques compared to intact mAbs targeted with 
top-down approaches.3,6 Several proteases such as papain,19 Lys-C,20 and 
pepsin21 have been described for cleaving in the IgG hinge region under non-
denaturing and controlled conditions. These proteases suffer however from 
limited specificity leading to nonspecific cleavages, complicating therefore the 
data analysis and interpretation.22 Recently, IdeS (Immunoglobulin G-
degrading enzyme of Streptococcus pyogenes) has been reported to specifically 
cleave between the two consecutive glycine residues under the hinge region.23 
It has the advantage of being rapid (30 min), low material consuming, and 
active in mAbs formulation buffers.22 The reduced complexity of IdeS-generated 
~25 kDa subunits allows an accurate profiling of N-glycans site by site and the 
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improved compared to intact IgG identification of various IgG microvariants 
(proteoforms) such as C-terminal lysine cleavage, cyclization of N-terminal 
glutamine and others.6,24 
In this paper, we investigated the utility of ETD coupled with high 
resolution high-field Orbitrap FTMS25 for the sequencing and characterization 
of approved therapeutic monoclonal antibodies in a middle-down fashion, 
Figure 1. The limited sample processing when using IdeS to generate medium-
sized subunits allows minimizing artifact introduction. On the other hand, 
their relatively small size and the reduction of the disulfide bonds give access 
to the fragmentation of the S-S protected areas that are not efficiently 
sequenced by top-down MS. To benchmark the efficiency of the presented 
method in monitoring post-translational modifications, we chose the oxidation 
of labile amino-acid side chains as a case study. Oxidation is one of the major 
challenges for improving the stability profile in the development of monoclonal 
antibodies.26 Oxidation of methionine residues from the sulfhydryl to the 
sulfoxide form is one of the common modifications known to occur in mAbs 
during the manufacturing, formulation, and/or storage process.27 It could 
decrease bioactivity and stability of IgGs which result in reduced serum half-
life and limited shelf life. Occurring mainly in Fc, it leads to decreased binding 
to the neonatal Fc receptor (FcRn) and loss of protection for catabolism.28  
Hydrophobic interaction chromatography and ion exchange are the most 
commonly used LC techniques to detect the presence of oxidized mAbs 
proteoforms.26,27 Bottom-up peptide mapping is then used to identify oxidation 
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sites. We employed mild oxidation conditions to generate oxidized IgG 
proteoforms that we analyzed by middle-down MS. Overall, the results reported 
here indicate that IdeS-based middle-down ETD MS can constitute a 
complementary or even an alternative method to bottom-up oxidation 
assessment in IgG quality control. 
 
Materials and methods 
Chemicals. Water, acetonitrile (ACN), trifluoroacetic acid (TFA) and isopropanol 
(IPA) were purchased in LC-MS purity grade. Water and ACN were obtained 
from Fluka Analytical (Buchs, Switzerland), formic acid (FA) from Merck (Zug, 
Switzerland), IPA from Thermo Fisher Scientific (Switzerland), and guanidinium 
chloride (GdnCl) from Carl Roth (Germany). Tris(2-carboxyethyl)phosphine, 
tert-butyl hydroperoxide, hydrogen peroxide and iron chloride were purchased 
from Sigma Aldrich (Buchs, Switzerland).  
 
Chemical mild oxidation of IgGs. Therapeutic monoclonal antibodies of the IgG1 
class, Adalimumab (Humira, Abbot Laboratories), Bevacizumab (Avastin, 
Genentech/Roche), and Trastuzumab (Herceptin, Genentech) were obtained as 
the European Medicines Agency approved versions and formulations, available 
commercially to the general public. To benchmark PTM identification by 
middle-down ETD MS, Adalimumab was oxidized prior to IdeS proteolysis. Two 
previously described protocols were employed.26 The first one required the 
incubation of the IgG with 1 mM of hydrogen peroxide and 60 µM of FeCl3 at 
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37° C for 19 hours. In the second, the IgG was treated with 1.4% of tert-butyl 
hydroperoxide for 19 hours at room temperature. 
 
IdeS digestion. IdeS (FabRICATOR, Genovis, Lund, Sweden) digestion of IgGs 
was performed in formulation buffers. One unit of IdeS was added to each µg of 
IgG and left to react for 30 minutes at 37° C. Then, IgGs were denatured and 
reduced by incubation with 6 M GdnCl and 30 mM TCEP at room temperature 
for 30 minutes. Finally, the reaction was quenched by acidifying the solution to 
1 % TFA. For analysis samples were diluted with 0.1% FA in water to a final 
concentration of 1µg/µl.  
 
Liquid chromatography – mass spectrometry. The chromatographic separation of 
IgG proteolytic fragments was performed using an Ultimate 3000 LC system 
(Thermo Scientific, Amsterdam, The Netherlands) under UPLC conditions. A 
combination of reversed phase C4 trap-column (Acquity UPLC PrST C4 
VanGuard pre-column, 2.1x5 mm, particle size 1.7 µm, pore size 300 Å, 
Waters, Baden-Dättwil, Switzerland) and C4 column (Acquity UPLC PrST C4, 
1x150 mm, particle size 1.7 µm, pore size 300 Å, Waters) was employed to 
ensure on-line IgG fragment desalting and separation. For each injection, 1 µg 
of digestion product was loaded on the column, heated at 65° C. After initial 
loading at 5% solution B (organic phase), a gradient of solution B from 15 to 
45% in 15 minutes was used at a flow rate of 100 µl/min. Solution A consisted 
of 0.1% of FA in water, whereas solution B was composed of 39.9% IPA, 60% 
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ACN, and 0.1% FA. The LC column outlet was on-line coupled with the 
electrospray (ESI) source of the mass spectrometer. MS experiments were 
performed on an ETD-enabled hybrid linear ion trap high-field Orbitrap FT 
mass spectrometer (LTQ Orbitrap Elite FTMS, Thermo Scientific, Bremen, 
Germany). Separate experiments were dedicated to record broadband mass 
spectra and ETD tandem mass spectra. Instrumental parameters were set as 
follows: S-lens RF level was set to 70%, the temperature of heated transfer 
capillary was 350° C, microESI source (IonMax source, Thermo Scientific) was 
used with a 3.7 kV potential, and sheath gas was set to 20 and auxiliary gas to 
10 arbitrary units. All the mass spectra were acquired using ion detection in 
the Orbitrap FTMS, in the m/z range 200-2000. For broadband and tandem 
mass spectrometry, we both reduced the gas (N2) “delta pressure” in the 
Orbitrap detector region to 0.1E-10 torr, and applied “HCD trapping”, which is 
a temporary ion storage in the HCD cell before ion transmission to the Orbitrap 
mass analyzer through the C-trap.29 Broadband mass spectra were recorded 
with either 15’000 or 120’000 resolution at 400 m/z, with a target value for the 
automatic gain control (AGC) of 1 million charges in either MS or MS/MS 
modes. For ETD experiments, precursor ions were isolated in the high pressure 
chamber of the LTQ and subsequently subjected to ETD MS/MS. The AGC 
target value for fluoranthene radical anions was set to 7-8E5 charges, with 
anion maximum injection time of 50 ms. ETD duration (i.e., ion-ion interaction 
time) was progressively increased from 3 ms to 9 ms in consecutive 
experiments. Product ion detection in the Orbitrap mass analyzer was 
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performed with 120’000 resolution at 400 m/z (eFT enabled). All Orbitrap FTMS 
scans were recorded averaging 10 microscans to improve the signal-to-noise 
ratio (SNR). Isolation windows for ETD of IgG fragments included one charge 
state per precursor ion (isolation width: 15 Th) in the case of Bevacizumab and 
Trastuzumab, or multiple charge states for Adalimumab (isolation width: 100 
Th and wider). 
 
Data processing and tandem MS analysis. Data were analyzed both as single 
LC-MS/MS runs, and after additional data processing aimed at improving SNR 
of tandem mass spectra. In the latter case, time-domain (transient) signals 
recorded in separate LC-MS/MS experiments were processed as previously 
described for top-down LC-MS/MS of mAbs.17 Briefly, Orbitrap FTMS transient 
signals were first recorded in MIDAS .dat format;30 these were then grouped 
according to the fragment type and duration of ETD MS/MS, averaged, and 
finally subjected to time-to-frequency conversion with the FT procedure. The 
resulting standard Thermo .RAW files could be then opened and processed with 
commercial XCalibur software (Thermo Scientific), and were thus ready for the 
data analysis. For each ETD duration, a summed mass spectrum for each IgG 
fragment was obtained; in addition, a total tandem mass spectrum was built by 
averaging all the transients (i.e., transients derived from different ETD duration 
experiments) available for a single IgG fragment. 
Data analysis was performed using Xtract and ProSightPC 3.0 (Thermo 
Scientific).31 First, Xtract was used for tandem mass spectra deconvolution, 
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peak centroiding, and peak picking. Then, cleavage sites were assigned with 
ProSightPC using 15 ppm tolerance. Both methionine and tryptophan were 
considered as possible oxidation sites. Complementary c- and z-type product 
ions were searched separately from b- and y-type product ions. 
 
Results and discussion 
LC-MS of IdeS-derived IgG fragments. Monoclonal antibodies digested with IdeS 
were subjected to chemical denaturation and disulfide bond reduction prior to 
LC-MS analysis. Notably, no alkylation of reduced thiols of cysteine residues 
was necessary, as the MS analysis was performed immediately after sample 
preparation and IgG fragments were maintained under acidic conditions (see 
Material and Methods), which helped preventing the re-formation of disulfide 
bridges. Figure 2 shows a typical total ion current (TIC) chromatogram of the 
three proteolytic fragments, namely Fc/2, Fd, and Lc, of Adalimumab. These 
are baseline separated and, as displayed in the figure insets, present over the 
selected m/z window (i.e., m/z 200-2000) extended charge state envelopes 
centered around charge states 24+-26+, with maximum charge state exceeding 
30+. A similar LC separation has been achieved for fragments derived from 
Bevacizumab and Trastuzumab, although, as expected, retention times of Lc 
and Fd fragments, containing IgG variable regions, are different among the 
three antibodies (Supporting Information, Figure S1). Importantly, the applied 
chromatographic conditions, with the UPLC C4 column heated at 65° C, 
ensured high elution reproducibility (data not shown).  
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The three fragments have masses in the range of 23-25 kDa. In the case 
of Adalimumab, for instance, theoretical average masses (neutral) of non-
modified fragments are the following: Fc/2, 23887.08 Da; Lc, 23412.17 Da; 
and Fd, 25458.63 Da. We observed and determined by MS1 two classical 
modifications, well described in literature, located on the Fc/2 fragment (of all 
the three antibodies), which is N-glycosylated and presents often C-terminal 
lysine clipping. Major glycosylations could be detected: in the case of 
Adalimumab, the most intense peak corresponds to Fc/2 with G0F 
glycosylation, followed by G1F with an intensity of about one third of the base 
peak.32 The mass accuracy achieved with the adopted MS settings (see Material 
and Methods) at 15’000 resolution (at m/z 400) was ~1 Da. With regard to 
mass accuracy, on the LC time scale it was also possible to fully resolve the 
isotopic distribution of the fragments using a resolution setting of 120’000 (at 
m/z 400), as shown in Figure 2 for Fc/2 fragment with G0F glycosylation of 
Adalimumab. Nevertheless, as a general consideration about the current state 
of available instrumentation, it is fundamental to recall that the advantage of 
isotopically resolved distributions of polypeptides relies mainly on the 
determination of the monoisotopic mass. According to calculations based on 
model proteins, the dynamic range needed for simultaneously detecting the 
most intense peak in the isotopic distribution and the monoisotopic one, is of 
~E32 for an intact IgG and ~6E4 for the ~29 kDa carbonic anhydrase. 
Therefore, considering the molecular weight of the IgG fragments, close to that 
of carbonic anhydrase, the utility of isotopically resolving the here studied 
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fragments is currently limited given that no current FTMS mass analyzer 
exceeds four orders of magnitude in spectral dynamic range. In addition, 
further complications are due to the restricted number of mass spectra 
recorded during a single LC experiment, the possible co-elution of protein 
adducts (e.g., Na+ adducts), and presence of proteoforms with small differences 
in mass. As an example, Chen et al. showed that the commonly employed 
method for monoisotopic mass estimation based on averagine (i.e., average 
amino acid with the formula C4.9384H7.7583N1.3577O1.4773S0.0417)33 can lead to an 
error of ~0.3 Da for isotopically resolved 15 kDa protein RNase A.34 
 
ETD MS/MS of IgG fragments. ETD of IdeS-produced IgG subunits was 
performed in two different fashions. Proteolytic subunits derived from 
Bevacizumab and Trastuzumab were subjected to ETD in a “proteomic” 
fashion, which corresponds to the isolation of precursor ions in a single charge 
state. These experiments proved the efficiency of ETD and facilitated tuning the 
instrumental parameters for further studies described below. 
Conversely, ETD MS/MS of Adalimumab was aimed at maximizing the 
sequence coverage, for direct comparison with top-down MS results, and was 
thus performed exploiting the high chromatographic reproducibility of subunit 
elution. The instrument was operating in MS/MS mode only during selected 
time windows corresponding to the elution times of the three fragments. In this 
case, a larger isolation window was used, for including ~5 highly charged 
precursors and increasing ETD efficiency. Isolation windows were selected on 
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the base of the charge state envelopes of each fragment (i.e., using the 
information previously obtained by MS1), and centered as indicated by the 
arrows in the bottom left inset of Figure 2. Note, in top-down and middle-down 
experiments, the sequence coverage is calculated as the ratio of assigned 
cleavage sites to the total number of possible backbone cleavage sites, whereas 
in bottom-up experiments, the identified peptides are used without regard to 
the number of cleavage sites assigned after evaluation of MS/MS data.  
As expected, the highest sequence coverage was obtained with the 
acquisition parameters previously optimized for Adalimumab analysis. The 
corresponding fragmentation map is represented in Figure 3. As reported in 
the Figure, a final coverage of almost 70% was obtained for Fc/2 and Lc 
fragments, whereas a slightly lower coverage, of nearly 60%, was obtained for 
the heavier Fd fragment, presumably because of different charge localization 
and lower charge-over-mass unit ratio relative to Fc/2. The final sequence 
coverage was calculated accounting all the cleavage sites assigned through the 
analysis of different experimental datasets, derived from experiments where the 
ETD duration spanned from 3 to 9 ms. For each dataset, 4 to 10 LC runs were 
acquired. In each LC run, up to 90 transients (microscans) per fragment were 
recorded (the number varies among the fragments, being dependent on the 
elution time frame). In total, ~3000 transients (microscans) were averaged. 
Importantly, all the complementarity determining regions (CDRs) were 
sequenced, and the position of the glycosylation site on the Fc/2 was 
confirmed, as well as the Lys-clipping on the same fragment, Figure 3. 
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For Bevacizumab and Trastuzumab, the averaging of a similar number of 
transients resulted in slightly lower sequence coverage (Table S1, Supporting 
Information). Nevertheless, sequencing of CDRs and confirmation of the 
glycosylation site as well as Lys-clipping were obtained (Figure S2, Supporting 
Information).  
Finally, it is noteworthy that the sequence coverage achieved with a 
single LC run (related ETD mass spectra are reported in Figure S3, Supporting 
Information) is considerably high for ~25 kDa polypeptides with sharp elution 
peaks (of 20-40 s): almost 50% sequence coverage is reached for Fc/2 and Lc 
and ~30% for Fd of Adalimumab (Table S2, Supporting Information). 
Importantly, the advantage in terms of sequence coverage obtainable operating 
the mass spectrometer under reduced HCD cell pressure and with HCD 
trapping enabled is dramatic for a single ETD LC-MS/MS experiment, as 
summarized in Table S2 and visually reported in Figure S4, Supporting 
Information.  
 
Middle-down LC-MS/MS analysis of oxidized IgG. The chromatographic 
separation of fragments derived from IdeS digestion of oxidized Adalimumab 
resulted in baseline-resolved elution peaks. Figure 4 illustrates a comparison 
between fragments of IgG oxidized with tert-buthyl hydroperoxide (red line) and 
those of the “native” IgG (black line). It is apparent how only the Fc/2 shows a 
different chromatographic behavior in the two cases, Figure 4 top panel. 
Effectively, whereas Lc and Fd where not oxidized (as determined by MS1 
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analysis), Fc/2 presented one or two oxidations, with the doubly oxidized 
species being about four fold more abundant than the mono-oxidized species, 
Figure 4 middle panel. Note that in the control experiment, no oxidation was 
detected which proves that no artifact oxidation was induced by the IdeS 
sample preparation (data not shown). By a single 3 ms ETD LC-MS/MS run it 
was possible to determine the sites of oxidation, Figure 4 bottom panel. These 
are located at two methionine residues, namely Met16 and Met192, as 
schematically indicated on the right inset in Figure 4 bottom panel and further 
detailed in Figure S5, top panel, Supporting Information. A more extended 
sequence coverage was then obtained by averaging 300 transients (microscans) 
deriving from ETD experiments with duration of 3 ms and 300 other transients 
(microscans) from 5 ms ETD experiments, Figure S5, bottom panel, Supporting 
Information. These results can be compared to the higher-energy collision 
dissociation (HCD)35 MS/MS results reported in the literature for similar ~25 
kDa antibody subunits.36 In this study, the two oxidized forms of the Fc/2 were 
also detected by MS1. However, HCD MS/MS yielded 8 % sequence coverage of 
the Fc/2 subunits with only one distant b fragment (b48) assigning the 
oxidation at Met30 and nine distant y fragments assigning oxidation at Met206. 
Our results show that ETD fragmentation increased significantly sequence 
coverage to more than 30% in one run with 3 ms ETD to 47.1% when averaging 
~10 runs of 3 and 5 ms ETD. Note that these percentages are influenced by the 
contemporary analysis of the two forms of oxidized Fc/2. Cleavage sites 
adjacent to the oxidized methionines and other potential oxidation sites 
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(tryptophanes) are obtained giving more confident assignment to the oxidation 
sites.  
 
Middle-down analysis of IgG mixtures. As displayed in Figure 5, we applied the 
above described LC-MS method for the analysis of an equimolar mixture of 
monoclonal IgGs digested with IdeS. Adalimumab, Bevacizumab, and 
Trastuzumab were first pooled together and subjected to IdeS digestion, 
reduction and subsequent LC-MS analysis (with 15’000 resolution at m/z 400). 
This validation experiment was aimed at verifying the actual possibilities 
offered by reversed phase UPLC for the future analysis of either IgG mixtures of 
biological origin (e.g., polyclonal antibodies) or so-called therapeutic “IgG 
cocktails”. While Fc/2 fragments share a very high sequence homology (over 
90%) and are therefore not separated, most of the other fragments can be 
isolated. Two fragments, Lc of Bevacizumab and Fd of Trastuzumab are co-
eluting, but this does not impair the recording of high SNR broadband mass 
spectra for the two (Figure 5, left inset). Single charge state precursor ion 
isolation and sequencing with ETD MS/MS should thus be possible as 
indicated by the data presented here.  
 
Conclusions.  
To improve structural analysis of monoclonal antibodies, IgGs, we introduce a 
middle-down mass spectrometry approach consisting in quick (about 1 hour) 
IgG sample preparation protocol followed by 25 kDa polypeptide analysis with 
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reversed phase LC-based protein separation on-line coupled to high-resolution 
Orbitrap FTMS with ETD capability. The reported results show that the 
application of the described middle-down approach doubles the IgG sequence 
coverage previously obtained with top-down MS. The particular advantage of 
the approach described here consists in the limited sample preparation 
reducing potential artifacts introduction. The described method proved to be 
efficient in detecting and assigning IgG oxidation sites, which makes it a quick 
and easily implemented technique for mAbs’ oxidation assessment. Finally, we 
demonstrate that the 25 kDa molecular weight range of the IgG fragments 
under study should enable an efficient structural analysis of simple, up to 
three IgGs considered here, antibody mixtures. We envision application of the 
developed approach for structural analysis of more complex mAbs mixtures, as 
required by modern drug discovery strategies. 
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Figure caption 
 
Figure 1. Schematics of the proposed middle-down workflow. Sample 
preparation lasts one hour, and it is followed by LC-MS/MS and ProSight PC 
analysis. The presented scheme can be applied to single IgGs or mixtures.  
 
Figure 2. Total ion current chromatogram of IdeS-digested Adalimumab. The 
three subunits (from left to right: Fc/2, Lc, and Fd) are baseline resolved. 
Broadband Orbitrap FTMS mass spectra recorded with 15’000 resolution at 
m/z 400 show the charge state distributions of the three subunits, insets. 
Arrows indicate the center of the employed precursor ion isolation window for 
ETD MS/MS. The bottom left inset displays a baseline resolved single charge 
state of the Fc/2 subunit with G0F glycosylation, recorded by LC-MS with 
120’000 resolution at m/z 400. 
 
Figure 3. Fragmentation maps of IdeS digested Adalimumab after spectral SNR 
improvement by averaging of transients from different LC runs. Product ions 
assigned from different ETD datasets are represented according to the color 
legend. Both c- and z-type as well as y-type product ions were assigned. CDRs 
are highlighted in yellow, whereas the N-glycosylation site on the Fc/2 fragment 
is indicated in green. Right bottom inset shows summary of sequence coverage 
for the corresponding fragments of Adalimumab. 
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Figure 4. Middle-down MS-based analysis of IgG oxidation. Top panel: 
comparison between TIC chromatograms of control (black line) and oxidized 
(red line) Adalimumab. The oxidized Fc is eluting earlier than the non-modified 
counterpart. Middle panel: expanded view of broadband mass spectra showing 
the isotopically resolved Fc/2 subunit (mass spectra recorded with 120’000 
resolution at m/z 400). This panel, made by overlapping mass spectra of 
“control” and “oxidized” IgGs, illustrates the presence of both singly and doubly 
oxidized Fc/2 subunits. Bottom panel: 3 ms ETD Orbitrap FTMS mass 
spectrum (single LC run) of oxidized Fc (isolation window 120 Th). The left inset 
shows a product ion confirming the position of oxidized Met16. The right inset is 
a scheme of identified product ions, with the positions of oxidized Met indicated 
by arrows. 
 
Figure 5. TIC chromatogram of an equimolar mixture of IdeS cleaved 
monoclonal antibodies Adalimumab, Bevacizumab, and Trastuzumab. The inset 
shows the Orbitrap FTMS mass spectrum of co-eluting Lc of Bevacizumab and 
Fd of Trastuzumab.  
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Table S1. Sequence coverage for IdeS-derived fragments of Trastuzumab and 
Bevacizumab after spectral SNR improvement by averaging of transients from 
different LC runs. 
 
 
 
Table S2. Comparison between sequence coverage of IdeS-obtained fragments 
of Adalimumab reached in a single LC run for high and low HCD cell pressure 
difference ∆p. 
 
 
 
  
Fragment Trastuzumab Bevacizumab
Fc/2 59.80% 52.86%
Lc 58.21% 58.21%
Fd 44.53% 45.64%
Fragment High ∆p Low ∆p
Fc/2 30.47% 49.04%
Lc 28.63% 49.29%
Fd 15.89% 29.28%
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Figure S1. TIC chromatograms of IdeS-derived fragments of monoclonal IgGs 
Bevacizumab (top panel) and Trastuzumab (bottom panel). Fragments are 
generally baseline separated, with the exception of the Lc and Fd of 
Bevacizumab, which have close retention times even under UPLC conditions 
with the applied gradient. Nevertheless, the identification of the single 
fragments by MS1 and the isolation of selected precursor for tandem MS is not 
affected. 
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Figure S2. Fragmentation map of Trastuzumab. Color legend is used for 
distinguishing cleavage sites identified from a specific ETD duration. CDRs are 
highlighted in yellow. The results for Bevacizumab are comparable. 
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Figure S3. ETD Orbitrap FTMS mass spectra obtained in a single LC run for 
Fc/2 (top), Lc (middle), and Fd (bottom) of Adalimumab. Mass spectra averaged 
in the time-frames of the fragment elution were seven, seven, and five, 
respectively. As an example of the good SNR obtained, three product ions of 
Fc/2 are displayed in the top right inset. Most of product ions are highly 
charged and comprised in the m/z 800-1100 window. 
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Figure S4. Fragmentation maps obtained from single 3 ms ETD LC-MS/MS 
run of IdeS-derived fragments of Adalimumab. The left column shows results of 
a run performed under “standard” HCD cell pressure conditions (∆p=0.35E-10 
torr), whereas the right column presents the corresponding fragmentation map 
for an experiment performed using a lower HCD cell pressure (∆p=0.1E-10 torr). 
Product ions considered include c-, z-, and y-types. 
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Figure S5. Fragmentation map of Fc/2 of oxidized Adalimumab. Top, 
fragmentation map derived from a single 3 ms ETD LC-MS/MS run. Bottom, 
fragmentation map obtained from the averaging of transients from 10 LC-
MS/MS runs, equally divided into 3 ms ETD and 5 ms ETD LC-MS/MS runs. 
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7.1 Summary of results 
The experimental studies presented in this Thesis advance the mass spectrometry (MS)-based in-
depth structural investigation of polypeptides with sizes ranging from the peptide level to intact 
proteins, reaching an apex in the analysis of intact ~150 kDa IgGs. Indispensable analytical 
characteristics for all the here reported studies are high mass resolution and mass accuracy, as 
well as efficient biomolecular ion activation and dissociation. Particular attention is paid to 
development and optimization of biomolecular sample preparation and separation techniques, as 
well as methods of data analysis. 
The importance of the analytical characteristics for biomolecular MS is first demonstrated by 
studies involving peptides, specifically the neuropeptide substance P and IgG-derived tryptic 
glycopeptides. In the former case, deamidation and transamidation of substance P by the enzyme 
tissue transglutaminase (tTGase) were found to be competitive processes as revealed by electron 
capture dissociation (ECD) FT-ICR MS (paper I). Interestingly, the employed LC-MS/MS setup 
allowed not only the differentiation between non-deamidated peptides and the singly or doubly 
deamidated counterparts, but also to define the precise order according to which the two 
glutamine residues present in substance P are sequentially converted into glutamic acid by the 
catalytic activity of the enzyme. The difference in reactivity of the two glutamines as tTGase 
substrates was further confirmed by the analysis of transamidation: substance P dimers with 
different deamidation degrees, fragmented by ECD without rupture of the newly formed amide 
bond, were found to be originated only from one of the two glutamines, the same which showed 
higher propensity to deamidation. 
Glycopeptides derived from tryptic digestion of a transiently expressed IgG were on the contrary 
identified on the base of MS1 thanks to high mass accuracy offered by Fourier transform MS and 
the important observation at the base of glycopeptide databases which consider only biologically 
relevant forms of oligosaccharides for a selected organism (paper II). This elegant methodology 
was considered, nevertheless, as only one part of the necessary glycan characterization for 
establishing the batch-to-batch consistence of IgG transient expression. Additional data, which 
can be considered as a prelude of  the remaining study described in this Thesis, included intact 
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mass measurements of IgGs by high resolution qTOF MS, and were applied for a qualitative 
definition of major glycoforms (i.e., combinations of two N-linked glycans to the IgG sequence) 
in the different IgG batches. 
From there, efforts have been focused on the developments of methodologies for targeted top-
down structural analysis of large intact proteins, particularly monoclonal IgGs, by electron 
transfer dissociation (ETD) MS. A detailed assessment was performed for the fragmentation of 
~79 kDa serotransferrin, which was analyzed in both oxidized and reduced forms, both resulting 
in ~10% sequence coverage with complementary fragmentation patterns in ETD qTOF MS 
experiments (paper III). These data elucidated the relevance of disulfide bridges in maintaining 
the protein in a conformation not easily fragmented in the gas phase, with most of the fragments 
derived from disulfide-free regions. At the same time, what had been previously reported for 
peptides, which is that radical-driven ion dissociation methods can cleave disulfide bonds, was 
also confirmed for ETD of transferrin, with a few product ions derived from disulfide-protected 
regions. Moreover, results also show the potential of high resolution TOF mass analyzers for 
ETD-based top-down MS. 
Papers IV, V, and VI were entirely dedicated to the top-down analysis of IgGs by ETD MS, 
employing both TOF and Orbitrap mass analyzers. Although a precise comparison of the 
performances of which different MS platforms were capable is impossible due to the 
heterogeneity of samples analyzed, both hybrid qTOF and LTQ-Orbitrap mass spectrometers 
allowed reaching  protein sequence coverage not only higher than that previously reported for 
single antibody chains fragmented via CID, but also more extended relative to that of the largest 
protein previously analyzed in intact form by ECD, the 142 kDa cardiac myosin binding protein 
C. Specifically, ~21% sequence coverage was reached for a murine IgG1 on the qTOF instrument 
(paper IV), whereas ~32% was obtained in a more extensive study for a human IgG1 by Orbitrap 
FTMS (paper V), which also allowed the identification of  pyroglutamic acid at the N-terminus of 
the IgG heavy chain. Dedicated strategies were also developed and applied for improving the 
signal-to-noise ratio of tandem mass spectra. Besides further confirming the ETD capabilities of 
cleaving disulfide bridges and, as proven in paper V, generating a relatively high number of y-
ions also during the fragmentation of large proteins, these two research projects highlighted that 
the multi-domain nature of IgGs or, more specifically, of their heavy and light chains reverberate 
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on the observed fragmentation pattern, which alternates high sequencing of disulfide-free areas 
and poor fragmentation of disulfide protected regions. Effectively, immunoglobulin domains, 
whose structure resembles that of beta barrels, have a compact conformation in solution which is 
potentially retained even in the gas phase due to the presence of an inter-molecular disulfide 
bridge. This hypothesis found new support in the results described in paper VI. The comparison 
of fragmentation patterns of IgGs belonging to the same subclass (IgG1) obtained on the same 
platform and under the same experimental conditions strongly suggested that a recurring 
fragmentation pattern and comparable total sequence coverage between the IgGs were 
consequence of a similar gas phase conformation: in fact, areas highly fragmented in both IgGs 
are the same and belong to the so-called complementarity determining regions, which differ from 
an antibody to the other, whereas among the non-sequenced regions we found wide areas with 
complete sequence homology. 
In addition to this, results of paper VI were also analyzed considering the product ion 
abundances. PIA analysis not only aided explaining the differences observable in ETD mass 
spectra recorded applying different ion-ion interaction times, but also reinforced the idea that, 
independently from the ETD parameters in use, ETD is effective only on loops interconnecting 
consecutive immunoglobulin domains. Finally, fragmentation of a monoclonal IgG2 served the 
purpose of elucidating the role of inter-molecular disulfide bridges in IgG fragmentation. From 
the analytical chemistry point of view, though, the most relevant achievements reported in the 
paper are the fine tuning of ETD and, particularly, ion transmission parameters, and the 
introduction for the top-down analysis of large proteins of an hybrid, two-stage fragmentation 
technique combining ETD and HCD, EThcD. 
Middle-down MS could represent one of the ways for overcoming the limit set to ~30% of 
sequence coverage in the case of the analysis of intact IgGs, and possibly obtaining sequence 
confirmation for all the CDR regions (paper VII). The developed middle-down method was based 
on a rapid, robust protocol centered on the bacterial enzyme IdeS, whose proteolytic products 
were analyzed by ETD MS/MS. This approach was demonstrated capable of yielding almost 50% 
sequence coverage in a single LC-MS/MS run on a recent generation LTQ-Orbitrap instrument 
(Orbitrap Elite FTMS). Importantly, this method, being based on the analysis of large IgG 
fragments of ~25 kDa each, took advantage of all the advances developed and successfully 
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employed for TD MS (time-domain (transient) signal averaging for increasing SNR, optimization 
of ion transmission by reduction of the gas pressure in the HCD cell and HCD trapping). The size 
of the analyzed fragments resulted is also compatible with the identification and localization of 
PTMs, specifically of methionine oxidation. 
 
7.2 Concluding remarks and future perspectives 
Without the presumptuous idea of following Hegel’s statement “contradictio est regula veri, non 
contradictio falsi”, on which his Dialectic is grounded, my personal opinion is that, nevertheless, 
relevant achievements contained in this work (and, in general, in a research that intends to 
propose or improve analytical methods) arise not only from positive experimental results but 
also, if not primarily, by the identification of limitations in the currently available techniques for 
top-down mass spectrometry. 
Among the former, the most important is surely represented by the record value of ~32% 
sequence coverage reached for an intact IgG1 by ETD Orbitrap FTMS (paper V). Disclosing the 
possibility of exploiting the theoretical advantages of TD MS over the other alternative 
approaches (e.g., MD MS and BU MS) in the analysis of therapeutic antibodies by finely tuning 
instrumental parameters will probably be beneficial in the close future for the biotechnology 
industry, where this technology will contribute in elevating quality control standards.  
Furthermore, beyond the high sequence coverage achieved by MD and TD MS, it is important to 
recall that deamidation of Asn and Gln as well as iso-Asp formation are PTMs commonly found 
in antibodies. Their relevance is due to the fact that their presence in the CDRs can modify the 
three-dimensional structure of the antigen binding site, thus impairing the biological activity of 
the antibody. For instance, about one fourth of therapeutic IgG Trastuzumab administered to 
patients is known to present an isomerized Asp on a CDR that completely prevents the antigen 
binding.[111, 112] On the other hand, in the pharmaceutical and biotechnological industry the 
interest around antibody-drug conjugates (ADCs) is rapidly increasing.[113] Several types of 
chemical reactions have been used so far to covalently bind small organic molecules to 
immunoglobulins, and potentially the bonds connecting amino acid side chains with drugs can be 
cleaved by vibrational-based ion activation. Altogether, therefore, results achieved with radical-
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driven tandem mass spectrometry even at the peptide level might disclose new opportunity for 
the future of fine antibody and ADC analysis. 
On the other hand, the challenging analysis of a high molecular weight, multichain protein 
imposed the optimization of specific settings for all the required experimental steps, namely: 
precursor ion charge state selection for efficient electron transfer dissociation, product ion 
transfer to the high resolution mass analyzer, and averaging of multiple mass spectra or time-
domain transient signals for SNR improvement. Therefore, the results presented in this Thesis, 
although based on targeted studies, can be interpreted in a wider horizon, as they open the 
possibility to concretely undertake the study of any large, multichain proteins in a top-down 
fashion. Pushing the upper limit of the molecular weight of proteins to analyze them in their 
intact forms is of fundamental importance in the perspective of challenging initiatives as the 
cellular-based Human Proteome Project, which aims at the definition of cellular types on the base 
of their respective proteomes conceived as peculiar pools of specific proteoforms, and therefore 
is indissolubly linked to TD proteomics.[114] It is noteworthy, however, that the use of 
proteolytic enzyme has been part of research studies presented in this Thesis, as the current 
contribution of proteolysis-based MS analysis of proteins is still fundamental and will most likely 
continue to complement for a very long time TD MS in the future. 
With regard to the limitations emerged during top-down MS of IgGs, the most apparent one is 
surely the divisions of both light and heavy chains in areas that are almost fully sequenced and 
others which are essentially not affected by fragmentation. Beyond this phenomenological 
description, a deeper reconsideration of obtained data was achieved by combining results of 
product ion abundance analysis and structural information derived from biophysical techniques. 
As a conclusion we formulated the plausible hypothesis that the retention of a compact, partially 
folded conformation in the gas phase is hindering the protein fragmentation efficiency. Waiting 
for the verification of this hypothesis by other MS-based techniques such as ion mobility MS, 
some facts already manifest, such as the characteristic of disulfide bonds of reducing drastically 
the sequence coverage, despite the capability of ETD of cleaving them and the possibility of 
applying strategies for improving spectral SNR. Understanding the reasons for the limited 
sequence coverage will surely facilitate the design of new ion fragmentation techniques. One 
attempt we already finalized consisted in exploiting the hybrid design of one of our mass 
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spectrometers to combine two different activation techniques, namely ETD and HCD, to gain 
new product ions and facilitate the separation of undissociated complexes. In addition to that, 
beneficial results might derive from pre-activation of ions via IR photons or collisions with 
neutral molecules, which are established methods for unfolding peptides and proteins before ECD 
and ETD fragmentation, that have not been applied yet to IgGs. Similarly, a new radical-driven 
ion activation method, 193 nm ultraviolet photodissociation, has demonstrated protein 
sequencing capabilities even superior to ETD, but so far it has not been applied to disulfide bond-
rich proteins like IgGs. A new possible solution might derive from a combination of 
photodissociation and hybrid design for MS2: Fung et al.[115] demonstrated that 157 nm photons 
can easily cleave disulfide bridges without relevant charge reduction of precursor cations, and 
hence an application of a 157 nm laser in combination with ECD or ETD could be envisioned. 
Finally, in parallel with instrumentation and method development, an improvement for the tools 
dedicated to the analysis of top-down MS data of large proteins is required. In tandem MS, the 
number of available fragmentation channels increases rapidly with the length of the polypeptidic 
chain. In the case of large protein, some of these channels lead to the formation of non-canonical 
fragments, such as internal fragments or, in ECD and ETD, product ions with atypical number of 
hydrogens (e.g., the so called “z·+n” ions). Therefore, given that current versions of software for 
top-down MS analysis do exclusively consider canonical product ion pairs (e.g., b- and y-type or 
c- and z-type), the actual risk in the analysis of high molecular weight protein is not only that 
good part of the information obtainable from tandem mass spectra remains unused, but, 
paradoxically, that increasing the number of product ions which are detected but not identified 
might result in lowering the identification scores. 
Effectively, as described in particular in papers III and V, specific data analysis strategies must be 
applied to the analysis of ETD TD MS mass spectra, especially for large proteins containing 
multiple disulfide bonds. The data collected for the here described research studies surely 
contributed to the understanding of the possibilities currently offered by available algorithms for 
TD data treatment. 
Besides the analytical aspects to be improved, however, it is reasonable to consider the methods 
for targeted studies as mature and sophisticated enough for being applied to large-scale 
investigations, i.e., proteomic studies, potentially with a focus on drug discovery. We envision 
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the use of a combination of middle-down and top-down MS, performed in different variants (e.g., 
from accurate mass measurement to sequence confirmation by MS2), to determine the presence in 
the serum of immunogenized animals of IgGs active against a specific antigen. Genetic 
information will provide a large pool of candidate IgGs, and MS-based analysis will be carried 
out to verify their actual presence.  
This project resembles a typical proteomic survey, with a database, in this case limited to IgGs, 
which is searched for finally achieving protein identification. Compared to what already 
performed, this study will be likely based primarily on the analysis of ~100 kDa F(ab’)2 
fragments, as they maintain the variable regions of light and heavy chains which are responsible 
for IgG diversification and, conversely, lack of the Fc region which is highly conserved and is a 
source of additional sample heterogeneity (i.e., it is N-glycosylated). My personal hope is that 
this will be just the first one of a series of large-scale biological applications involving large, >50 
kDa, proteins to be performed by top-down mass spectrometry. 
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